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Abbreviations and Conventions
The following abbreviations are used throughout the text
Ax) Absorbance at x nm
aa-dUTP aminoallyl-dUTP
aRNA amplified RNA
ATP Adenosine triphophate
AVE Anterior visceral endoderm
bp Base pairs
BSA Bovine serum albumin
cDNA Complementary DNA
CTP Cytosine triphosphate
dATP Deoxy-Adenosine-T riphosphate
dCTP Deoxy-Cy tidine-T riphosphate
dGTP Deoxy-Guanosine-T riphosphate
DNA Deoxyribonucleic acid
dNTP Deoxyribonucleotide
d.p.c. days post coitum
DTT dithiothreitol
dTTP Deoxy-Thymine-T riphosphate
dUTP Deoxy-Uricil-T ri-Phosphate
EC Embryonal carcinoma (cells)
EDG equivalent day of gestation
EEct Embryonic ectoderm
EPL Early primitive ectoderm like (cells)
ES Embryonic stem (cells)
EST Expressed sequence tag
ExE Extraembryonic ectoderm
FBS Foetal bovine serum
GTP Guanosine triphophate
h.p.c. hours post coitum
HRP Horse radish peroxidase
ICM Inner cell mass
IVT In vitro transcription
kb Kilo bases
lbs pounds
LIF Leukaemia inhibitory factor
M Molar concentration
mol mole
mRNA Messenger RNA
N Normal
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Abbreviations and Conventions
NBS Newborn bovine serum
NTP Ribonucleotide
pc Post Coitum
PCR Polymerase chain reaction
PGC Primordial germ cells
pmt Photo multiplier tube
RNA Ribonucleic acid
RNase Enzyme which degrades RNA
RT-PCR Reverse transcription polymerase chain 
reaction
Sq.in. Square inch
TE Trophectoderm
TS Trophectoderm stem cells
UTP Uracil triphophate
VE Visceral endoderm
U Units of activity
v/v volume by volume
w/v weight by volume
6 Extinction coefficient
<D Quantum yield
Throughout this thesis, microarraying definitions are as established by Duggan et a i , 
1999. The DNA present on the spot is referred to as the “probe”, and the labelled 
cDNA used to hybridise to the microarray as the “target”.
The term “totipotent” is used to describe a cell from which the whole conceptus can 
be derived. “Pluripotent” applies to cells which can contribute to many different 
tissues in a whole animal when supported by other cells or can differentiate to cells 
from multiple lineages (Solter, 2006).
In many publications the abbreviation aRNA is used interchangeably for amplified 
and antisense since in most cases it is both. In this thesis amplified RNA can be in the 
sense orientation so this abbreviation has not been used to denote amplified RNA.
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Summary
Summary
Embryonic stem cells (ES cells) are derived by explantation of the embryonic portion 
of the pre-implantation embryo into culture. These cells have unique properties which 
have made them invaluable in study of the function of genes in vivo and of cell 
differentiation in vitro. They can be grown in culture for extended periods of time in 
an undifferentiated state and induced to differentiate in vitro. While undifferentiated 
they can be genetically manipulated. Subsequent reintroduction of these cells into the 
blastocyst results in the cells being integrated and contributing to all the cells of the 
animal including the germ line thus leading to designed genetic change.
The homology of these cells, however, to their tissue of origin is not unambiguous. 
The primary aim of this thesis was to apply global transcriptome analysis to 
investigate the homology of ES cells to the pluripotent compartment of the embryo.
Although ES cells can be grown in bulk, the tissue of origin, the embryonic portion of 
the peri-implantation embryo are small and inaccessible. It was therefore necessary to 
develop methods which would allow the transcriptome to be amplified without 
distorting the transcript profile. A linear amplification method proved to give the best 
result. The best method for fluorescently labelling the cDNA was shown to be 
enzymatic incorporation of aminoallyl dUTP followed by coupling to monoreactive 
Cy dyes. With these tools it was then possible to amplify the transcriptome of both 
colonies of ES cells and the embryonic portion of various peri-implantation embryos 
and apply the labelled cDNA to microarray slides. Statistical analysis of the results 
proved that the transcriptome of ES cells most resembles that of the embryonic 
ectoderm on day 5.5 of development.
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1. Introduction
Embryonic stem cells (ES cells) are pluripotent cells isolated into culture from the 
pluripotent compartment of pre-implantation stage embryos (Evans and Kaufman, 
1981; Martin, 1981). Under suitable conditions, they are capable of indefinite growth 
in culture in an undifferentiated state. They can be induced to differentiate in vitro and 
most importantly, when reintroduced into the embryonic environment of the 
blastocyst, will reintegrate into the embryo contributing to all tissues of the resulting 
adult mouse including the germ line. Because these cells can be grown in an 
undifferentiated condition, we can manipulate their genetic constitution (Thomas and 
Capecchi, 1987). On reintroduction to a blastocyst, lines of mice with precise genetic 
changes can be produced.
In the 25 years since murine embryonic stem cells were first isolated, a large 
technological base has evolved which exploits these unique features. Despite this, 
there is very little known about the origin of ES cells and their relationship to 
pluripotent stem cells in vivo. The need to fill this knowledge gap has become more 
pressing with the isolation of human cell lines that share some properties of the mouse 
cells.
The recent advent of microarray technology (Schena et al., 1995) and RNA 
amplification (Van Gelder et al., 1990) allows us to compare gene expression profiles 
of thousands of genes from small samples of cells and tissue fragments. Similarities 
and differences in gene expression between samples will allow us to provide a 
molecular phenotype: a “fingerprint” which should allow assignment of identity of 
samples and reveal relationships between them.
11
Chapter 1: Introduction
1.1 Origins and Properties of ES Cells.
1.1.1 Teratocarcinomas.
The successful derivation and culture of ES cells rests firmly on the work carried out 
with teratocarcinomas and their derivative cell lines. Teratocarcinomas are malignant 
tumours most commonly found in the gonads. These tumours are composed of both 
malignant undifferentiated cells and a wide range of non-malignant differentiated 
tissues. Male mice of the 129 strain and female mice of the LT strain have a higher 
incidence of such tumours. In the case of 129 male mice the tumours were believed to 
be of germ cell origin. Confirmation of the germ cells ability to produce such tumours 
was provided by experiments where genital ridges from embryos on day 11.5 -12.5 of 
gestation were transplanted to the adult testis (Stevens, 1964). Homozygous embryos 
of mice carrying the S1J or S1D alleles of the steel gene are nearly devoid of primordial 
germ cells (Bennett, 1956). Stevens (1967) backcrossed these alleles on to the 129/Sv 
background, took genital ridges from homozygous mutant embryos on day 12 of 
gestation and grafted them into the testis capsule of normal 129/Sv mice. The mutant 
embryos did not develop teratocarcinomas while the heterozygous littermates did. By 
using a recombinant inbred line between C57B16J and the LT/Sv strain female mice 
which developed ovarian teratomas at a high rate and were heterozygous for the 
electrophoretic marker Gpi-1 (G pi-la/G pi-lb); Eppig et al (1977) showed that the 
tumours arose from parthenogenetically activated oocytes initiating development in 
the ovary.
It was further demonstrated that the transplantation to ectopic sites of pre­
implantation embryos up to the 8-cell stage resulted in teratocarcinomas (Stevens,
1968). Grafts of post-implantation embryos up to day 8 of gestation before
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gastrulation is completed, also gave rise to teratocarcinomas. When post-gastrulation 
stage embryos were transplanted no teratocarcinomas were found (Solter et al., 1970; 
Stevens, 1968; Stevens, 1970). Transplantation of the isolated tissues from embryos 
on day 6 of gestation demonstrated that only embryonic ectoderm gave rise to 
teratocarcinomas. Extra embryonic ectoderm only resulted in invasive giant 
trophoblast tumours and endoderm did not develop (Diwan and Stevens, 1976).
Evans (1972) showed that the undifferentiated component of spontaneously occurring 
teratocarcinomas could be expanded in vitro. Single cells from these cultures could be 
expanded clonally (Martin and Evans, 1974). Furthermore, these lines of embryonal 
carcinoma (EC) cells could be differentiated in vitro as embryoid bodies (Adams et 
al., 1991). Further, lines of clonal origin could both be expanded and differentiated 
producing cell types from all three primary germ layers: ectoderm, mesoderm and 
endoderm demonstrating the pluripotent nature of these cells (Martin and Evans, 
1975b). Brinster (1974) produced the first evidence that EC cells taken from 
embryoid bodies grown in vivo were able to contribute to the development of a 
chimaera when introduced into the blastocyst of a host embryo. Illmensee and Mintz 
(1976) reported extensive chimaerism including germ line from similar experiments. 
However, because these cells are derived by passing through an in vivo phase as a 
tumour in an ectopic site, and are subjected to the pressures of this abnormal 
environment, they are typically aneuploid. The ascites tumour cell line used by 
Illmensee and Mintz -  OTT 6050 -  does not contain a Y chromosome and their 
reported results are unrepeatable and considered unreliable. In later experiments EC 
cells were derived from a karyotypically normal tumour which had underwent 
relatively few subdivisions thus maintaining the normal karyotype before injection 
into blastocysts. These cells can contribute to the germ line of a chimera (Stewart and
13
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Mintz, 1981). EC cells from in vitro cultured cell lines were shown to be able to 
contribute to extensive chimaerism but these mice often develop early 
teratocarcinomas or late tumours of differentiated cell type derived from the tissue 
culture cells (Papaioannou et al., 1975).
Further evidence that these cells were a paradigm for the undifferentiated cells of the 
early embryo was provided by studies on markers expressed by both cells of the 
embryo and EC cells. Alkaline phosphatase is expressed by the inner cell mass (ICM) 
and EC cells (Jacob, 1978). An anti-F9 cell antibody (Artzt et al., 1973) was made by 
injecting F9, an EC line originating from a 129 strain mouse, into a 129 mouse. This 
antibody reacted with the cell surface of EC cells and with the ICM of the blastocyst. 
The advent of monoclonal antibodies led to the production of the antibody to Stage 
Specific Embryonic Antigen-1 (SSEA1). This monoclonal antibody was made by 
inoculation of mice with F9 cells before fusing the lymphocytes from the spleens to a 
myeloma cell line. The antibody reacts to an antigen present on the cell surface of the 
morula stage embryo, the ICM of the blastocyst and the undifferentiated component 
of teratocarcinomas and EC cell lines (Solter and Knowles, 1978). Gooi et al (1981) 
showed the carbohydrate nature of the antigen to which SSEA1 and other monoclonal 
antibodies raised in a similar way react. All these observations reinforced the belief 
that undifferentiated cell lines could be derived directly from an embryo without the 
intermediate stage of tumour formation (Evans, 1981). ES cells are derived by 
explanting into culture the embryonic portion of the pre-implantation embryo.
However their homology to the pluripotent compartment of the embryo is not clear. 
Dewey et al (1978), using 2-d electrophoresis, carried out comparisons of pluripotent 
EC cells with pre-implantation embryos and detected both similarities and
14
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dissimilarities to all stages examined. Martin et al (1978) also utilised 2-d 
electrophoresis to compare the proteome of EC cells with isolated ICMs and 
embryonic ectoderm and not only showed an overall homology of EC cells to the 
embryonic ectoderm but also showed the presence of a single protein uniquely held in 
common between this peri-implantation stage and EC cells suggesting identity with 
this stage. In a more detailed analysis Lovell-Badge et al (1980) showed substantial 
differences between EC cells and the ICM using 2-d protein electrophoresis. In this 
study the EC line OTT5568 S PCMB was grown in monolayer without feeders and 
differentiated as embryoid bodies. The undifferentiated cells and embryoid bodies at 
various times post formation were run on 2d-gels. Cells from the nullipotent EC line, 
Nulli SCC1 (Martin and Evans, 1975a), the endodermal line PSA5-E and STO, the 
feeders used to routinely maintain the OTT5568 S PCMB cells were also analysed. 
Isolated ICM from early blastocysts at about 86hpc, were also analysed. Comparison 
of EC cells, ICMs and STO cells showed a degree of dissimilarity between EC cells 
and the ICM comparable to the dissimilarity between EC cells and STOs. When the 
gels from the ICMs were examined for the presence of spots which varied over the 
time course of embryoid body differentiation, they appeared to have more spots in 
common with embryoid bodies 6-12 hours after initiation.
It was shown that the Forsmann antigen was expressed by the ICM from both early 
and late blastocysts (Willison and Stem, 1978) using immunofluorescence. Further to 
this work Stinnakre (1981) showed that although Forsmann antigen was expressed by 
the early post-implantation epiblast, as the epiblast developed further to form the 
embryonic ectoderm, expression of the Forsmann antigen became restricted to the 
endoderm. These observations taken together have suggested a homology of EC cells 
with the epiblast of the late peri-implantation embryo rather than the early ICM or the
15
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embryonic ectoderm. However, the work of Gardner (1985) has shown by injecting 
isolated ICM and epiblast that over the peri-implantation period the ability to 
contribute to chimaeras drops dramatically giving half the chimaerism rates with 
epiblast from day 5 of gestation embryos than from preimplantation stage ICMs and 
no chimaeras have been reported from injection of ectoderm cells from day 6.5 days 
post coitum (d.p.c.) into blastocysts. Furthermore, Wells et al (1991) demonstrated 
that over this time period, the rate of derivation of ES lines dropped from 13.2% for 
3.5-d.p.c embryos to 2.5% for epiblast from embryos 5.5-d.p.c.
The belief that the equivalent of EC cells could be derived directly from the embryo 
without a period as a tumour was converted to reality with the landmark work of 
Evans and Kaufman (1981). EC cell lines were used to optimise culture conditions 
which allowed ES cells to be derived. An important observation arising from the 
initial maintenance of pluripotentiality in vitro (Evans, 1972) was that in most cases 
EC cells grew poorly except in mixed cultures with their differentiated derivatives. 
This led to the use of mitotically inactivated fibroblasts as feeders (Martin and Evans, 
1974).
1.1.2 Pluripotent Tissues in the Embryo.
The totipotent fertilised egg undergoes a series of cleavage divisions. These are
characterised by the cells becoming successively smaller with each round of cell
division and little change in the size of the embryo until expansion of the blastocyst
cavity. It has been revealed that over the preimplantation period the embryo switches
from maternal mRNA stored in the oocyte to zygotic mRNA transcribed de novo from
the genome in three waves (Hamatani et a l, 2004a); a minor wave on fertilisation
followed by two waves, the major-ZGA (zygote gene activation) the at 2-4 cell stage
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and mid-preimplantation gene activation (MGA) that peaks at 8 cell stage and is 
complete by transition of the morula to blastocyst.
After the 3rd cleavage division, the eight cell stage, a process of flattening and cell 
polarisation called compaction begins (Pratt et a l , 1982). The 4th cleavage divisions 
can be either conservative resulting in the production of two polar cells or 
differentiative resulting in one polar cell and one non polar (Johnson and Ziomek, 
1981; Sutherland et al., 1990). Thus a morula, made up of two cells types which on 
the basis of position and morphology can be distinguished, is formed. The cells with 
an outside position are polarised with a smooth surface and a villus surface 
preparatory to forming an epithelium, the trophectoderm (TE). Those with an internal 
position have no villus cap. Although predictions can be made about the cellular fate 
of these cells in the undisturbed embryo, experimental manipulation has shown the 
considerable capacity of the embryo for regulation.
As the term totipotent is usually reserved for the ability to generate the whole 
conceptus, cells of the four and eight cell stage will be described as pluripotent since 
an individual cell cannot develop to form a complete conceptus (Solter, 2006). 
However, single cells at the eight cell morula stage have been shown to retain their 
pluripotent properties by aggregation of single cells with blastomeres expressing 
electrophoretically distinct markers and implantation into pseudopregnant foster 
mothers. Analysis of the post implantation conceptus shows cells contribute to all 
tissues including the extraembryonic membranes which are only derived from the 
trophectoderm (Kelly, 1977). More recently, triplets have been generated by 
aggregation of single eight cell blastomeres with electrophoretically distinct tetraploid 
blastomeres (Tarkowski et a l,  2005). So far it has not been possible to produce a
17
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conceptus with less than two aggregated blastomeres from 16-cell stage embryos, 
however aggregates made up of either 16 internal apolar blastomeres from 16-cell 
stage embryos, or from 16 outer polar blastomeres will develop to term (Ziomek et 
al., 1982).
The first differentiation event in the pre-implantation embryo is the formation of the 
trophectoderm (TE) from the outer polar cells of the morula. Blastulation begins 
towards the end of the 5th cleavage division (Smith and McLaren, 1977). After 
implantation the TE, which expresses FGFR2 (fibroblast growth factor receptor 2), 
overlying the ICM proliferates in response to FGF4 (fibroblast growth factor 4) which 
is produced by the epiblast (Rossant and Cross, 2001). This polar TE grows into a 
column of extraembryonic ectoderm (ExEct) which pushes down into the blastocoel 
cavity with the epiblast at its distal end. The mural TE is restricted to the outer surface 
of Reichert’s membrane while the ICM differentiates further to produce a layer of 
primitive endoderm on its blastocoelic surface. This primitive endoderm migrates 
round the inner surface of the trophectoderm to form the parietal endoderm (that 
manufactures the extracellular matrix which makes up the Reichert’s membrane) 
while the endoderm which remains in contact with the ICM becomes the visceral 
endoderm (VE). Over this peri-implantation period the ICM is proliferating and is 
often at this stage referred to as the epiblast. Experiments with immunosurgically 
isolated ICM from early cavitating blastocysts show that at this early stage the ICM 
retains the ability to form trophectoderm (Handyside, 1978) but this property is lost 
and by the late preimplantation stage isolated ICMs only differentiate endoderm.
Apoptotic signals from the VE and survival signals from the basement membrane 
trigger the epiblast to form a pro-amniotic cavity and to transform into a pseudo­
18
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stratified epithelium; the embryonic ectoderm (EEct)(Coucouvanis and Martin, 1995). 
The distal VE at this time thickens and some genes become expressed in a regional 
manner (Pfister et al., 2007). Labelling of individual cells of the epiblast with HRP 
(Lawson et al., 1991) showed that pluripotency was maintained and the labelled cells 
contributed to all three germ layers of the mid-streak embryo. Movement of the distal 
visceral endoderm (DVE) cells to form an anterior signalling centre, the AVE, is 
believed to be the symmetry breaking event which determines the anterior end of the 
embryo (Beddington and Robertson, 1998; Thomas et al., 1998).
The process of embryogenesis is controlled by complex networks of growth factors 
and cytokines. The delineation of the TE requires expression of Cdx-2 (caudal type 
homeo box 2) (Strumpf et al., 2005) during compaction and eomes (eomesodermin) 
expression is required to transform TE to trophoblast (Russ et al., 2000). The ICM 
expresses Pou5fl (pou domain, class 5, transcription factor 1), sox2 (SRY-box 
containing gene 2) and nanog (Nanog homeobox) (Avilion et al., 2003; Chambers et 
al., 2003; Mitsui et al., 2003; Nichols et al., 1998; Niwa et al., 2000). Gradients of 
ligands for the BMP, WNT and NODAL pathways are established from the junction 
of the EEct and ExEct i.e. the proximal EEct and distal ExEct, ligands appear to be 
widely expressed throughout the EEct and VE while signals from the DVE endoderm 
cells normally antagonize signals received by the proximal epiblast and thus act to 
maintain anterior identity (Beddington and Robertson, 1999) Nodal antagonists such 
as Lefty 1 and Cerl are expressed in the DVE (Brennan et al., 2001). The nodal 
gradient becomes restricted to the posterior of the embryo where the primitive streak 
will initiate. Embryos that lacks nodal fail to gastrulate and are deficient in mesoderm 
(Conlon et al., 1994; Zhou et al., 1993).
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1.1.3 Derivation of ES Cells from the Pluripotent Compartment of the 
Embryo
ES cells are directly isolated into culture without transformation or immortalisation 
and can be maintained for many generations without change to the karyotype. They 
are morphologically indistinguishable from EC cells and furthermore, express SSEA- 
1 and alkaline phosphatase. They also differentiate via embryoid bodies. Most 
importantly, on injection into a blastocyst, they give chimaeras at a high rate and only 
rarely give rise to teratocarcinomas. Furthermore, the cells are integrated into the 
gametes and are transmitted to subsequent generations.
The first ES lines were isolated by plating out whole blastocysts from 129SvE mice 
which had undergone a period of diapause (Evans and Kaufman, 1981). Embryonic 
diapause is an adaptation which allows blastocysts to survive for several weeks 
without implantation while the mother has a suckling litter. When the litter is weaned 
the blastocysts implant and development proceeds to term. The state of delay can be 
experimentally induced by removing the source of oestrogen and providing 
exogenous progesterone. After the blastocysts had attached to the culture surface and 
outgrown for a few days, the clump of embryonic cells was picked, dissociated with 
trypsin and plated on to mitotically inactivated feeder cells. Blastocysts which have 
undergone a period of delay of implantation appear to give an improved rate of 
forming ES lines although it is not a requirement. Lines can also be derived from 
ICM’s which have been isolated by immunosurgery (Martin, 1981; Solter and 
Knowles, 1975).
The success rate in isolating ES lines appears to have a strong genetic component with
the most efficient strain being 129 which yields lines at up to 30% (Robertson,
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1987).The other commonly used strains which have given rise to ES lines, C57 Bl/6 
and BALB/C, yield lines at much lower rates. Mice of the strain CBA have been 
considered non-permissive for ES line derivation, although this has been shown not to 
be the case (Brook and Gardner, 1997). Interestingly, formation of EC is much less 
affected by genetic composition (Damjanov et al., 1983). This has led to various 
strategies to enhance the rate of success. Only two factors so far convincingly 
improve success rates. Delay of implantation clearly plays a role in the successful 
derivation of ES lines. Although this was believed to be due to a larger number of 
cells in the ICM the increase is marginal. Copp (1982) showed that the ICM of 
delayed blastocysts on both the equivalent day of gestation (EDG) 5 and 10 contained 
approximately 29 cells and the ICM of non delayed blastocysts 4days and 17h post 
coitum contained, shortly before implantation, about 43 cells. Nichols et al 2001 
showed that delayed ICMs on EDG-6.5 and 8.5 had approximately 32 and 42 cells 
respectively and are not significantly different from each other.
The inner cell mass of the late blastocyst stage has a layer of primitive endoderm on 
the blastocoelic surface. When ICMs are isolated by immunosurgery, this layer grows 
in culture to surround the whole ICM. The primitive endoderm produces a layer of 
basement membrane which is involved in the conversion of the epiblast to a pseudo 
columnar epithelium and also produces a signal leading to the apoptotic events which 
result in the formation of the pro-amniotic cavity (Coucouvanis and Martin, 1995). 
This event has been generally held as poor prognostically when isolating ES lines 
(Robertson, 1987). It has been suggested that denuding the ICM of endoderm removes 
signals which promote differentiation (Handyside et al., 1989). Furthermore Brook 
and Gardner (1997) demonstrated that microsurgical removal of both the
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trophectoderm and endoderm from delayed blastocysts facilitates the isolation of ES 
lines including non-permissive strains such as CBA/Ca.
The earliest stage at which ES cell lines have been established is from 8-cell 
compacted morula (Tesar, 2005). The latest reported stage at which ES lines have 
been derived is the epiblast of day 5.5 hatched, post-implantation egg cylinder stage 
embryo (Wells et al., 1991).
1.1.4 Extrinsic Factors and the Maintenance of Pluripotency in ES cells.
Several cytokines have been shown to have relevance in the maintenance of ES cells 
in vitro. However their role in maintenance of the pluripotent compartment in vivo is 
less clear. LIF, BMPs, WNTs and FGFs have all been demonstrated to play a role in 
the balancing act between differentiation and pluripotency in ES cells.
The early work of Martin and Evans (1974) indicated that feeder cells produced a 
trophic factor that supported undifferentiated growth of the co-cultured ES cells. This 
was confirmed when it was shown that feeders could be replaced by conditioned 
media from the STO feeder cells or from Buffalo Rat Liver cells (BRL cells) (Smith 
and Hooper, 1987; Smith and Hooper, 1983). Subsequently the active factor was 
isolated and shown to be a single cytokine; leukemia inhibitory factor (LIF) (Smith et 
al., 1988; Williams et al., 1988). Further evidence that LIF is the relevant factor is 
provided by the experiments which showed that feeders lacking a functional L if gene 
do not support ES proliferation in an undifferentiated state (Stewart et al., 1992) 
Removal of LIF from the culture medium of ES cells in monolayer culture leads to 
differentiation to primitive endoderm like cells (Niwa et al., 1998; Niwa et al., 2000). 
It has been shown that ES cells can be maintained for at least a short period of time
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without a source of LIF (Berger and Sturm, 1997; Dani et al., 1998) suggesting the 
presence of an unidentified factor or factors in serum which can repress the 
differentiation of ES cells to endoderm.
LIF is a member of a family of cytokines related to interleukin-6 (IL-6) which have 
multiple functions and usually drive differentiation of adult stem cells. It was later 
shown that undifferentiated growth of ES cells could be supported by other members 
of the IL-6 family, which act via the gpl30 receptor (Conover et al., 1993; Pennica et 
al., 1995; Yoshida et al., 1996). LIF, oncostatin-M (OSM) and cardiotrophin-1 (CT-1) 
bind to the leukaemia inhibitory factor receptor a (LIFRa) forming a heterodimeric 
receptor complex consisting of LIFRa and gpl30. Ciliary neurotrophic factor (CNTF) 
requires the CNTFR (also expressed by ES cells) to engage the LIFR-gpl30 
heterodimer (Stevens, 1970). IL-6, whose receptor is not expressed by ES cells, acts 
independently of LIFRa through a hexameric complex containing a homodimer of 
gpl30 and two IL-6 and IL-6R modules (Murakami et al., 1993; Nichols et a l, 1994; 
Yoshida et a l ,  1994; Yoshida et a l ,  1996). Thus, gpl30 is the common receptor 
component involved in cytokine mediated ES cell renewal which was originally 
identified as the signal transducing subunit of the IL-6 receptor complex (Hibi et a l, 
1990; Taga et a l,  1989).
Gpl30, a member of the cytokine receptor superfamily (Bazan, 1990) has no tyrosine 
kinase activity and so recruits the Janus kinase (JAK), a non receptor tyrosine kinase 
(Darnell et a l ,  1994). The JAK kinases are believed to be associated with the 
unpolymerised receptor modules. Ligand binding induces oligonucleotidemerization 
and by a largely unknown mechanism, brings the associated JAK molecules into close 
proximity culminating in phosphorylation and activation of the receptor complex
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(Stahl and Yancopoulos, 1994). In ES cells JAK-1, JAK-2 and TYK-2 are activated in 
response to LIF stimulation (Ernst et al., 1996). The phosphorylated tyrosines on the 
receptor form binding sites for proteins containing the Src-homology (SH-2) domain, 
in ES cells STAT-3 (signal transducer and activator of transcription 3) which are in 
their turn phosphorylated by the JAK kinases and released from the receptor complex 
as dimers. On dimerization, they are translocated to the nucleus where they bind to the 
DNA and direct specific gene expression.
The Gpl30/JAK receptor complex in ES cells direct two major pathways; a stem cell 
renewal pathway through STAT-3 and a pathway which promotes cell differentiation 
via SHP-2 (also known as Ptpnl 1, protein tyrosine phophatase, non-receptor type 11) 
(Burdon et al., 1999). It has been shown that activated STAT-3 is sufficient to support 
stem cell renewal in the absence of LIF (Matsuda et al., 1999) and cells stably 
expressing a dominant negative form of STAT-3 cannot be maintained in an 
undifferentiated form (Niwa et al., 1998)
On the other hand it has been shown that SHP-2, which by associating with either 
GRB-2 (growth factor receptor bound protein 2) and SOS (son of sevenless) or GAB- 
1 (GRB-2 associated binding protein 1) and phosphoinositol kinase, activates the 
MAP Kinase pathway through RAS (rat sarcoma virus oncogene 1) and ERK (extra­
cellular signal related kinase). The antagonistic effect on stem cell renewal can be 
partly explained by the phosphokinase activity of SHP-2. However blockade of ERK 
activating enzyme MEK-1 (mitogen activated protein kinase-1) with the specific 
blocking agent PD05809 reduces ES differentiation both in monolayer culture and in 
embryoid bodies.
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Reciprocal patterns of LIF-R expression in the ICM and LIF in the trophectoderm add 
weight to the theory that Gpl30 signalling is important for the expansion of the 
pluripotent compartment of the peri-implantation embryo (Nichols et al., 1996). 
Paradoxically, knockout of the Lif gene has no effect on embryonic development 
(Stewart et al., 1992). Knockout of the Lif receptor or of Gpl30, the common 
component of the IL-6 cytokine family of receptors, results in death at mid-gestation 
(Ware et al., 1995; Yoshida et al., 1996). Disruption of the Stat-3 gene results in early 
embryonic lethality but not until onset of gastrulation (Takeda et al., 1997)
Experiments with gp!30'A mice (see Sect 1.1.3) may throw some light on why LIF has 
an effect on ES cells while being redundant over the relevant period of development. 
Nichols et al (2001) have shown that gpl30 signalling, mediated by LIF is essential to 
the survival of the ICM during diapause.
It has been shown that BMP2/4 (bone morphogenetic protein), a member of the TGF- 
P (transforming growth factor-P) superfamily, can in concert with LIF support 
undifferentiated growth of mouse ES cells in the absence of other extrinsic factors, 
supplied by feeders or serum, (Ying et al., 2003b) and appears to work by suppressing 
both the differentiation of neuronal lineages through SMAD (small mothers against 
decapentaplegic) and Id (inhibitor of differentiation) and by blocking the MAPK 
(mitogen activated phophokinase) pathway which promotes differentiation under the 
influence of LIF (Qi et al., 2004). The role of different signalling cascades has been 
hampered by the complexity of the media used to maintain the cells in their 
undifferentiated state. The ability to grow ES cells in the absence of complex factor 
mixtures such as serum should help in the elucidation of the interacting pathways.
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Array experiments with ES cells have also highlighted the canonical WNT (named for 
the drosophila wingless gene and its mammalian homologue Int-1) and TGFp 
pathways as having putative roles in the maintenance of pluripotency (Sato et al., 
2003). The TGFp pathway again appears to operate on the MAPK pathway.
WNTs are a family of secreted protein which binds to the cell surface receptor 
Frizzled resulting in inhibition of the kinase Gsk-3p (glycogen synthase kinase-3P), a 
component of the Axin/APC complex which acts to mark P-catenin for degradation. 
Axin is a protein with several protein interaction domains and acts as a scaffold for 
the complex and APC (adenomatous polyopsis coli) is a tumour suppressor protein 
commonly deleted in familial and sporadic colorectal cancer. Inhibition of the 
phosphophorylation of P-catenin results in translocation to the nucleus where it 
interacts with the factors Tcf (T-cell factor) and Lef (lymphocyte enhancer factor) to 
regulate target genes. Mouse embryo fibroblasts (MEFs) which are often used as 
feeders for ES cells produce the WNT ligands. WNTs have been implicated in 
maintenance of the multipotent cells of the haemopoetic system. Moreover, inhibition 
of WNT by SFRP2 (secreted frizzled-related protein-2), an extracellular antagonist of 
WNT which competes for the frizzled receptor, appears to direct cells down a 
neuronal route (Aubert et al., 2002)
It has been shown that both human and mouse ES cells can be maintained short term 
in the pluripotent state by WNT-3a provided by either media conditioned by cells 
which stably produce it or by the inhibitor of GSK-3P (Sato et al., 2004) derived from 
Tyrian purple known as BIO (Meijer et al., 2003). Also both WNT3a and WNT4 are 
expressed by the blastocyst (Lloyd et a l,  2003). It has been suggested that the effect 
of WNT on neuronal differentiation is due to downstream regulation of BMPs
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(Haegele et al., 2003). However, in vivo analysis suggest that, like the JAK/STAT 
pathway, their ability to maintain ES cells in an undifferentiated state may be an 
artefact of culture rather than a reflection of this very important developmental stage 
characterised by the expansion of the epiblast. Disruption of p-catenin by disruption 
of the endogenous gene does not affect formation of the embryonic egg cylinder but 
appears to be important to axis formation (Huelsken et al., 2000).
It has been recently shown that WNT-3a in the absence of LIF and other serum 
factors can produce a transient expression of Cdx2 which is sufficient, on the 
subsequent addition of the permissive factors, for the production of trophectoderm 
stem cells (TS) (He et al., 2008). This is the first time the ability of mouse ES to 
differentiate to TE simply by manipulating the in vitro growth conditions has been 
demonstrated. Moreover, it shows how transient signals might be able to initiate 
differentiation cascades in vivo.
It should not be forgotten that ES cells grow on a substrate which even when non- 
cellular still provides signals which are potentially important in maintenance of the 
pluripotent state. In vivo, the epiblast is induced to form a cavity and an epithelium by 
a combination of signals from the primitive endoderm and the extra-cellular matrix it 
produces (Coucouvanis and Martin, 1995).
The signalling networks involved in the control of pluripotency are becoming ever 
more complex. The different pathways initiated on the cell surface each seem to have 
both pro- and anti-differentiative effects and each pathway may interact to modulate 
the others. The WNT pathway appears to acts in concert with the BMP pathway to 
repress neural differentiation (Haegele et al., 2003). It also appears to interact with the 
JAK-STAT pathway by up-regulation of Stat3 (Hao et al., 2006). In contrast LIF and
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the JAK-STAT pathway in concert with BMP are believed to interfere with Lefl 
expression which is required to activate Cdx2 which induces TE (He et al., 2008; 
Strumpf et al., 2005). It is important to remember that the context of any signalling is 
context dependant. Although WNT induces CDX2, the continued presence of WNT 
acts as a negative feedback loop, and the terminal differentiation of the stimulated 
cells can only be achieved when the signalling molecules are changed to a permissive 
combination.
Although the mechanism is unclear, the differentiation of the endoderm in vivo seems 
to be controlled by GRB2 and the MAPK pathway as Grb2 -/- embryos lose Gata-6 
expression and produce no primitive endoderm (Chazaud et al., 2006). The BMP and 
STAT3 pathways have to be balanced in their effects to maintain the undifferentiated 
state. Expression of a constitutive BMP receptor or over-expression of SMAD1/4 
(Ying et a l,  2003b) will cancel out the STAT3 pathway leading to non neuronal 
differentiation. ERK and p38 MAP kinase which are activated by LIF or FGF 
signalling act to promote differentiation to neurons (Ying et al., 2003a; Ying and 
Smith, 2003). The PI3/AKT (phophatidylinosital-3/ a serine threonine kinase) also 
inhibits the ERK MAPK pathway (Paling et al., 2004). Disruption of any one of these 
pathways in vivo does not lead to peri-implantation loss.
Interestingly, c-myc is a direct target of STAT-3 (Cartwright et al., 2005),and of the 
TGFp and WNT pathways (Kanehisa and Goto, 2000) and is one of the four genes 
which on co-introduction to somatic cells results in transformation to ES like cells 
which can contribute to chimaeras (Takahashi and Yamanaka, 2006).
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1.1.5 Intrinsic Factors and the Maintenance of Pluripotency.
In contrast with ES cells, the pluripotent compartment of the embryo is neither static 
nor permanent. The pluripotent cells of the epiblast are transcriptionally distinct from 
those of the embryonic ectoderm.
The mouse embryo can develop from the one cell stage to the blastocyst stage in the 
absence of extrinsic factors and embryogenesis appears to be driven by asymmetrical 
gene expression inherent in the embryo although the mechanism of establishment of 
the asymetry is unclear. On differentiation of the trophectoderm, signalling between 
the two tissues can guide further development. After implantation, the embryo is 
provided with nutrients and signalling molecules from the mother. However, many of 
the important developmental cues appear to still be provided by signalling centres 
established within the embryo.
The provision of extrinsic signals in the growth medium of ES cells leads to the 
regulation of nuclear transcription factors which regulate downstream targets which 
define cell type. Many of these factors associated with pluripotent cell lines and 
tissues have been discovered. Of these, OCT4, a POU domain transcription factor and 
the product of the Pou5fl gene, has been widely studied. In vitro it is expressed in ES, 
EC and EG cells (Okamoto et al., 1990; Rosner et a l, 1990; Yeom et a l,  1996) in all 
pluripotent tissues of the embryo: oocytes, all cells of preimplantation embryos until 
the blastocyst stage when it is restricted to the ICM, the epiblast and embryonic 
ectoderm (Palmieri et a l ,  1994; Scholer et a l, 1989) when it becomes again restricted 
to the primordial germ cells (Rosner et a l,  1990). Deletion of the gene in the mouse 
results is an early embryonic lethal. Although cells are allocated to the ICM resulting 
in a blastocyst with normal appearance, the embryo is only composed of
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trophectoderm cells and develops no further (Nichols et al., 1998). Regulation of this 
gene is critical to the differentiation of ES cells. Repression of PouSfl leads to the 
cells adopting trophectodermal morphology while up-regulation leads to formation of 
primitive endoderm (Niwa et al., 2000). However, OCT4 functions within a complex 
system of other factors which in the embryo lead to the dynamic process which is 
embryogenesis. One of the best studied of the genes which are involved in the co­
regulation of other genes is Sox2.
SOX2 (an SRY related HMG box transcription factor Sox2) is a member of a group of 
proteins which act as partners for transcription factors which then regulate gene 
expression in the context of the factors present. In the chick lens SOX2 partners with 
the 5EF3 protein to direct 8-crystallin gene expression (Kamachi et al., 1995). In F9 
EC cells it partners with OCT4 in the activation of the Fgf4 gene (Ambrosetti et al., 
2000) and Handl which are involved in the proliferation or differentiation of 
trophectoderm in the blastocyst (Niwa, 2001; Rossant and Cross, 2001). It also 
partners OCT4 in its own regulation and the regulation of OCT4 (Okumura-Nakanishi 
et al., 2005; Tomioka et a l , 2002).
Sox2 RNA is first expressed in some cells of the morula. The protein SOX2 is present 
in all blastomeres of the cleavage stage embryo and also becomes restricted to the 
ICM and epiblast at the blastocyst stage (Avilion et al., 2003). Expression persists in 
the epiblast stage through to gastrulation when mid streak it becomes restricted to the 
anterior embryonic ectoderm which is destined to form neurectoderm. However, a 
new site of expression of Sox2 is initiated in the ectoplacental cone where there is no 
Pou5fl expression. Disruption of the Sox2 gene leads to peri-implantation death with 
loss of the epiblast at a stage slightly later than for Pou5fl knockout embryos.
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Partnership with both OCT4 and KLF4 is not only important in the specification of 
ES cells being one of the three proteins which can reprogram mouse fibroblasts 
(Nakagawa et al., 2008) but also for expression of Lefty 1 (Nakatake et al., 2006). 
Deletion of Lefty 1 leads to loss of the left right axis during differentiation of the 
embryo (Meno et al., 1998) and may contribute to axis specification in the early 
postimplantation epiblast (Takaoka et al., 2006)
A gene for a homeodomain containing transcription factor was first identified as Enk 
(Wang et al., 2003) and subsequently renamed as Nanog (Chambers et al., 2003; 
Mitsui et al., 2003) has been proposed as a candidate gene for self-renewal. In vitro it 
is expressed in ES cells, embryonic germ cells (EG cells) and both LIF dependant and 
independent EC cells (Chambers et al., 2003). In vivo, Nanog is first detected in the 
inside cells of the compacted morula, the cells destined to form the ICM. Expression 
in the blastocyst is restricted to the ectoderm and is down regulated in the late 
blastocyst before implantation. Nanog is also expressed in the germ cells of the 
genital ridge on day 11.5 of gestation (Chambers et al., 2003) a tissue from which EG 
cells can be derived (Matsui et al., 1992; Resnick et al., 1992) DPP A3, also known as 
Stella and considered to be a marker of pluripotency (Bowles et al., 2003), is present 
in pre-migratory primordial germ cells on day 7.5 of gestation. However, nanog was 
absent from these cells (Hatano et al., 2005).
Over expression of Nanog maintains ES cells in an undifferentiated state in the 
absence of LIF but still requires the expression of PouSfl. ES cells deficient in Nanog 
differentiate to form primitive endoderm but not mesoderm. In line with the belief that 
the EC line P19 represents a later developmental stage more akin to embryonic
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ectoderm, Nanog is expressed at a much lower level. Also expression in EPL (early 
primitive ectoderm like) cells (Section 1.1.5) is reduced (Wang et al., 2003)
Nanog deficient embryos at day 5.5 appear to be only composed of disorganised 
extra-embryonic endoderm with no epiblast or extra-embryonic ectoderm. Nanog 
deficient blastocysts at day 3.5 appear to be normal but cells in ICMs isolated from 
these embryos fail to proliferate and differentiate to parietal endoderm. Although 
Nanog-/- ES cells can be derived from mutant Nanog-/- blastocysts they differentiate 
slowly into parietal endoderm (Mitsui et al., 2003).
The anti-differentiative effects of Nanog apply to all three lineages depending on the 
context. NANOG can block the formation of primitive endoderm in response to the 
removal of LIF in serum containing medium (Chambers et al., 2003) or on the 
formation of embryoid bodies (Hamazaki et al., 2004) in the presence of LIF and 
serum. Neuronal differentiation is blocked in the absence of LIF and BMP in serum 
free culture (Ying et al., 2003b). Mesodermal differentiation has been shown to be 
inhibited by up-regulation of Nanog brought about by the binding of the transcription 
factor T (the product of the Brachyury gene) and STAT3 (regulated by LIF) to an 
enhancer element of the Nanog gene and NANOG binds to SMAD1 (Suzuki et al., 
2006b). Cells which have been induced to form mesodermal progenitors by 
stimulation with BMP regenerate ES cells in response to Brachyury, in combination 
with LIF (Suzuki et al., 2006a).
Although neither Oct4 nor Nanog can be regarded as a master gene of pluripotency, 
as neither gene can prevent differentiation on its own, NANOG, OCT4 and SOX2 
have been shown to act in concert both to self regulate and to regulate other genes. 
Although the STAT3 pathway does not appear to interact with Oct4; differentiation
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cannot be prevented by Oct4 expression if LIF has been withdrawn or on blockade of 
the Stat3 pathway. It has been shown that co-transfection of Oct4, Sox2, Klf4 and c- 
myc into fibroblasts is able to reprogram fibroblasts to Nanog expressing cells which 
resemble ES cells including the ability to contribute to chimaeras (Takahashi and 
Yamanaka, 2006; Wemig et al., 2007) and to the germ line (Okita et al., 2007) 
although the mice generated frequently develop tumours due to reactivation of the 
transfected c-myc gene. The re-specification of fibroblasts to ES cells occurs at low 
frequency which may be in part due to the requirement of the genes to be expressed at 
the correct level. Subsequently it has been shown that the transfection of c-myc is 
dispensable (Nakagawa et al., 2008). The oncogene c-myc enhances DNA replication 
leading to a more relaxed chromatin structure. The authors noted that the induced ES 
cells took longer to emerge without c-myc and at a lower frequency. I suggest that the 
ability of Sox2 to open the DNA in a local fashion (Pevny and Lovell-Badge, 1997) 
may play a role in initiating the epigenetic state required to establish the 
transcriptional network.
The ease with which ES cells can be genetically manipulated has led to the belief that 
the DNA is open and that transcriptional control is leaky (Evans et al., 1997). 
Furthermore, when ES cells differentiate the nuclei shrink and the distribution of 
heterochromatin changes (Niwa, 2007). In addition, the epigenetic status of ES cells is 
unique in that the DNA bears co-localised histone marks characteristic of both 
inactive and active genes (Bernstein et al., 2006) that are associated with genes 
expressed at low levels. In general, chromatin marks associated with active genes are 
abundant in ES cells (Azuara et al., 2006; Jeong-Heon Lee, 2004) and rapid changes 
occur in the histones during self renewal (Meshorer et al., 2006). Since pluripotency 
can be restored to ES cells which are deficient for certain of the genes which are
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involved in this open chromatin state Niwa (2007) has proposed that the epigenetic 
processes facilitate the transcription factor network rather than maintain pluripotency.
1.1.6 EG Cells
Primordial germ cells can first be detected by alkaline phosphatase staining in the 
extra-embryonic mesoderm at the base of the allentoic bud on day 7.5.from where 
they migrate to the hindgut area then to the genital ridge where they stay in the 
developed gonad. As discussed in above (Section 1.1.1), teratocarcinomas can be 
established from post- migratory germ cells.
Although pre-migratory germ cells have not so far been shown capable of forming 
teratocarcinomas, it has been shown that limited culture of germ cells could be 
achieved by culture in the presence of LIF and the Steel growth factor (Matsui et al., 
1991). Further, addition of bFGF to cultures of primordial germ cells resulted in their 
conversion to EG cells, so named to denote their origin, which resembled ES cells and 
which could also be maintained indefinitely (Labosky et al., 1994; Matsui et al., 
1992; Stewart et al., 1994). However, lines derived from later stage embryos 
progressively lose their ability to contribute to normal embryogenesis as they lose 
their imprinted patterns (Tada et al., 1998). EG cells, like their germ cells founders, 
have the ability to erase imprints (Tada et al., 1997). ES cells do not appear to have 
this capacity.
1.1.7 EPL Cells
Progression from ICM to primitive ectoderm involves differentiative stages 
characterised by differences in the expression of the genes Rexl, Fgf5, Gbx2,Pscl,
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CRTR-1 and PRCE resulting in distinguishable pluripotent cell populations (Pelton et 
al., 1998).
Day 3.5 Day4.5 Day4.75 Day5 Day5.25 Day5.5
Rexl
CRTRJ
Pscl
9
PRCE1
Oct3/4
ES EPL
Rexl
CRTR1
Pscl
Fgf5
PRCE1
Oct3/4
Figure 1.1: Diagram of expression of genes in the pluripotent compartment of 
embryos associated with differentiation over the period from the early blastocyst to 
formation of the primitive ectoderm. Below expression of the same genes in EPL and 
ES cells. Red indicates high expression, pink low expression and blanks no 
expression. Data extracted from Pelton et al, (1998).
Early primitive ectoderm cells (EPL cells) have been isolated as a distinct cell type by 
the culture of ES cells in conditioned media from a human hepatocarcinoma cell line 
HepG2 (Lake et al., 2000; Rathjen et a l ,  1999). Analysis of expressed markers, 
morphology, cytokine responsiveness and differentiation potential both in vivo and in 
vitro, have led the investigators to suggest that EPL cells are more related to the 
embryonic primitive ectoderm and are distinct from ES cells. These cells do not 
contribute to chimaeras but can be reverted to the ES state by removal of the 
conditioned media and replacing Lif whereupon they regain their ability to contribute 
to chimaeras.
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1.1.8 Pluripotent Cells from Human.
It has proved remarkably difficult to produce ES cells from other species. Where cells 
which share properties with mouse ES cells have been isolated it has proved either 
impossible to confirm by the making of chimaeras for technical reasons, as in the 
hamster or for ethical reasons as in the human.
ES like cells have been isolated from primate blastocysts and this includes human. 
These ES cells hold the promise of therapy for people with degenerative illnesses or 
accidents resulting in the loss of organs. Before this dream can be realized, we must 
understand not only how they are similar to the mouse but also how they differ. 
Unlike the mouse ES cells, human ES cells (hES) can differentiate to form 
trophectoderm. This suggests that hES cells may represent an earlier stage of 
development before the delamination of the primitive endoderm. Also, only the pro- 
differentiative ERK/MAPK pathway and not the Jak/STAT pathway appear to be 
responsive to Lif (Sato et a l, 2004) BMP promotes differentiation to trophectoderm 
rather inhibiting it. Blocking of BMP with the antagonist Noggin leads to 
differentiation into neurons (Pera et al., 2004) which appears to be a common effect in 
mouse and in Xenopus (Munoz-Sanjuan and Brivanlou, 2002) suggesting a common 
function of BMP in blocking neuronal differentiation. The other arm of the TGFp 
family appears to be more important in controlling pluripotency in hES cells. The 
factors TGFp, activin and nodal activating SMAD2/3 are able to inhibit 
differentiation (James et a l ,  2005; Vallier et a l, 2004)}. FGF2 acts as a competence 
factor, by a poorly understood mechanism, with nodal and activin to increase this 
inhibitory effect (Vallier et a l,  2005).
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1.2 Microarrays
Microarrays are ordered arrays of probes (also known as elements) printed in columns 
and rows on solid, planar substrates thus giving a unique address to each probe. This 
allows the best use of current technologies such as robots, scanners and software. The 
probes can be nucleic acid, protein or even tissue. Probes can be almost anything 
which can be deposited on the substrate e.g. protein, nucleotides or even tissue 
sections.
A major application of microarray technology is transcriptome analysis. Other 
methods for analysis of gene expression include Northern blotting (Alwine et al., 
1977), SI nuclease protection (Berk and Sharp, 1977), differential display (Liang and 
Pardee, 1992), sequencing of cDNA libraries (Adams et al., 1991; Okubo et al., 1992) 
and serial analysis of gene expression (SAGE) (Velculescu et al., 1995). Microarrays 
have the advantage of allowing this analysis on a global scale
For transcriptional analysis the probes, which are tethered to the matrix, are either 
oligonucleotides or cDNA. The matrix is usually a standard glass microscope slide 
with a chemically modified surface.
The best known commercially produced oligonucleotide array platform is the 
GeneChip® produced by Affymetrix Inc, CA, U.S.A. which consists of a quartz chip 
on which up to 500,000 probe locations can exist on an area of 1.28cm2. The probes 
are synthesised in situ by light-directed chemistry (Affymetrix). The GeneChip® 
arrays are termed one colour platforms because only one sample is applied to each 
chip and absolute expression levels are measured for each gene being queried, several
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positive and negative oligonucleotides are present. Accuracy of measurement relies 
on the small array-array differences achieved during production of the GeneChip®.
The other commonly used technology is the two colour array where cDNA PCR 
products are tethered to the slides. Two samples are independently fluorescently 
labelled and then co-hybridised to the slide effectively eliminating the array-array 
differences. Relative gene expression levels are determined by measuring the ratio of 
the intensities of fluorescence for both Cy3™ and Cy5™ dye at each probe/spot.
Although the one colour platforms have the advantage of producing absolute levels 
for each gene, the selection of positive and negative oligonucleotide for each gene is 
critical. A particular issue with amplified material is the 3' bias introduced in the 
reverse transcription of the mRNA. Affymetrix, in recognition of this problem, have 
started to produce chips designed for this 3' biased material.
The NIA 15K gene set was compiled to address the problem of the lack of coverage 
of genes important during early mammalian development. A PCR based cDNA 
library construction method was used to compile a total of 52,374 ESTs from pre- and 
peri-implantation embryos (Ko et a l,  1998) embryonic and extra embryonic tissues 
on 7.5-d.p.c., female gonad and mesonephros on 12.5-d.p.c. and newborn ovary 
(Tanaka et al., 2000). From the 52,374 ESTs, 15,264 putative unique genes were 
extracted.
The majority of these probes were derived from the 3' end of the cDNAs, an 
important consideration as linear amplified RNA is used as the target and have an 
average length of 1.5kb. Only 30% of the sequences represent known genes, the rest 
are either novel (-50%) or are similar but not identical to known genes (-20%).
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1.3 Aims of the Project
In this thesis I have used microarrays to phenotype ES cells and pluripotent tissues of 
the embryo to address the question of homology of ES cells to the pluripotent cellular 
compartment of early embryos. To this end I have assessed techniques for extracting 
and handling RNA from small samples, amplification of the transcriptome and 
labelling of the samples. A number of software packages for the image analysis of the 
microarray slides and data mining were also scrutinised.
39
Chapter 2: Materials and Methods
Chapter 2 
Materials and Methods
40
Chapter 2: Materials and Methods
2. Materials and Methods
2.1 Cell Culture
2.1.1 Media.
The following media and reagents were purchased:
Distilled water, tissue culture tested GIBCO™
Invitrogen Ltd, Paisley, 
Renfrewshire, UK
DPBS-A, Dulbecco’s Phosphate Buffered Saline (lx) 
liquid, without Ca2+ and Mg2+,
GIBCO™
Invitrogen Ltd, Paisley, 
Renfrewshire, UK
Foetal Bovine Serum (FBS), selected batches PAA Laboratories GmbH, 
Linz, A-4020 Austria
Gelatin, 0.1 % in water StemCell Technologies, 
Vancouver, BC, Canada
Glutamine 200mM (lOOx) GIBCO™
Invitrogen Ltd, Paisley, 
Renfrewshire, UK
Murine LIF (ESGRO™) Chemicon International, 
Temecula, California 
92590, USA
MEM Alpha medium (lx), liquid with glutamine, without 
ribonucleosides and deoxyribonuceosides
GIBCO™
Invitrogen Ltd, Paisley, 
Renfrewshire, UK
Newborn Bovine Serum (NBS), selected batches PAA Laboratories GmbH, 
Linz, A-4020 Austria
Penicillin/Streptomycin Solution, liquid 5,000units/ml 
Penicillin and 5,000mg/ml Streptomycin in normal saline
GIBCO™
Invitrogen Ltd, Paisley, 
Renfrewshire, UK
Trypsin-EDTA (lx) in HBSS, prepared as 0.5g/l Trypsin 
(1:250), 0.2g EDTA in Hanks’ Balanced Salt Solution 
without Ca2+ and Mg2+
GIBCO™
Invitrogen Ltd, Paisley, 
Renfrewshire, UK
Table 2.1: Cell Culture Media
Other Reagents
A 10_1M (lOOx) stock solution of P-mercaptoethanol was prepared by adding 72pl of p- 
mercaptoethanol (Merck KGaA, 64293 Darmstadt, Germany) to 100ml DPBS-A.
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Selected batches of Foetal Bovine Serum (FBS) and Newborn Bovine Serum (NBS) 
were heat inactivated before use by incubating at 56°C for 20 minutes. All reagents 
were made up and stored in sterile disposable plastic vessels (NUNC™, Falcon™).
2. 7.2 Culture o f Embryonic Stem Cells
Embryonic stem cells (ES cells) of the line IMT-11 (Bierbaum et al., 1994) were used 
in all experiments. The precise genetic constitution of these cells is unclear; the original 
stock of mice was acquired from Dr E. Wagner who acquired his stock from Prof R. 
Kemmler. These mice were described as 129SvSl cp, therefore agouti, white bellied and 
dark eyed. The breeding program did not select for the Steel locus so this was most 
likely lost. Thus these ES cells are most similar to the D3 cell line (Doetschman et al., 
1985) although further genetic contamination of the original mouse stocks can not be 
ruled out.
These ES lines were maintained in their undifferentiated state in the medium MEM- 
Alpha supplemented with 10'4M p-Mercaptoethanol, 10'3 U/ml murine LIF 
(ESGRO™), 2mM glutamine, 10% FBS and 10% NBS (MEMa-ES). The cells were 
maintained at 37°C in a humidified atmosphere with 5% CO2 on gelatin coated tissue 
culture grade plastic ware (NUNC™). The gelatinization was achieved by flooding the 
plates with 0.1% gelatin (Stem Cell Technologies) then aspirating the solution from the 
plates before use.
Subculture was carried out by washing the cells twice with Dulbecco’s Phosphate 
Buffered Saline without Ca2+ and Mg2+ (DPBS-A, GIBCO™) at room temperature then 
rinsing the cells with Trypsin-EDTA at 4°C. When the cells had rounded up and 
detached from the plastic substrate, MEM-a was added and the cell suspension
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triturated to give a single cell suspension. Cells were counted and plated at 
3xl04cells/cm2, i.e. 2xl06 cells were plated on a 100mm dish. After 48 hours of culture 
the media was changed and after further 24h cultivation a 100mm dish would yield 
approximately 1.5xl07 cells.
2.2. Animal Husbandry, Embryo and Tissue Isolation
The following reagents were purchased.
Albumin, Bovine Fraction V Powder, 96- 
99% albumin, Embryo tested, BSA
Sigma-Aldrich Company Ltd, Poole, 
Dorset, UK
Depo-Provera™ Upjohn Ltd, Crawley, UK
Opti-MEM™-l Reduced Serum Medium 
(lx), liquid
GIBCO™
Invitrogen Ltd, Paisley, Renfrewshire, 
UK
Tamoxifen Sigma-Aldrich Company Ltd, Poole, 
Dorset, UK
Tyrode’s Solution, Acidic Sigma-Aldrich Company Ltd, Poole, 
Dorset, UK
Table 2.2: Reagents for collection of embryos.
2.2.1. Timed Matings.
Mice of the strain 129SvEv were maintained on a 12h light/12h dark light cycle. Food 
and water were available ad libitum. Females were caged with males and the females 
checked each morning for the presence of a vaginal plug. As oestrus females usually 
ovulate at the mid-point of the dark period, embryo stages are represented as days post 
coitum (d.p.c.) or as hours post coitum (h.p.c.) assuming that fertilization occurred at 
midnight preceding the discovery of the vaginal plug. For the timings of the different 
developmental stages see Appendix 1. Embryo isolation was carried out in sterile 
disposable dishes (NUNC™, Sterlin™). Embryos were manipulated by means of a
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finely drawn out glass Pasteur pipette attached to a mouthpiece. For full details of all 
embryo manipulation techniques see (Nagy, 2003).
2.2.2 Embryo Isolation.
All embryos were collected and handled in OptiMEM-1™ (Gibco) supplemented with 
4mg/ml BSA (OptiMEM+BSA). OptiMEM-1™ is a convenient ready made medium 
which is HEPES buffered and suitable for embryo handling outside of the COj 
controlled atmosphere of the incubator (Ouhibi et al., 1995).
2.2.2a Oocytes.
Oocytes were isolated between six and eight h.p.c from females which had been mated 
with vasectomised males. The oviducts were dissected from the mice into a dish of 
OptiMEM+BSA and the ampulla was opened with No 5 watchmaker’s forceps allowing 
the escape of the oocytes with their associated cumulus cells into the medium. The 
cumulus cells were separated from the oocytes by incubating in hyaluronidase (Sigma), 
0.3mg/ml in OptiMEM at room temperature until the cumulus cells drop off. The 
oocytes were then rinsed through several drops of OptiMEM+BSA to free them from 
cumulus cells, hyaluronidase and other debris. The oocytes were then transferred to an 
RNase free microcentrifuge tube in the smallest volume of medium before lysis in the 
buffer supplied in the Zymo Mini RNA Isolation kit™(Zymo).
2.2.2b Fertilised Eggs.
Fertilised eggs were collected from timed matings (8-10 h.p.c.) with fertile males in 
exactly the same manner as for oocytes (2.2.2b)
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2.2.2c Two-cell to Compacted Morulae.
The oviducts from timed matings with fertile males were dissected into dishes. Embryos 
were isolated from the oviducts by inserting a 33-gauge needle into the infindibulum of 
the oviduct and flushing with OptiMEM+BSA by means of a syringe.
2.2.2d Blastocysts
Pregnant females were sacrificed on days 3.5- 5 post coitum. Blastocysts were flushed 
from the uteri in OptiMEM™-l supplemented with 4mg/ml BSA (OptiMEM+ BSA).
2.2.2e Post implantation Embryos.
Pregnant females were sacrificed on days 5.5-6.5 post-coitum and the decidua were 
dissected free of the uteri. Embryos were carefully removed from the decidua with 
tungsten needles.
2.2.2d Delayed Implantation.
Embryonic diapause was induced by intraperitoneal injection of lOpg of tamoxifen 
(Sigma) and subcutaneous injection of lmg of DepoProvera™ (Hunter and Evans, 
1999) on day 2.5-3 of gestation.
2.2.3 Tissue Isolation.
2.2.3a Production o f Rabbit anti Mouse Spleen Cell Antibodies.
Mouse spleens were teased in DPBS-A then spun down at 200g for 5min. The red blood 
cells were lysed by washing in isotonic TRIS Ammonium Chloride, pH 7.2 (17mM 
TRIS base, 139mM Ammonium Chloride, pH7.2). At weekly intervals 2xl08 cells were 
injected into a rabbit. After 4 weeks a test bleed was taken and the efficacy of the
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antibody was tested. The anti-serum was heat inactivated at 56°C for 20min to destroy 
endogenous complement activity.
This antibody was kindly produced by Dr Eryl Liddell, School of Biosciences, Cardiff 
University.
2.2.3b Isolation o f the Inner Cell Mass by Immunosurgery.
The inner cell masses of blastocysts were dissected by immunosurgery (Solter and 
Knowles, 1975). Briefly, where necessary, the zona pellucida was removed from the 
embryos with acidic Tyrode’s solution (Nicolson et al., 1975). The embryos were then 
incubated in rabbit anti mouse spleen antibody (see sect 2.2.3a.) diluted 1:10 in 
OptiMEM+BSA at room temperature for 20 minutes. The embryos were then washed 
through six drops of OptiMEM+BSA to remove all unbound antibody. The blastocysts 
were then incubated in Guinea pig complement diluted 1:5 in OptiMEM+BSA at 37°C 
for 20minutes. After washing through 3 drops of OptiMEM+BSA, the lysed 
trophectoderm was removed by pipetting through a finely drawn glass capillary
2.2.3c. Dissection o f the Dy6 Epiblast.
Embryos were dissected from the uterus and decidua as described in Sect 2.2.2b. The 
Reichert’s Membrane and ectoplacental cone were removed with tungsten needles and 
the embryonic portion was separated from the rest of the embryo. The visceral 
endoderm layer was removed by incubating the embryonic tissue in 0.25% pancreatin, 
0.5% trypsin in DPBS-A at 4°C for lOmin. The endoderm layer was then peeled off by 
pipetting through a glass capillary drawn to a diameter slightly smaller than the 
embryonic cylinder
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2.3 Molecular Methods
When handling RNA, care was taken to avoid contamination with RNase. Gloves were 
worn at all times and changed frequently. Sterile disposable plastics were used wherever 
possible. Pipette tips with filters (Maximum Recovery™, Axygen Scientific Inc.) and 
microcentrifuge tubes (Sigma-Aldrich) were purchased nuclease free. All glassware was 
dry autoclaved in an oven at 240°C for a minimum of four hours. Solutions and water 
were treated with DEPC (0.1% diethylpyrocarbonate) then autoclaved at 151bs/sq.in. for 
15mins. Solutions which could not be treated this way such as TRIS, were either 
purchased as nuclease free concentrated stocks or made up from dedicated chemicals in 
RNase free glassware with DEPC treated water. Equipment such as electrophoresis 
tanks were sprayed with RnaseZap™ (Ambion) then rinsed with DEPC treated water.
Traces of DEPC can be detrimental to many enzyme reactions. In this case nuclease- 
free water (Ambion) was used.
All chemicals were purchased as Molecular Biology Grade.
2.3.1 Purification of RNA.
2.3.1a Isolation o f total and cytoplasmic RNA.
The following kits for RNA isolation were purchased (Table2.2)
QIAgen RNeasy™ Midi Kit Qiagen Ltd., Crawley, Sussex, UK.
QIAgen RNeasy™ Mini Kit Qiagen Ltd., Crawley, Sussex, UK.
Zymo Mini RNA Isolation 
Kit™
Zymo Research, Orange, California, 
USA
Table 2.3: Kits purchased for iso ation of RNA.
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All three of these kits work on the same principle. The cells or the cytoplasm was 
disrupted in a high salt guanidinium buffer which provides optimal binding conditions 
for the RNA to the silica gel membrane. Contaminants were washed away with wash 
buffer and the RNA eluted with water.
Embryonic stem cells were washed twice with DPBS-A then were treated with trypsin- 
EDTA as for subculture. The cells were counted in a haemocytometer and collected as a 
pellet by centrifugation at 200g at room temperature. As ES cells are believed to be rich 
in RNA, to avoid overloading the columns, the midi column was used for all samples 
with more than 5xl06 cells and the mini column was used for samples with less than 
5xl06 cells. The cells were then processed using the protocol provided with the kit for 
the isolation of total RNA from the cytoplasm of the cells to minimise DNA 
contamination of the RNA and to enrich for mature, fully spliced mRNA.
The Zymo Mini RNA Isolation kit™ works exactly as above but is designed for the 
extraction of RNA from very small samples down to 101 cells and elutes in 8pi of water. 
In this case to avoid losing precious material, we isolated total RNA rather than 
cytoplasmic. Isolated tissues from embryos or colonies of ES cells picked by means of a 
glass capillary and were collected in a minimal volume of DPBS-A in sterile 
microcentrifuge tubes. The cellular material was lysed in 200pl of Zymo RNA 
Extraction Buffer. The manufacturers’ protocols were followed in all cases.
2.3.1b Purification o f mRNA using Dynabeads™
Messenger RNA (mRNA) was extracted by means of a magnetic poly-T bead. These 
magnetic beads have oligo(dT) 25 covalently bound to their surface .The polyA tail
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present on the mRNA hybridises to the oligo(dT) on the bead. By placing the tube in a 
magnetic stand, the supernatant with the impurities can be removed.
Resuspended beads (200pl) (Dynal, Oslo, Norway) were placed in a sterile 
microcentrifuge tube which was then placed in a magnetic stand (Promega Ltd., 
Southampton, UK). The beads were left for approximately 30 seconds to allow the 
suspension to clear, and then the supernatant was removed. The beads were pre-washed 
in 200pl 2x binding buffer (20mM Tris-HCl pH 7.5, 1M LiCl, 2mM EDTA), and again 
placed in a magnetic stand. Meanwhile, 150jig of total RNA (200pl) was incubated at 
65°C for 2 minutes. The 2x binding buffer was removed from the beads and these were 
resuspended in a further 200pi of 2x binding buffer. The total RNA was added to the 
bead suspension, and mixed thoroughly for 5 minutes at room temperature. The vial was 
placed in the magnetic stand for 2 minutes and the supernatant removed. The bound 
mRNA was washed twice by the addition of 400pl of washing solution (lOmM Tris- 
HCl pH 8.0, 0.15M LiCl, ImM EDTA). After thorough mixing, the tube was placed 
back in the magnetic stand, and the supernatant removed. Care was taken to remove as 
much of the wash solution as possible. Elution solution (lOmM Tris-HCl pH 8.0) was 
added to the tube (20 j l l 1) and was incubated at 80°C for 2 minutes. The tube was placed 
in the magnetic stand, and the supernatant containing the mRNA was removed to a 
sterile microcentrifuge tube. The mRNA was stored at -70°C until use.
2.3.2. Ethanol Precipitation o f Nucleic Acids.
DNA was precipitated by the addition of 0.1 volume of 3M Sodium Acetate (Sigma) 
and 2.0 volumes of absolute ethanol and incubation at -20°C for 1 -2 hour or overnight. 
The DNA was then pelleted by centrifugation for 20minutes at 14,000g at 4°C. The 
pellet was washed once in 70% ethanol then air dried.
49
Chapter 2: Materials and Methods
RNA and cDNA was treated in the same manner except that 2.5 volumes of absolute 
ethanol were used.
2.3.3 Analysis o f Nucleic acids By Optical Density
Nucleic acids absorb at a wavelength of 260nm. Given that an absorbance of I o d  i s  
equivalent to 50|ig m l'1 of double-stranded DNA or 37pg ml'1 single-stranded DNA and 
40Dg ml'1 RNA, it was possible to quantify DNA and RNA concentrations. 
Furthermore, determining absorbencies at 230nm and 280nm provides a means of 
examining sample purity. Pure preparations of DNA and RNA will have an A260/A280 
ratio of approximately 1.8 and 2.0 respectively. Any protein or phenol contaminants 
will lower these values. Likewise an A260/A280 ratio of less than 2 is considered to be 
indicative of ethanol or salt contamination (Sambrook et al., 1998).
2.3.4 Analysis of Labelled Target by Optical Density.
For each labelling reaction the A260 and A550 or A650 for Cy3™ and Cy5™ respectively 
were measured. These measurements were used to calculate the amount of cDNA 
synthesised and the amount of dye incorporated into the cDNA. See Appendix 2 for 
calculations.
2.3.5. Slide Gels.
A  slide gel was produced by pouring approximately 2.5ml of 1.5% agarose dissolved in 
TAE buffer (40mM TRIS, ImM EDTA and 20mM acetic acid, pH8.5) into a slide gel 
mould (kindly fabricated by Mr John Harris, School of Biosciences, Cardiff University) 
and carefully placing a cleaned microscope slide over the molten agarose. After the gel 
had set, the gel on its slide was carefully peeled from the mould and the gel placed in a
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normal submerged gel tank under TAE buffer. For RNA analysis the sample was mixed 
with loading dye and loaded onto the gel. An appropriate molecular weight marker was 
also loaded to ascertain size. The gel was stained with SYBR® greenll (Molecular 
Probes) and viewed on a UV transilluminator.
For analysis of Cy™ dye labelled targets, a l|il aliquot of the sample was mixed with an 
equal volume of 50% glycerol and was carefully loaded into a well. Electrophoresis was 
performed at 90V for approximately 30 minutes. For molecular size analysis, either 
ALFexpress Sizer 50-500(Amersham Pharmacia Biotech) or DNA ladder of the 
appropriate size range (lOObp or 1Kb Plus, Gibco BRL) labelled with Cy3™ or Cy5™ 
was run in an adjacent slot. Cy™ labelled cDNA was then visualised following 
scanning at the appropriate wavelength using the GeneTac™ LSIV scanner.
2.3.6. Analysis of RNA by gel Electrophoresis.
RNA samples were resolved by gel electrophoresis using dissociating conditions. The 
denaturing conditions were provided by NorthemMax™ buffers (Ambion) which are a 
proprietary mix containing formaldehyde and MOPS. Agarose gels were prepared by 
melting the required amount of agarose (l-2%w/v) in lx TAE buffer. When below 
50°C, NorthemMax™ denaturing gel buffer (Ambion) was added and the gel poured 
into a prepared mould. When solid, the gel was put in a gel tank and submerged in 
NorthemMax™ running buffer (Ambion). The appropriate amount of RNA was mixed 
with 5x RNA loading buffer (0.25% bromophenol blue, 4mM EDTA, 0.9M 
formaldehyde, 20% glycerol, 30% formamide, 4x NorthemMax gel buffer), was heated 
to 65°C for 5min then quenched on ice before loading into gel slots. Millenium™ 
markers (Ambion) or 0.1-1 Kb RNA Marker (Sigma) were run in adjacent slots. The
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gels were stained with SYBR™ Green Gold (Invitrogen) RNA stain diluted 1:5,000 in 
TAE buffer pH 8.5 Nucleic acid bands were then visualised under UV light.
2.4 Microarray
2.4.1. Slides.
The cDNA from the NIA 15,000 mouse gene set were printed in a known format on to 
CMT-GAPS coated slides (Coming) using the Flexys™ High Density Arrayer 
(Genomic Solutions, Cambridge, UK). The cDNA was immobilised on the slide by first 
UV cross linking, achieved by placing the printed slides in a UV Stratalinker™ 2400 
bench top transilluminator (Stratagene Ltd), then by baking within a lightproof box in 
an oven at 80°C for 2 hours. The printing and immobilisation of the slides was carried 
out by the Microarray Facility, School of Biosciences, Cardiff University.
If not used immediately, the microarrays were stored in a desiccator at room 
temperature, protected from light.
2.4.2. Blocking Of CMT-GAPS™ Coated Slides
Immediately prior to use for hybridisation, the slides were blocked to prevent non­
specific binding of target DNA to reactive amine groups present in the Gamma Amino 
PropylSilane coating. This was achieved by placing the microarray in a 50ml Coplin jar 
containing blocking solution (1% Bovine Serum Albumin (Fraction V) (Sigma-Aldrich, 
Poole, UK), 5x SSC (20x SSC consists of 3M NaCl and 0.3M Na Citrate) and 0.1% 
SDS) pre-warmed to 42°C. Ensuring the slide was completely covered with blocking 
solution, blocking was performed in a water bath set at 42°C for 45 minutes. The 
microarray was then dipped briefly (2 seconds each) five times in sterile, filtered Milli- 
Q™ water. This was followed by a single 5-second dip in room temperature
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isopropanol. The blocked slide was then air dried for approximately 10 minutes. After 
blocking, it was imperative that the microarray be utilised for hybridisation within 1 
hour, since hybridisation efficiency decreases rapidly if left for any longer (Hegde et al., 
2000).
2.4.3. Using Target Labelled with Cy3/Cy5
The required amount of Cy3™ and Cy5™ labelled targets were combined in a sterile 
amber microcentrifuge tube and mixed thoroughly. The labelled cDNAs were reduced 
in volume to 18jxl using a rotary evaporator at 30°C. To the 1 8jll1 of target, l.Opl of each 
Poly-dA30(lm g mf'XM W G Biotech) and human COT-1 DNA(lmg.ml'1) (Gibco BRL) 
was added to the cDNA followed by denaturation at 95°C for 3 minutes to anneal to any 
poly-dT sequences. Prior to hybridisation, the volume of the labelled target was 
adjusted by the addition of hybridisation solution (2x hybridization solution, 50% 
formamide, 10% SSC, 0.2%SDS) and water. The labelled target was added to the 
microarray either in the hybridisation station (Genomic Solutions, Cambridge, UK) or 
under Hybri-slips (Sigma) and hybridised for 18 hours at 42°C.
2.4.4 Post Hybridization.
Following hybridisation unbound label was removed by washing once for 10 minutes at 
55°C in Wash Solution l(lxSSC, 0.2% SDS) then twice for 10 minutes each at 55°C in 
Wash Solution 2 (0.1% SSC, 0.2% SDS). The slides were finally rinsed in filtered 
Milli-Q water and dried with compressed air.
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2.4.5 Scanning.
Hybridised and washed slides were scanned at the appropriate wavelength using the 
GeneTAC™ LS-IV scanner (Genomic Solutions, Cambridge, UK) or Scan Array® 
Express HT (Perkin Elmer)
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3. Labelling of Target 
3. 1 1ntroduction
The success of an array experiment rests on the quality of the RNA target labelling. 
There are two commonly used labelling methods; fluorescent dyes or radioactive 
isotopes. Labelling can be achieved by three different methods; direct conjugation of 
label to the RNA, integration of labelled nucleotides into cDNA and introduction of 
nucleotides with an active side group into cDNA to which labelling molecules can be 
conjugated.
The most commonly used labelling procedures utilise either RNA polymerases (T7, T3 
and SP6 ), the Klenow fragment of DNA polymerase or reverse transcriptase to 
incorporate modified nucleotides or deoxynucleotides into RNA or DNA. For example 
RNA polymerase is used to produce biotinylated RNA for hybridisation with 
Affymetrix™ chips. The RNA polymerase promoter is attached to the cDNA copy 
during the reverse transcription of the RNA. This is described in more detail in Chapter
4. Although the use of RNA polymerase has the advantage of amplifying the RNA 
target, the RNA product is more labile and is at risk of degradation by RNases which 
are plentiful in the environment.
Reverse transcriptase is probably the most used enzyme for labelling target, particularly 
for cDNA arrays. Although reverse transcriptase has no intrinsic ability to amplify the 
target, it has the advantage that it produces a stable cDNA target. The disadvantage of 
reactions driven by reverse transcriptase is that they tend to copy only the 3' ends of the 
mRNA species due to limited processivity of the enzyme and secondary structure of the 
RNA (Yeakley et al., 2002)
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3.1.1 Labelling Molecules.
Fluorescent probes are preferable because of their general safety and low toxicity. 
Radioactive probes are not only hazardous but the signal from them is very prone to 
spreading, an effect also known as blooming, such that the signal from spots of highly 
expressed genes will contaminate neighbouring spots.
Most microarray slide scanners use fluorescence as the detection system. Lasers excite 
fluorescent dyes integrated into the target at their maximum excitation wavelength and 
the emitted light is measured. The dyes Cy3™ and Cy5™ are most commonly used in 
microarraying because of their combination of desirable properties (Table 3.1). The 
Stokes shift for these dyes are 20 and 21 respectively thus simplifying the separation of 
fluorescent signal from the excitation light. The negatively charged sulphate groups 
give the dyes good solubility and reduce aggregation. This allows them to function well 
in the aqueous solutions required by enzymes and hybridisation. They also reduce 
quenching. The high extinction coefficient is a reflection of the efficiency of these 
fluorophores to absorb light. The emission maxima are well separated so both dyes can 
be detected on the same array spot with little cross talk between the two signals. The 
intensity of a fluorophore is proportional to both the extinction coefficient (e), the 
measure of efficiency of light absorption and the quantum yield (())), the measure of the 
efficiency of photon release. Cy3™ and Cy5™ both have high extinction coefficients, 
150,000m'1 cm ' 1 and 250,000m 1 cm ' 1 respectively, and quantum yields of 0.14 and 
0.15.
The quantum yield of dyes used in microarrays usually lies between 0.1 and 0.5. 
Fluorescein, which has an extinction coefficient of 67,000M'1cm'1 and a quantum yield 
of 0.71, would be expected to give intensities similar to Cy5. However, fluorescein is
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sensitive to photobleaching and to fluctuations in pH. This has lead to the development 
of the Alexa dyes which have a similar ring structure to fluorescein but different side 
chains resulting in different excitation and emission spectra and different degrees of 
solubility. Cy3™ and Cy5™ are derived from the dyes C3 and C5 and differ from them 
only by the addition of the two sulphate groups which improves solubility.
Cy3™ Cy5™
Structure
HOjSva J v ywSOjH
J  )
Stoke’s Shift 2 0 2 1
Quantum Yield(O) 0.14 0.15
Extinction Coefficient(s) 150,000M-lcm-l 250,000M-lcm-l
Absorption 550 649
Maximum(nm) Green Red
Fluorescence 570 670
Maximum(nm) Yellow red/far-red
Table3.1: Properties of the dyes Cy3™ and Cy5™
In this study Cy3™ and Cy5™ were used as the fluorescent labelling molecules.
3.1.2 Labelling o f Target 
3.1.2a Labelling o f mRNA
Direct chemical labelling is at present the only way of avoiding a reverse transcription 
step. The method examined here couples fluorescent dyes to RNA or DNA using the 
ability of PtII compounds to attach to the N7 of purine residues (Figure 3.1) (van 
Belkum et al., 1994). After coupling of the Cy3™ or Cy5™ modified guanine to the
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cytoplasmic RNA sample, the labelled mRNA is separated by using a standard mRNA 
selection kit. These kits consist of beads with polyT covalently bound to the surface. 
The polyA tail of the mRNA hybridises with the polyT and the beads can then be 
washed clean of free dye and other contaminants. The dye labelled mRNA is then 
released from the bead.
Figure 3.1. Diagram of labelled PtII complex binding to the N7 of guanine.
Because no enzymes are involved there should be fewer problems with sequence 
specific variation and premature termination of the reverse transcriptase. Thus both dyes 
would be expected to be incorporated to the same extent and the problem of 3' bias
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would be eliminated. This may be particularly useful when RNA is amplified before 
labelling; further selection by another round of enzyme treatment could be avoided. 
However instability of an RNA target remains a problem. Furthermore, as the target is 
sense, it can only be used with cDNA or antisense oligo arrays.
3.1.2b Direct labelling o f cDNA
Direct labelling is carried out by incorporation of dNTPs with fluorescent side groups. 
Table 3.2 summarizes the steps involved in producing the labelled target by the method 
used in this laboratory.
Step
1 Anneal primer Heat to between 60°C and 70°C and cool to temperature for reverse transcriptase
2 Reverse transcribe
3 Remove template Alkali treatment followed by neutralisation
4 Clean labelled probe PCR cleanup kit.
Table 3.2: Steps involved in the production of labelled target by incorporation 
of Cy3™ or Cy5™ dUTP into cDNA by reverse transcriptase.
The first step consists of heating the RNA sample to between 60°C and 70°C in the 
presence of the primer. This has the effect of both removing secondary structure such as 
hairpin loops from the RNA which can result in premature termination of reverse 
transcription, and as the sample cools, allows specific annealing of the primer to the 
RNA. As the samples were cytoplasmic RNA all reverse transcription reactions were 
primed using oligo-(dT) which anneals preferentially to the poly-A tail of the mRNA. 
Where the primer was not supplied with a kit, oligo-(dT)23 with a single 
deoxynucleotide, either dA, dG or dC at the 3' end as the anchor was used. This ensures 
the hybridisation of the primer at the 5' end of the message.
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In the second step, a master mix containing the rest of the reverse transcription reaction 
components; enzyme, buffer, and a dNTP mix including Cy3™ or Cy5™ labelled 
dUTP, was added to the RNA and its annealed primer.
For efficient target hybridisatation, the unlabelled RNA template must be degraded. 
This is achieved in Step3 treatment with by alkali followed by neutralisation. The 
labelled cDNA is then cleaned of enzymes and oligos with a PCR cleanup kit.
3.1.2c Indirect labelling o f cDNA.
To alleviate the problem of uneven incorporation of the two dyes commonly seen with 
direct incorporation of Cy dye conjugated dUTP and to keep the advantages of a stable 
cDNA product, many workers have turned to indirect labelling of the cDNA.
Although the procedure has more steps and does not avoid the 3' bias inherent in the 
reverse transcription, the use of indirect labelling with aminoallyl dUTP is reputed to 
avoid some of the problems associated with the direct integration of Cy™ labelled 
dUTP. As the aminoallyl group is small, it is believed to be as efficiently incorporated 
into cDNA as unmodified and therefore integrates into the cDNA at a higher density 
thus resulting in more labelled target for a given amount of RNA template than for Cy- 
dUTP. The same molecule, the primary amine aminoallyl dUTP, is incorporated into 
both the samples being compared so the targets should be more similarly labelled.
The aminoallyl group is attached to the C5 on the dUTP base and has a 2 carbon spacer. 
This position ensures it will interfere least with ability of the enzyme to incorporate it 
and where the fluorescent side groups will be less likely to interfere with hybridisation 
(Figure 3.2)
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Figure 3.2: Aminoallyl dUTP
The process of indirect labelling can be broken down into a number of discrete steps 
each of which can be achieved in a number of ways, thus many factors can influence the 
outcome of labelling target (Table 3.3).
Step Methods available
1 Anneal primer
2 Reverse transcribe Enzyme, ratio of aminoallyl dUTP to dTTP
3 Remove template RNase H, alkali treatment followed by neutralisation
4 Clean cDNA and exchange buffer
PCR cleanup kit, ultrafiltration, resin + 
precipitation
5 Bind label
6 Clean labelled probe PCR cleanup kit, ion exchange chromatography, desalting, precipitation
Table 3.3: Steps involved in the production of labelled target by incorporation 
of aminoallyl dUTP into cDNA by reverse transcriptase.
Before the aminoallyl modified cDNA is reacted with the Cy dye it must be cleaned of 
enzyme, dNTPs, primers and oligos. Also the buffer must be changed from TRIS, which 
would compete with the coupling of the reactive monofunctional N-hydroxysuccinimide 
Cy™ dyes to the aminoallyl groups on the cDNA (Figure 3.3).
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Figure 3.3: Reaction between the primary amine group on aminoallyl dUTP 
and the monoreactive Cy™ dye
One method, the QIAquick™ PCR kit, is designed for purification of double- or single­
stranded DNA between lOObp and lOkb and utilises a silica-gel membrane in a spin 
column. The DNA adsorbs to the silica-membrane in the presence of high salt and the 
degraded RNA oligomers and unincorporated CyDye-nucleotides are washed away. The 
labelled cDNA is then eluted in water. Another method uses a resin to remove enzymes 
followed by ethanol precipitation to remove the primers, oligos and dNTPs. This also 
achieves the removal of the TRIS buffer. Reactions can also be cleaned and the TRIS 
buffer removed by applying to a Microcon-30™ ultrafiltration unit. These devices 
consist of a filter with a nominal molecular weight cutoff of 30,000 Daltons in a 
centrifuge tube. Sequentially adding water and spinning the tube achieves both desalting 
and concentration of the sample.
The conjugation of the monoreactive Cy dye to the aminoallyl groups on the cDNA 
takes place at pH9.0 in a buffer without TRIS at room temperature, usually 0.1M 
NaHC03.
The final clean up of the labelled target to remove the unbound dye can be achieved also 
by PCR cleanup kit, ion exchange chromatography, desalting or precipitation.
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At the time when this project was initiated, there were few well optimised protocols for 
labelling. Also the development of commercial kits was at early stages. The kit most 
often used in our laboratory was the CyScribe™ direct labelling kit which incorporates 
Cy™ dye labelled dUTP into cDNA by means of reverse transcription. Even then it was 
known that this labelling method suffered from a number of drawbacks the most 
important of which was that Cy3™ was incorporated at a much higher density into the 
cDNA than the larger and more hydrophobic Cy5™.
A number of experiments were undertaken to examine the different methods of labelling 
and to test some of the newly emerging kits as they became available. Fluorescently 
labelled target was produced by integration of modified nucleotides into cDNA using 
cytoplasmic RNA as the template for the DNA polymerase reverse transcriptase. A 
summary of the experiments involving incorporation of label by reverse transcriptase is 
provided in Table 3.4.
Cytoplasmic RNA has the advantage of being full length and fully processed. In the 
direct labelling protocol, dUTP conjugated to the fluorescent dyes, Cy3™ or Cy5™ was 
incorporated into the cDNA using the CyScribe™ Direct Labelling kit. Indirect 
labelling was achieved by integration of dUTP modified by the addition of an amino 
group with a short spacer, aminoallyl-dUTP. Monofunctional N-hydroxysuccinimide 
activated fluorescent dyes were then coupled to the amino groups (Figure 3.3). A 
number of experiments were conducted based on a method published on the web by 
Joseph DeRisi (http://derisilab.ucsf.edu/pdfs/amino-allvl-protocol.pdf). Three 
commercial kits using integration of aminoallyl dUTP (Atlas™ Glass Fluorescent 
Labelling Kit, Atlas™ PowerScript™ Fluorescent Labelling Kit and CyScribe™ Post- 
Labelling Kit) were also assessed.
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Direct
Incorporation 
CyScribe™ First- 
Strand Labelling 
Kit
Indirect Incorporation
http://derisilab.ucsf.edu/pdfs/amino-
allvl-protocol.pdf
Indirect 
Incorporation 
Atlas™ Glass 
Fluorescent 
Labelling Kit
Indirect
Incorporation
Atlas™
PowerScript™
Fluorescent
Labelling Kit
Indirect 
Incorporation 
CyScribe™ Post- 
Labelling Kit
Maximum Input 
RNA
lOug lOug lOug 8ug 5ug
Anneal Primer 70°C, 5min, 
anchored oligo- 
(dT)
65°C, 5min, 160pmol anchored 
oligo-(dT)
70°C, 5min, 70pM 
anchored oligo- 
(dT)
70°C, 5min, 70pM 
anchored oligo- 
(dT)
70°C, 5min, 
anchored oligo- 
(dT)
Reverse
Transcribe
1.5h, 42°C l-2h, 42°C 30min, 42°C lh, 42°C 1.5h, 42°C
Destroy Template NaOH NaOH RNasin RNasin NaOH
Clean cDNA Not applicable Microcon-30™ or ethanol 
precipitation
ethanol
precipitation
ethanol
precipitation
ethanol
precipitation
Bind Label Not applicable 0.1MNaHCO3, pH9.0 Supplied buffer Supplied buffer 0.1M NaHC03, 
Pl 19.0
Clean Labelled 
Probe
QIAquik™ PCR 
Cleanup Kit
QIAquik™ PCR Cleanup Kit ethanol 
precipitation 
followed by Atlas 
NucleoSpin™ 
Extraction Kit
ethanol 
precipitation 
followed by 
QIAquik™ PCR 
Cleanup Kit
QIAquik™ PCR 
Cleanup Kit
Full Protocol Table 3.7 Table 3.8 Table 3.9 Table 3.10 Table 3.11
Table 3.4: Summary of the methods used to integrate Cy dye labelled molecules into cDNA using reverse transcription
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The principle of the DeRisi method and all three kits was similar, with differences only 
in detail. To check if problems arising were inherent in the method or due to poor 
optimization, the performance of two kits from the same manufacturer were assessed. 
The PowerScript™ kit was supposed to be an improvement on the Atlas™ Glass kit.
Direct chemical labelling of RNA was achieved by platinum-linked cyanine dyes 
(Gupta et a l,  2003) using the MICROMAX™ ASAP RNA Labelling Kit.
3.2 Materials and Methods
The ES line IMT-1 l(Bierbaum et al., 1994) was cultured as described in Section 2.1. 
Cytoplasmic RNA was purified from the cells at passage 17 according to the protocol 
described (Section 2.3.2). The same sample was used for all experiments.
All labelled targets were either used immediately or stored at -20°C protected from 
light.
Analysis of the probes was carried out by spectrophotometric analysis (Section 2.3.4) 
and slide gel electrophoresis (Section 2.3.5). The amount of cDNA synthesised and the 
incorporation of dyes was calculated by application of Beer-Lambert’s Law.
Beer-Lambert’s Law 
A=clc
where A is the absorbance 
e is the extinction coefficient in cm'1 M'1 
1 is the pathiength in cm 
c is the concentration in mol I'1
The amount of cDNA synthesised and the incorporation of Cy™ dye was quantified by 
measuring the optical density of the labelled cDNA at 260nm and 550nm for Cy3™ and
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at 260nm and 650nm for Cy5™. The amount of cDNA synthesised was calculated as 1 
A26ounit=37jig/ml. The number of pmols of dye incorporated into cDNA was calculated 
using the formulae: pmol Cy3= OD550 x 100/0.15, where 100 is the volume of the probe 
in pi and 0.15 is the extinction coefficient for Cy3™ and pmol Cy5™= OD650 x 
100/0.25 where 0.25 is the extinction coefficient for Cy5™.
The FOI for each labelled sample, which is the number of Cy-dUTPs per 1,000 
nucleotides of cDNA, was also calculated according to the formulae: FOI Cy3™= 
OD550 x 58.5/OD26oand FOI Cy5= OD6so x 35.1/OD260
See Appendix 2 for details of calculations.
Slide gels (2.3.5) were also run to assess the molecular weight spread and the level of 
residual free dye.
Kits and reagents were purchased as listed in Table 3.5. All the manufacturers’
protocols are reproduced for ease of comparison.
CyScribe™ First-Strand Labelling Kit Amersham Pharmacia Biotech
Advantage reverse transcriptase BD Biosciences, Paola Alto, Ca
Aminoallyl dUTP Sigma
Anchored oligo-(dT) Sigma
Atlas™ Glass Fluorescent Labelling Kit BD Biosciences, Paola Alto, Ca
Atlas™ PowerScript™ Fluorescent Labelling Kit BD Biosciences, Paola Alto, Ca
Cy3™, monoreactive NHS ester derivatized Amersham Pharmacia Biotech
Cy3™-dUTP Amersham Pharmacia Biotech
Cy5™, monoreactive NHS ester derivatized Amersham Pharmacia Biotech
Cy5™-dUTP Amersham Pharmacia Biotech
CyScribe™ Post- Labelling Kit Amersham Pharmacia Biotech
dNTP set lOOmM each Invitrogen
Microcon™ YM-30 filters Amicon
MICROMAX™ ASAP RNA Labelling Kit PerkinElmer Life Sciences
MMLV reverse transcriptase Promega
Oligotex™ mRNA Mini Kit Qiagen
QIAquick™ PCR purification kit Qiagen
Superscript II™ reverse transcriptase Invitrogen
Table 3.5: Reagents and kits used.
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3.2.1 Direct Labelling
3.2.1a. Production o f fluorescently labelled target RNA using the MICROMAX ASAP 
kit.
The MICROMAX ASAP kit conjugates the Cy dyes directly to the N7 of the guanine 
and adenine residues of the RNA through a platinum universal linker, (van Belkum et 
al., 1994)
Cytoplasmic RNA (10pg) was labelled with Cy dye and then labelled mRNA purified 
from the sample using the Oligotex™ mRNA Mini Kit as described in Table 3.6.
Instead of combining the Cy3™ and Cy5™ labelled RNA before purifying the mRNA, 
as in the manufacturer’s protocol, the two labelled products were handled separately so 
that each could be analysed by spectrophotometry and slide gel electrophoresis.
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1 Labelling
AlOpg sample of cytoplasmic RNA was combined with the 
provided labelling buffer in a total volume of 20pl. To this, 2pl 
of the labelling reagent was added and the reaction mixture was 
incubated at 85°C for 15 min then was cooled on ice. The 
reaction was stopped by the addition of the ASAP stop buffer.
2 Purification of mRNA
The Qiagen Oligotex™ mRNA Mini Kit was used to purify the 
labelled mRNA..
Prepared Oligotex suspension by heating to 37°C, mixing by 
vortex and holding at room temperature. Buffer OEB was 
preheated to 70°C.
The volume of the sample was adjusted to 250pl with nuclease 
free water then 250pl of buffer OBB and 15pl of Oligotex 
suspension were added.
The sample was incubated at 70°C for 3min then held at room 
temperature (between 20°C and 30°C) for lOmin.
The Oligotex-mRNA complex was pelleted by centrifugation at 
14000g for 2min in a microcentrifuge and the supernatant was 
removed.
The Oligotex-mRNA was resuspended in 400pl Buffer OW2 and 
transferred to a small spin column inside a 1.5ml microcentrifuge 
tube.
This was then centrifuged at 14000g for lmin.
The tube with the flowthrough was discarded, the column was 
transferred to a fresh tube, 400pl of fresh Buffer OW2 was added 
to the column and the centrifugation was repeated.
The column was transferred to a fresh amber 1.5ml centrifuge 
tube and the labelled mRNA was eluted by resuspension of the 
resin in 40pl of Buffer OEB at 70°C and centrifugation for lmin 
at 14000g. This elution step was repeated.
Table 3.6. Protocol for the production of labelled mRNA using the MicroMax 
ASAP kit.
3.2.1b Production o f fluorescently labelled target cDNA using the CyScribe™ First 
Strand cDNA Labelling Kit.
The CyScribe™ First Strand Labelling Kit is designed to incorporate either Cy3™ or 
Cy5™ labelled dUTP into cDNA by reverse transcription. All components except the 
NaOH, HEPES and the QIAquick™ purification kit components were supplied with the
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CyScribe™ First strand cDNA Labelling Kit. The QIAquick™ kit was supplied with all 
components except the nuclease free water.
Labelling of lOug of target was carried out using the protocol supplied with the kit as 
described in Table 3.7. The probes were analysed by spectrophotometry and the amount 
of cDNA synthesised, the amount of dye incorporated into the cDNA and the number of 
dye molecules incorporated per 1000 nucleotides, the FOI, were calculated.
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1 Anneal primer
Mixed in PCR tube: 
lOpg cytoplasmic RNA 
1 pi anchored oligo-(dT)
Nuclease free water to 1 lpl 
Heated to 70°C for 5min.
Cooled to room temperature lOmin.
2 Reverse transcribe
The following master mix was assembled on ice and
added to the sample
4pl of 5x CyScribe™ buffer,
2pl lOOmM DTT,
1 pi dUTP nucleotide mix,
1 pi of ImM Cy3™ or Cy5™ labelled dUTP
1 pi CyScript™ reverse transcriptase
The 20pl reverse transcription reaction was
incubated for 1.5h at 42°C.
3 Remove template
2pl of 2.5M NaOH was added and the mixture was 
incubated at 37°C for 15min, then neutralised with 
lOpl of 2M HEPES.
4 Clean labelled probe
QIAquick™ PCR Cleanup Kit 
Five volumes of Buffer PB were added to the 
sample and the whole volume was applied to a 
QIAquick spin column in a 2ml collection tube.
The cDNA was bound to the membrane by spinning 
at 13,000g for 1 min in a microcentrifuge and the 
flowthrough discarded.
The column was washed once with 700pl, and then 
twice with 400pl Buffer PE discarding the 
flowthrough after each lmin centrifugation at 
13,000g.
The column was dried of residual ethanol by 
centrifugation for an additional minute.
The probe was then eluted from the column into a 
sterile, amber microcentrifuge tube by adding 50D1 
of nuclease free water to the centre of the membrane 
and incubation for lmin at room temperature before 
centrifugation for lmin at 13000g. A repeat of this 
elution step completed the release of the purified 
probe.
Table 3.7: Protocol for production of labelled cDNA with the CyScribe™ Direct 
abelling kit.
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3.2.2. Indirect Labelling
3.2.2a. Protocol to test parameters o f fluorescently labelled target production by 
aminoallyl labelling.
The protocol used and described in Table 3.8 was adapted from one published by 
Joseph DeRisi on the web http://derisilab.ucsf.edu/pdfs/amino-allvl-protocol.pdf.
All the experiments carried out using this protocol were performed with lOpg of 
cytoplasmic RNA. Labelled target was cleaned with the QIAquick™ cleanup kit using a 
modified washing protocol (Table 3.7, Step 6)
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1 Annealprimer
Mixed in PCR tube:
lOpg cytoplasmic RNA
150pmol anchored oligo-(dT)(Sigma)
Nuclease free water to 20pl (Ambion)
Heated to 65°C for 5min
Cooled to the reaction temperature being tested
2 Reversetranscribe
A master mix was assembled on ice and added to the sample:
8|xl of 5x First Strand Buffer (as provided with the enzyme under 
test),
lOmM DTT
0.5mM each of dG, dA and dC mix.
Aminoallyl-dUTP and dTTP, each at 5mM were added in varying 
proportions such that the final concentration of aminoallyl-dUTP 
+ dTTP was 0.5mM, the same as for each of the other dNTPs. 
Rnasin (Invitrogen) 40U 
Reverse transcriptase, 400U, was added.
The complete reaction volume was 40 j l l 1.
The reverse transcription reactions were incubated at 42°C for 
between l and 2h.
3 Removetemplate
Added:
4jiL of 50mM EDTA 
2jliL of ION NaOH 
Incubated at 65°C for 20min.
Samples were neutralised with 4|iL of 5M Acetic Acid.
4
Clean cDNA 
and exchange 
buffer
450 j l i 1 of nuclease free water was added to the reaction tube and 
applied to a Microcon-30™ ultrafiltration unit Spun for 8min at 
12,000g in a microcentrifuge. 500|il of water was added to the 
ultrafiltration unit Repeated centrifugation for 8min at 12,000rpm. 
This wash step was repeated twice.
The sample reservoir was inverted over a fresh collection tube and 
spun at 4,000g to transfer the sample. The sample was then 
reduced in volume in a rotary evaporator to 1-2j l i 1.
Table 3.7: Protocol for the production of labelled cDNA by the incorporation of 
aminoallyl dUTP using a modification of the method of Joseph DeRisi. 
http://derisilab.ucsf.edu/pdfs/amino-allvl-protocol.pdf continued on next page
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4* Alternative 
clean cDNA 
and exchange 
buffer
Alternatively; removal of oligonucleotides, primers and 
exchange of buffers was achieved by ethanol precipitation 
(2.3.2.)
5 Bind label
A 12.5mM stock of mono-functional Cy3™ and Cy5™ in 
DMSO was made and 1.25|xl was added to the cDNA which was 
dissolved in 9|il of 0.1 M NaHCC>3 pH9.0. The coupling reaction 
was incubated for 45min at room temperature in the dark The 
reactions were quenched by the addition of 4.5|xl of 4M 
hydroxylamine and incubation in the dark, at room temperature 
for 15min.
6 Clean labelled probe
Samples were then purified with a Qiagen QIAquick™ PCR 
purification kit with a modified washing procedure. The whole 
protocol was executed at room temperature. All centrifugation 
steps were carried out at 13,000g in a microcentrifuge. The 
column was washed 3 times with 500pl of the wash buffer PE 
before elution with the buffer EB. Elution was carried out by 
incubation of the column with 50pl of EB for lmin followed by 
centrifugation for lmin. The elution step was repeated once.
Table 3.7 contd: Proltocol for the production of labelled cDNA by the incorporation
of aminoallyl dUTP using a modification of the method of Joseph DeRisi. 
http://derisilab.ucsf.edu/pdfs/amino-allvl-protocol.pdf
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3.2.2b Comparison o f three commercially available kits.
Three commercially available kits were tested.
3.2.2b. 1 Production of Fluorescently Labelled Target cDNA using the 
CLONTECH Atlas™ Glass Fluorescent Labelling Kit
The CLONTECH Atlas™ Glass Fluorescent Labelling kit was used according to the 
manufacturer’s protocol described in Table 3.8. The NucleoSpin™ purification kit was 
supplied with the Atlas™ Glass Fluorescent Labelling Kit. This kit is similar in function 
and in use to the QIAquick™ Cleanup kit used in the other protocols.
This kit also recommends a maximum of lOpg input of total RNA. In this case lOpg of 
cytoplasmic RNA as in the other protocols was used.
3.2.2b.2 Production of fluorescently labelled target cDNA using the CLONTECH 
Atlas™ PowerScript™ Fluorescent Labelling Kit.
The CLONTECH Atlas™ PowerScript™ Fluorescent Labelling kit was used according 
to the manufacturer’s protocol (Table 3.9). For this kit a maximum of 8ug of 
cytoplasmic RNA was combined, in a PCR tube, with anchored oligo-(dT) (Sigma) and 
the reverse transcription was carried out in exactly the same way as for the Atlas™ 
Glass Fluorescent Labelling Kit. As no purification kit is supplied with this kit, the 
QIAquick™ Cleanup Kit was purchased separately. A modification of the QIAquick™ 
Cleanup Kit protocol as described in Table 3.6 Step 6 was used.
Instead of using RNase H to degrade the template, in some cases NaOH was used 
(Table 3.9, Step3*).
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1 Anneal primer
Cytoplasmic RNA (10pg) was combined with 70|iM 
anchored oligo-(dT) (Sigma) to give a concentration of 
5pM in the final 50jil synthesis reaction and the volume 
was made up to 25pl with nuclease free water. The tube 
was then heated to 70°C for 5min then cooled to the 
temperature being tested.
2 Reverse transcribe
A master mix was assembled from 
10pl of 5x cDNA Synthesis Buffer,
5fil of lOx dNTP Mix,
7.5jnl of nuclease free water
2.5pl (200units/|Lil) MMLV Reverse Transcriptase 
provided in the kit, total volume 25pl. This was added 
to the RNA/oligo-(dT) and the reaction was allowed to 
proceed for the 30min. At the end of the incubation 
period, the reaction was heated to 70°C for 5min to 
inactivate the enzyme then was spun briefly in a 
microcentrifuge to collect the tube contents
3 Remove template
The tube was then equilibrated at 37°C, 0.5fxl RnaseH 
(10units/pl) were added and incubation continued for 
15min to degrade the template.
4 Clean cDNA and exchange buffer
Reactions were stopped, cleaned and the TRIS buffer 
removed by the addition of 0.5|xl EDTA (pH8.0) and 
5|il QuickClean™ resin. After mixing by vortexing for 
1 minute, the tube was spun in a microcentrifuge and the 
supernatant transferred to a 0.45pm spin filter in a 
collection tube. The filter assembly was then spun at full 
speed for 1 minute. The cDNA was precipitated from the 
eluate by ethanol (Section 2.3.2) at -20°C for a 
minimum of lh. The cDNA was then pelleted by 
centrifugation for 20min at full speed in a 
microcentrifuge. The pellet was washed once in 70% 
ethanol then airdryed.
5 Bind label
The cDNA pellets were dissolved in lOpl of 2x 
Fluorescent Labelling Buffer.
A 5mM solution of mono-reactive fluorescent dye, Cy3 
or Cy5, was prepared by adding 45pl of DMSO to a 
tube of dye. To the cDNA solution, lOpl of the dye was 
added and coupling was allowed to proceed for between 
30min and lh in the dark.
Table 3.8: Protocol for the production of fluorescently labelled Target cDNA using 
the CLONTECH Atlas™ Glass Fluorescent Labelling Kit. Continued on next page.
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6 Clean labelled probe
The dye-coupled cDNA was precipitated ethanol 
(Section 2.3.2) at -20°C for a minimum of 2h.The 
cDNA was then pelleted by centrifugation for 
20minutes at full speed in a microcentrifuge. The pellet 
was washed once in 70% ethanol then airdryed. The 
dried pellet was dissolved in lOOjil nuclease free water 
and cleaned as described in the manufacturer’s protocol 
with the Atlas NucleoSpin™ Extraction Kit provided 
with the labelling kit.
The whole process was carried out at room temperature. 
All centrifugation steps were carried out at 13,000g in a 
microcentrifuge. 400pl of Buffer NT2 was added to the 
sample and the thoroughly mixed sample was then 
loaded on to a column. The column was spun at for 
lmin. The column was washed 3 times with 700pl of 
Buffer NT3, spinning as before. The column was dried 
of residual Buffer NT3 by spinning for a further 2min. 
The sample was eluted into a fresh amber 
microcentrifuge tube by applying 50pl of Buffer NE to 
the column, incubating for lmin and spinning for lmin. 
This elution step was repeated once._________________
Table 3.8 Contd: Protocol for the production of fluorescently labelled Target 
cDNA using the CLONTECH Atlas™ Glass Fluorescent Labelling Kit.
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1 Anneal primer
A maximum of 8ug of total RNA was combined, in a 
PCR tube with 70pM anchored oligo-(dT) (Sigma) to 
give a concentration of 5pM in the final 20pl synthesis 
reaction and the volume was made up to lOpl with 
nuclease free water. The tube was then heated to 70°C 
for 5min.
2 Reverse transcribe
A master mix was assembled from lOjil of 5x cDNA 
Synthesis Buffer, 5 j l l 1 of lOx dNTP Mix, 7.5pl of 
nuclease free water and 2.5|il (200units/pl) MMLV 
Reverse Transcriptase provided in the kit, total volume 
25|l i 1. This was added to the RNA/oligo-(dT) and the 
reaction was allowed to proceed for lh. At the end of 
the incubation period, the reaction was heated to 70°C 
for 5min to inactivate the enzyme then was spun 
briefly in a microcentrifuge to collect the tube contents
3 Remove template
The tube was then equilibrated at 37°C, 0.5|il RnaseH 
(lOunits/jil) were added and incubation continued for 
15min to degrade the template.
3* Remove template
The RNA template and other RNA species were 
degraded by the addition of 2pl of 2.5M NaOH and 
incubation at 37°C for 15min, followed by 
neutralisation with lOpl of 2M HEPES.
4 Clean cDNA and exchange buffer
Reactions were stopped, cleaned and the TRIS buffer 
removed by the addition of 0.5pl EDTA (pH8.0) and 
5|il QuickClean™ resin. After mixing by vortexing for 
lmin, the tube was spun in a microcentrifuge and the 
supernatant transferred to a 0.45pm spin filter in a 
collection tube. The filter assembly was then spun at 
full speed for lmin. The cDNA was precipitated from 
the eluate by ethanol (Section 2.3.2) at -20°C for a 
minimum of lh.The cDNA was then pelleted by 
centrifugation for 20min at full speed in a 
microcentrifuge. The pellet was washed once in 70% 
ethanol then airdryed.
5 Bind label
The cDNA pellets were dissolved in lOpl of 2x 
Fluorescent Labelling Buffer.
A 5mM solution of mono-reactive fluorescent dye, 
Cy3 or Cy5, was prepared by adding 45pl of DMSO to 
a tube of dye. To the cDNA solution, lOpl of the dye 
was added and coupling was allowed to proceed for 
between 30min and lh in the dark.
Table 3.9: Protocol for the production of fluorescently labelled target cDNA using the 
CLONTECH Atlas™ PowerScript™ Fluorescent Labelling Kit. Continued on next 
page.
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6 Clean labelled probe
The dye-coupled cDNA precipitated from by ethanol 
(Section 2.3.2) at -20°C for a minimum of 2h.The 
cDNA was then pelleted by centrifugation for 20min at 
full speed in a microcentrifuge. The pellet was washed 
once in 70% ethanol then airdryed as before. The dried 
pellet was dissolved in lOOpl nuclease free water and 
cleaned with the QIAquick™ kit (Table 3.6 Step 6).
Table 3.9 contd: Protocol for the production of fluorescently labelled target 
cDNA using the CLONTECH Atlas™ PowerScript™ Fluorescent Labelling Kit.
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3.2.2b.3 Production of fluorescently labelled target using the CyScribe™ cDNA 
Post Labelling Kit
The CyScribe™ cDNA Post Labelling kit was used according to the manufacturer’s 
protocol (Table 3.11). Labelling was performed with 5pg of RNA using the CyScribe™ 
cDNA Post labelling kit. Purification of the labelled targets was carried out using the 
QIAquick™ cleanup kit with the modified protocol described in Table 3.8 Step 6. The
labelled targets were analysed by spectrophotometry and quantified as before.
1 Anneal primer
Mixed in PCR tube:
5pg cytoplasmic RNA 
ljil anchored oligo-(dT)
Nuclease free water to 11 jxl 
Heated to 70°C for 5min 
Cooled to room temperature lOmin.
2 Reverse transcribe
A master mix was assembled from 
4pJ of 5x CyScribe™ buffer 
2pl lOOmM DTT 
lpl dUTP nucleotide mix 
lp l AA-dUTP
1 pi CyScript™ reverse transcriptase
Total reaction volume 20|il. The reverse transcription
reaction 1.5h at 42°C.
3 Remove template Added 2pl of 2.5M NaOH, incubated at 37°C for 15min, and neutralised with lOjul of 2M HEPES.
4 Clean cDNA and exchange buffer
Ethanol precipitated the cDNA (Section 2.3.2) at -20°C 
for a minimum of 2h.The cDNA was then pelleted by 
centrifugation for 20min at full speed in a 
microcentrifuge. The pellet was washed once in 70% 
ethanol then airdryed.
5 Bind label
The cDNA pellet was dissolved in 15pl of nuclease water 
and mixed with the contents of one vial of mono-reactive 
Cy3™ or Cy5™ (as supplied in the kit) dissolved in 15|il 
0.1M Sodium Bicarbonate pH9.0.The dye coupling 
reaction was incubated at room temperature for 1 h in the 
dark. Unreacted Cy dye NHS ester molecules were 
inactivated by the addition of 15pl of 4M 
Hydroxylamine.
6 Clean labelled probe
The cDNA was then purified using a QIAquick™ kit as 
in Table 3.6 Step 6.
Table 3.10: Protocol for the production of fluorescently labelled target using the 
CyScribe™ cDNA Post Labelling Kit
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3.2.3 Comparison o f Arrays Hybridised with Target prepared by the 
Atlas™  PowerScript™  Fluorescent Labelling Kit, the Template being 
Destroyed either by RNase H or NaOH.
Fluorescently labelled target was prepared using the Atlas™ PowerScript™ Fluorescent 
Labelling Kit and 5pg of cytoplasmic RNA (Table 3.9). The RNA template was 
destroyed (Step3) by either RNaseH or by the alternative NaOH (Step 3*)
Slides printed with the NIA 15K mouse gene set were prepared and hybridisations 
carried out with 15pmol of dye incorporated into the targets according to the protocols 
in Section 2.4. One slide for each pair of targets were hybridised. The targets were 
hybridised with array slides according to the plan in Table 3.12.
Slide Number ExperimentNumber Cy3 Cy5
1 1 RNase RNase
2 1 NaOH NaOH
3 2 RNase RNase
4 2 NaOH NaOH
Table 3.11: Hybridisation plan
The hybridised and washed slides were scanned in a ScanArray Express HT scanner 
(Perkin Elmer) at 65pmt (photo multiplier tube) and 90% laser power gain. The scan 
resolution was lOp and was run at full speed. The pmt gain was derived empirically to 
maximise sensitivity and minimise both signal to noise ratio and saturation. The value 
recommended by the manufacturer is 70-80%, however with these arrays this led to 
saturation of the highly expressed spots. The laser power and scan resolution were set 
according to the manufacturer’s recommendations.
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Image analysis of the slides was carried out using the software ImaGene5.5™ 
(Biodiscovery). Spots were detected using automatic spot finding with the grid 
constraints enforced and spot detection set with local flexibility of 20 pixels and global 
flexibilty set just above half (Fig 3.4). These settings maximise the spots found while 
minimising the false detection of contamination as spots. As there was no evidence of 
negative spots (spots which show on the slides as holes with signal less than the 
background) this was left unmarked. A spot was designated as empty (Flag 2) if both 
channels were so flagged and as poor (Flag 3) or negative (Flag 4) if either channel was 
flagged. The threshold for the designation of a spot as empty was adjusted to 0.6 by 
using an unflagged Blank spot, and increasing the threshold till it was flagged .
The data from the two experiments was combined such that only spots which were good 
in both experiments (unflagged) were included. For NaOH this was 1746 spots and for 
RNase 1219 spots. These spots were further analysed using the linest function; which 
fits a linear regression line to the data by the least squares method and calculates the test 
statistics; in Microsoft Excel™ 2003 forcing the intercept to go through the origen. 
Scatter plots were generated of Cy3™ against Cy5™ and a trendline produced. 
Statistics from the linest output were examined.
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Figure 3.4: Screen shots of the settings used in the image analysis of the slides with RNase or NaOH treated 
aminoallyl cDNA
00u>
Chapter 3: Labelling of Target
3.3 Results and Discussion
3.3.1 Direct Labelling
3.3.1a. Production o f  fluorescently labelled target RNA using the MICROMAX ASAP 
kit.
Because no enzymes are involved when using the MICROMAX ASAP kit, there should 
be fewer problems with sequence specific variation and premature termination of the 
reverse transcriptase. Also, both dyes would be expected to be incorporated to the same 
extent.
Unfortunately, the fines sometimes left in the labelled mRNA by the Oligotex™ 
mRNA purification kit interfered with the optical density of the samples making it 
impossible to assess the incorporation of the dye into the mRNA. Also, it proved very 
difficult to run the labelled RNA on slide gels so the molecular weight spread and the 
amount of residual free dye could not be assessed. However, when hybridised to an 
array slide, the degree of hybridisation was good with little background problems. There 
is no numerical data for this as the array slides used were only partially printed (Figure 
3.5).
It was also discovered while using this kit that the Cy5™ labelling reagent was 
considerably less stable than the Cy3 and that both were very unstable in the summer 
months due to high humidity.
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Figure 3.5: Example area of array hybridised with mRNA labelled 
with the MICROMAX™ ASAP kit (PerkinElmer). Green spots are 
genes which are more highly expressed in the Cy3™ channel, red are 
more highly expressed in the Cy5™ channel. Yellow indicates equal 
expression in both channels.
3.3.1b Production o f fluorescently labelled target cDNA using the CyScribe™ First 
Strand cDNA Labelling Kit.
From the result in Table 3.13 it can be seen that approximately double the amount of 
Cy5™ labelled target would be required to achieve similar levels of fluorescence in
both channels which would be expected to result in loss of sensitivity, particularly with 
highly expressed genes. This is despite the CyScribe™ enzyme which was developed to 
overcome the problems of incorporating the large bulky groups and to reduce the 
problem of uneven incorporation due to the larger size of the Cy5™.
cDNA ng pmol dye FOI
CyScribe™ direct kit Cy3™ 616.05 27.33 14.41
CyScribe™ direct kit Cy5™ 455.10 13.00 9.27
Table3.13: Amount of cD SA  and dye incorporation using
CyScribe™ direct labelling kit.lOpg of cytoplasmic RNA was 
labelled using the CyScribe™ labelling kit. The amount of cDNA 
produced was calculated from the OD260 and the pmol of dye 
incorporated was calculated from the OD550 for Cy3™ and the OD65o 
for Cy5™. The FOI, which is the number of Cy-dUTPs per 1,000 
nucleotides of cDNA, was also calculated.
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The protocol supplied with this kit suggests between 10 and 15pmol of dye integrated 
into the cDNA is required for adequate detection on the microarrays. It required 10pg of 
cytoplasmic RNA to provide enough labelled target for two array slides in the case of 
Cy3™ and one slide in the case of Cy5™.
3.3.2 Indirect Labelling: Testing parameters o f fluorescently labelled 
target production by aminoallyl labelling.
3.3.2a Comparison o f different Reverse Transcriptase Enzymes and their activity at 
various temperatures.
Reverse transcriptases vary in their ability to incorporate dNTP analogues into cDNA. 
They also vary in their optimum working temperature which can be important when the 
RNA template has secondary structure as this can cause the reverse transcriptase to 
detach from the template leading to premature termination of cDNA synthesis. 
Genetically modified reverse transcriptases have been produced which work at higher 
temperatures and are more efficient at incorporating modified dNTPs. SuperScriptll™ 
reverse transcriptase is a modified MMLV made by the introduction of point mutations 
in the RNase H activity centre resulting in reduced RNase H activity while retaining full 
activity at 42°C. These modifications should result in greater first-strand cDNA yields 
and more full length copies of the message. The Clontech Advantage™ enzyme is also 
a modified MMLV which is more active at higher temperatures. PowerScript™ is also 
MMLV with a point mutation in the RNase H activity centre.
Reverse transcriptase from different sources were tested for their ability to incorporate 
aminoallyl dUTP into cDNA at various temperatures (Table 3.14).The protocol in Table
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3.8 with the Microcon™ ultrafiltration method to achieve step 4, the cleaning of the 
amoinoallyl cDNA, was used in this experiment.
cDNA ng pmol dye FOI
Cy3™ Cy5™ Cy3™ Cy5™ Cy3™ Cy5™
Superscript II™ 
37°C
170.94 248.64 4.40 15.60 8.36 20.37
MMLV 37°C 130.98 68.82 6.40 5.04 15.86 23.78
Advantage™ 37°C 210.90 193.14 8.80 9.12 13.55 15.33
Superscript II™ 
42°C
231.12 233.10 7.20 15.12 10.97 21.06
MMLV 42°C 208.68 142.08 7.6 4.80 11.82 10.97
Advantage™ 42°C 117.66 93.24 2.40 9.12 6.62 31.76
Superscript II™ 
48°C
108.78 148.74 2.80 3.84 8.36 8.38
MMLV 48°C 126.54 73.26 2.80 2.88 7.18 12.76
Advantage™ 48°C 111.00 66.60 2.80 4.56 8.19 22.23
Powerscript™ 37°C 228.66 173.16 8.40 4.08 11.93 7.65
Mean 162.73 144.08 5.36 7.42 10.28 17.43
Standard Deviation 48.67 67.83 2.58 4.68 3.02 7.22
Table 3.14: Testing of various reverse transcriptases at different temperatures:
10pg of cytoplasmic RNA was labelled using reverse transcriptase at the temperature 
indicated in the table for 1.5h. The ratio of aa-dUTP to dTTP was 2:1. Aminoallyl 
modified cDNA was cleaned using a Microcon™30.The FOI is the number of Cy-dUTP 
molecules per 1,000 nucleotides of cDNA.
There does not appear to be any significant differences in the synthesis of cDNA 
between the different reverse transcriptases or the different reaction temperatures. There 
is considerable variation in the amount of cDNA recovered at the end of the procedure 
which can be due to many factors. Although some variation could be due to pipetting 
errors, a particular problem when small volumes are being dispensed, reactions used the 
same sample of total RNA and the same master mix between Cy3™ and Cy5™. A 
particular problem with this protocol is the use of the Microcon™30 concentration 
ultrafilters. The recovery from these devices can be highly variable. Variation in the 
amount of dye incorporated could be due to the sensitivity of the reactions to pH. Any
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TRIS buffer left after the Microcon™30 treatment would both disrupt the pH of the 
coupling buffer and compete for the binding of the mono-reactive dye. Another factor is 
the degree of hydration of the dye stock which must stored with extreme care. 
Furthermore, the DMSO used to dissolve the dye must be completely dry. These factors 
have complicated the interpretation of the results. However only twice did lOmg of 
cytoplasmic RNA yield enough labelled target to hybridize to an array.
3.3.2b Ratio o f aminoallyl d-UTP to d-TTP.
The ratio of aminoallyl dUTP to unmodified dTTP is also important; too high a 
concentration can inhibit the reverse transcriptase enzyme. Furthermore, if the modified 
side groups are incorporated too frequently and are too close together on the cDNA 
product, fluorescence quenching can occur or steric hindrance can prevent efficient 
hybridisation of cDNA with the probes on the array slides.
As the published protocol (http://derisilab.ucsf.edu/pdfs/amino-allyl-protocol.pdf)was 
optimised using yeast DNA and DNA from different species vary in their A/T ratios, 
experiments were performed using the same protocol with various ratios of aminoallyl 
d-UTP to unmodified d-TTP. Excess aminoallyl dUTP can inhibit the synthesis of 
cDNA in the reverse transcription reaction. As Cy5™ is the dye which causes most 
problems due to its larger size and greater hydrophobicity, initial experiments were 
carried out with Cy5™ only.
The results in Table 3.15 show all ratios of aminoallyl-dUTP to dTTP produced 
acceptable amounts of cDNA although the highest amount of cDNA was obtained when 
using a ratio of 2aa-dUTP: 3dTTP. As expected, the highest labelling index was 
obtained with a ratio of 2aa-dUTP:ldTTP. Only the dNTP mix supplied with the kit 
failed to yield enough labelled target for an array.
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Ratio of aminoallyl dUTP to 
dTTP
cDNA ng pmol dye FOI
aa-dUTP:dTTP 1:3 188.70 10.08 17.34
aa-dUTP:dTTP 1:2 259.74 13.68 17.10
aa-dUTP:dTTP 1:1 217.56 17.04 25.43
aa-dUTP:dTTP 2:3 348.54 18.24 16.99
aa-dUTP:dTTP 2:1 213.12 19.20 29.25
Kit dNTP mix 255.30 8.88 11.29
Mean
Standard Deviation
247.16
56.49
14.52
4.34
19.57
6.55
Table 3.15: Testing the optimal ratio of amiinoallyl dUTP to dTTP in
labelling. 1 Opg of total RNA was labelled using the above ratios of aa-dUTP 
to dTTP and SuperScriptll™ reverse transcriptase. A final reaction was 
labelled using the dNTP mix from the PowerScript kit whose composition is 
proprietary information. The aminoallyl modified cDNA was cleaned with a 
Microcon™30. The FOI is the number of Cy-dUTP molecules per 1,000 
nucleotides of cDNA.
Further high ratios were tested by labelling both with Cy3™ and Cy5™. Ethanol 
precipitation (Table 3.8, Step4*) was also tested as a means of both cleaning up the 
aminoallyl cDNA and changing the buffer from TRIS.
Ratio of aminoallyl cDNA ng pmol dye FOI
dUTP to dTTP Cy3™ Cy5™ Cy3™ Cy5™ Cy3™ Cy5™
aa-dUTP:dTTP 3:2 97.68 275.28 0.80 12.00 2.66 14.15
aa-dUTP:dTTP 3:1 202.02 270.84 11.60 30.24 18.64 36.25
aa-dUTP:dTTP 4:1 299.70 299.70 20.80 28.56 22.53 30.94
Mean 199.80 281.94 11.07 23.60 14.61 27.11
Standard Deviation 101.03 15.54 10.02 10.08 10.53 11.54
Table 3.16: Testing further ratios of aminoallyl-dUTP to dTTP: lOpg of 
total RNA was labelled using the above ratios of aa-dUTP to dTTP and 
Superscript II reverse transcriptase. Buffer exchange and aminoallyl cDNA 
cleanup was achieved by EtOH precipitation. The FOI is the number of Cy- 
dUTP molecules per 1,000 nucleotides of cDNA.
Table 3.16 shows that even a ratio of 4 aminoallyl dUTP to 1 dTTP gives a good yield 
of cDNA. The variation in cDNA yield between the Cy3 and Cy5 samples with the 3:2
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aa-dUTP:dTTP ratio possibly reflects loss of the pelleted cDNA from ethanol 
precipitation as the pellets are small, hard to see and easy to dislodge from the wall of 
the tube. The uneven labelling is less easy to explain. If the higher channel had been the 
Cy3, then it could have been explained on the grounds of the incorporated aminoallyl 
groups being too close together and steric hindrance or quenching of the larger Cy5 side 
chains. The most probable explanation is a difference in the degree of hydration of the 
dye stocks used in the labelling.
3.3.2c Purification o f  Aminoallyl modified cDNA.
To try and improve the reliability of recovery of the cDNA, the aminoallyl cDNA was 
cleaned and the buffers exchanged by either using the QIAquick™ PCR purification kit 
at Step 4 Table 3.8 or ethanol precipitation. The QIAquick™ protocol used is exactly as 
in Step6 Table 3.8.The results are presented in Table 3.17.
Although both ethanol precipitation and QIAquick™ purification appear to be more 
reliable than the Microcon™30 for cleaning and buffer exchange, major losses can still 
occur.
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Aminoallyl
cDNA
cleanup
cDNA n,I pmol dye FOI
Cy3™ Cy5™ Cy3™ Cy5™ Cy3™ Cy5™
SuperScriptll™
QIAquick™
PCR
purification
kit
124.32 164.28 8.40 6.72 21.94 13.28
PowerScript™
QIAquick™
PCR
purification
kit
175.38 122.10 6.00 4.80 11.11 12.76
PowerScript™ Ethanolprecipitation 64.38 215.34 0.00 18.48 0.00 27.86
Mean
Standard
Deviaion
121.36
55.56
167.24
46.69
4.80
4.33
10.00
7.41
11.02
10.97
17.97
8.57
Table 3.17: Testing methods of aminoallyl cDNA cleanup. lOgg of total RNA was 
labelled using a ratio of aminoallyl dUTP to dTTP of 4:1.The aminoallyl modified 
cDNA was cleaned of enzymes, unincorporated nucleotides and fragments of the 
RNA template and the buffer exchanged as indicated The FOI is the number of Cy- 
dUTP molecules per 1,000 nucleotides of cDNA.
3.3.3 Kits
3.3.3a Comparison o f the Atlas™ glass and Atlas™ PowerScript™ labelling kits.
The performance of the Atlas™ glass and Atlas™ PowerScript™ labelling kits, both 
produced by Promega, were compared. The PowerScript™ kit has a maximum input of 
8pg of RNA while the Atlas™ kit has a maximum input of lOpg of RNA. Labelling 
was carried out according to the protocols in Table 3.7 and 3.8 and the probes were 
analysed as before (Table 3.18).
These kits use a resin, followed by ethanol precipitation to to remove the enzymes, 
primers and fragments of mRNA from the aminoallyl modified cDNA. This should
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result in better, more consistent recovery of cDNA and indeed the amount of cDNA in 
the Cy3™ and Cy5™ reactions, with one exception, is more reproducable.
cDNA ng %cDN A/total pmol dye FOI
Cy3™ Cy™5 Cy3™ Cy5™ Cy3™ Cy5™ Cy3™ Cy5™
Atlas kit 37°C 4280.90 4539.90 42.81 45.40 42.00 47.60 3.19 3.40
Atlas kit 42°C 3537.20 358.90 35.37 3.59 38.67 7.60 3.55 6.88
Atlas kit 48°C 4206.90 4221.70 42.07 42.22 29.33 19.20 2.26 1.48
PowerScript kit 
37°C
3888.70 3936.80 48.61 49.21 23.33 20.40 1.95 1.68
Mean
Standard Deviation
3978.42
339.81
3264.32
1952.55
42.22
5.42
35.10
21.20
33.33
8.56
23.70
16.95
2.74
0.76
3,36
2.50
Table 3.18: Comparison of Atlas™ Glass and PowerScript™ kit. 10pg of total RNA 
and 8pg of total RNA was labelled with the Atlas™ kit and PowerScript™ kit 
respectively. The Atlas kit was tested with the reverse transcription carried out at the 
temperature indicated. The FOI is the number of Cy-dUTP molecules per 1,000 
nucleotides of cDNA
The picomoles of dye incorporated compares well with the best conditions described 
above. However, the amount of cDNA recovered with these two kits is unreasonably 
high. The proportion of mRNA in cells is between 1 and 5% of the total RNA. Although 
ES cells are believed to have high levels of mRNA, even if reverse transcription was 
100% efficient, this is an unlikely amount of cDNA. The only reaction which produced 
the expected amount of cDNA, the Atlas kit at 42°C with Cy5™ conjugated also had 
much less dye incorporated suggesting the lower amount of cDNA was due to loss of 
the cDNA pellet. Moreover the reverse transcription reactions between Cy3™ and 
Cy5™ are identical.
These two kits rely on RNaseH to degrade the RNA template. The RNA fragments are 
perhaps not efficiently removed by the purification protocol resulting in artificially high 
values for cDNA recovery. This is further suggested by the amount of cDNA produced
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by the both CyScribe™ Direct kit and the by the experimental results reported in Tables 
3.13, 3.14 3.15and 3.16, where NaOH was used to hydrolise the RNA template.
3.3.3b Comparison o f Powerscript Kit with Modified protocol and the Cyscribe™ 
cDNA Post Labelling kit.
To test whether the RNase H degradation of the mRNA template is responsible for the 
excess amount of cDNA, the protocol for the Powerscript™ kit was modified. Step 3 of 
the Atlas™ PowerScript™ Fluorescent labelling kit protocol (Table 3.10) was replaced 
hydrolysis with NaOH (Step 3*) and compared with the CyScribe™ cDNA Post 
Labelling kit which uses NaOH degradation of the template as standard protocol. The 
amount of cDNA synthesised still is more than might be expected (Table 3.19). 
However, the methods used for the removal of oligo nucleotide fragments are not 100% 
efficient,some will coprecipitate with the cDNA. The amount of cDNA is similar in 
both channels as is the amount of dye. This is enough target to hybridise to 2 array 
slides.
cDNA ng %cDNA/total pmol dye FOI
Cy3™ Cy5™ Cy3™ Cy5™ Cy3™ Cy5™ Cy3™ Cy5™
PowerScript kit 
42°C
547.60 573.50 10.95 11.47 29.33 28.80 17.39 16.30
CyScribe Indirect kit 
42°C
440.30 458.80 8.81 9.18 29.33 28.40 21.63 20.10
Mean
Standard Deviation
493.95
75.87
516.15
81.10
9.88
1.51
10.32
1.62
29.33
0
28.60
0.28
19.51
3.00
18.20
2.69
Table3.19: Comparison of the PowerScript™ kit with the CyScribe™ Indirect 
kit.5pg of total RNA was labelled with the above kits. Reverse Transcription was 
carried out at 42°C. In both cases the RNA template was destroyed using NaOH. The 
FOI is the number of Cy-dUTP molecules per 1,000 nucleotides of cDNA
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3.3.3c Comparison o f  the method o f template removal and the effect on Microarrays.
Discussion with colleagues (Ngoc Nga Vingh, Victoria Workman) suggested that the 
arrays hybridised with targets labelled using the Atlas™ Glass and Powerscript™ kits 
with RNA template destruction by RnaseH were not as bright as those labelled by the 
direct labelling method. This might be expected if the unlabelled nucleic acids in the 
targets competed with the labelled cDNA,
Five micrograms of cytoplasmic RNA from the same IMT-11 sample as for all the 
experiments described in this chapter was used to prepare targets using the Powerscript 
kit. The RNA template was destroyed by either RnaseH or NaOH. Reverse transcription 
was carried out at 42°C for lh.
The labelled target was analysed as before (results are presented in Table 3.20).
Template removed by RNase Template removed by NaOH
Experiment 
Number 
and Dye
cDNA
synthesises(ng)
Dye
incorporated
(pmol)
FOI cDNA
synthesises(ng)
Dye
incorporated
(pmol)
FOI
1 Cy3™ 2002.0 20.0 3.24 469.9 43.3 29.94
2 Cy3™ 1357.9 15.3 3.72 758.5 46.3 19.99
1 Cy5™ 1491.0 20.0 4.35 384.8 38.8 32.74
2 Cy5™ 1311.5 11.2 2.75 455.1 20.0 18.04
Mean 1540.60 16.62 3.52 517.08 37.1 25.18
Standard
Deviation
316.87 4.24 0.68 165.18 11.81 7.25
Table 3.20Labelled cDNA 5 pg of cytop asmic RNA was labe led per reaction. In
Experiment 1 enough labelled cDNA was produced by one 5pg reaction for the 
experiment. In Expt2, two reactions were carried out so the figures represent the mean of 
the two labelling reactions. The FOI is the number of Cy-dUTP molecules per 1,000 
nucleotides of cDNA
The amount of cDNA produced and the level of dye incorporation was consistent with 
the earlier results. The FOI (the number of Cy-dUTP molecules per 1,000 nucleotides of
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cDNA) for each experiment was very similar between the two channels, however was 
much lower in the RnaseH treated targets. When run out on slide gels the targets 
prepared by both methods looked very similar (Figure 3.6).
Figure 3.6. Examples of slide gels of Cy3™ and Cy5™ labelled targets.
Gel(a) Cy3™ labelled target, RNA template degraded with RNase H.
Lane 1 A.DNA Hindlll fragment ladder (Invitrogen)
Lane 2 Sample Experiment 1 (see Table 3.19)
Lane 3 Sample Experiment2 (see Table 3.19)
Lane 4 Empty
Gel(b) Cy5™ labelled target, RNA template degraded with RNase H.
Lane 1 ?DNA Hindlll fragment ladder (Invitrogen)
Lane 2 Sample Experiment 1 (see Table 3.19)
Lane 3 Sample Experiment2 (see Table 3.19)
Lane 4 Empty
Gel(c) Cy3™ labelled target, RNA template degraded with NaOH 
Lane 1 A.DNA Hindlll fragment ladder (Invitrogen)
Lane 2 Sample Experiment 1 (see Table 3.19)
Lane 3 Sample Experiment2 (see Table 3.19)
Lane 4 Empty
Gel(d) Cy5™ labelled target, RNA template degraded with NaOH. 
Lane 1 >X)NA Hindlll fragment ladder (Invitrogen)
Lane 2 Sample Experimentl (see Table 3.19)
Lane 3 Sample Experiment2 (see Table 3.19)
Lane 4 Empty
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The total number of good quality spots (flagged 0) were counted on each slide and the 
mean was calculated (Table 3.21. No significant difference in the number of spots was 
detected.
RNase NaOH
Mean Number 
of Spots per 
slide
3055 3168.5
Standard
Deviation 1571 963.5
Table 3.21 Mean number of unflagged spots 
identified from two experiments. Total number 
of 15247 gene spots on each slide.
The total intensity for the good spots in the two channels on each slide was aquired and 
the mean was calculated (Table 3.22). Again there was no significant difference 
between targets produced using RNaseH and NaOH treated cDNA.
RNase NaOH
Cy3™ Cy5™ Cy3™ Cy5™
Mean Total 
Intensity (n=4) 1,435,606 1,812,615 1,426,739 1,610,123
Standard
Deviation 452,036.6 882,522.3 155,978.5 338,497.5
Table 3.22Total spot intensity of the unflagged spots for the Cy3 and Cy5 
channels for two experiments.
The data from the two experiments was combined such that only spots which were 
unflagged in both experiments were included. For NaOH this was 1746 spots and for 
RNase H 1219 spots. These spots were further analysed using the linest and Pearson 
coefficient function in Microsoft Excel™ 2003 (Table 3.23). Scatter plots were
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generated of Cy3 against Cy5 and a trendline produced forcing the intercept to go 
through the origen. (Fig 3.7 ).
Treatment
aminoallyl
cDNA
of
Slope Pearson Coefficient R F-statistic
Degrees of 
Freedom
NaOH 0.47910.004 0.955 14616.17p<0.0001 1745
RNase 0.53810.004 0.964 15406.78p<0.0001 1217
Table 3.23 Staltistics from the inest output for the correlation of fluorescence
intensity of Cy3 against Cy5 for NaOH treated cDNA and RNase H treated 
cDNA.
The model produced is highly significant as indicated by both the Pearson Coefficient 
and the F-statistic.The slope of the line shows that despite the very even labelling of 
both targets as described by the FOI (the number of Cy-dUTP molecules per 1,000 
nucleotides of cDNA), and the very similar total intensities for each channel, the 
fluoresence intensity of the Cy3 channel is about half that of the Cy5 channel 
suggesting dye dependant differences in hybridisation.
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(a) Cy3 vs Cy5 RNase treated cDNA
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(b) Cy3 vs Cy5 NaOH treated cDNA
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Fig 3.7: Scatter plots of the spot fluorescence intensity of Cy3™ against Cy5™ for (a) 
RNase and (b) NaOH treated aminoallyl cDNA.
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The data from the Cy3™ Rnase H and NaOH was combined and again the data was 
filtered such that only spots which were unflagged on all four slides were included in 
the analysis. This was also done for the Cy5™ channels. This left 760 spots for both 
Cy3™ and Cy5™. The Cy3 ™ and Cy5™ data was combined, the scatter plot was made 
and the trendline calculated (Figure 3.8). The significance of the model was again tested 
using linest and the Pearson coefficient functions in Microsoft Excel™ 2003.
The slope of the the trendline, very close to 1, suggests that the method of destroying 
the RNA template has no consequences for the fluoresence intensity of the spots. The 
model produced is highly significant as indicated by both the Pearson Coefficient and 
the F-statistic.
25000
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y = 0.998x  
R2 = 0.9542
15000
® 10000
3  5000
0 5000 10000 15000 20000 25000
F l u o r e s c e n c e  I n t e n s i t y  R N a s e
Figure 3.8: Scatter plot of the spot fluorescence intensity for NaOH 
against RNase H.
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However, the NaOH treatment method can produce significantly more labelled target, 
enough for three arrays whereas the RNase treatment method generally only produces 
enough for one array (Table 3.16).
Slope Pearson Coefficient R F-statistic
Degrees of 
Freedom
0.998±0.005 0.977 31674.67p<0.0001 1519
Table 3.23 Statistics from the linest output for the correlation of 
fluorescence intensity of RNase H treated template and NaOH 
treated template.
3.4 Conclusions
Production of labelled target is not a trivial process and a number of factors have to be 
taken into account when performing this task. All but one of the labelling procdures 
described in this thesis involve incoporation of modified dNTPs into cDNA produced 
by reverse transcription. The other method involved the chemical modification of RNA. 
This method, had it worked well, would have offered a number of advantages over 
reverse transcription based methods.
The aim of labelled target production is to produce labelled molecules which are as long 
as possible and labelled to the highest specific activity without compromising the ability 
of the molecules to hybridise to the glass bound probes. As two differantly labelled 
samples are being compared it would be advantageous for the two targets to label to the 
same extent. Furthermore sequence specific distortions should be avoided.
The direct chemical labelling of the RNA seemed to tick many of these boxes. By 
avoiding reverse transcription, the length of the target is not affected. As the labelling is
100
Chapter 3: Labelling of Target
a direct chemical process the two targets being compared should label to the same 
extent irrespective of the dye molecules being incorporated and sequence specific 
anomolies should be minimal. In practice, although the labelling could be shown to 
perform as expected, there were problems. The most difficult was the very short shelf 
life of the kit in combination with the problems with quality control. The production of 
the samples is both very expensive and time consuming and the level of unreliablity was 
unacceptable.
Labelling by direct incorporation of labelled dNTP via reverse transcription has the 
drawback that due to the difference in size and hydrophobicity of the two dye 
molecules, the specific activity of the two targets differ. In this study three times the 
amount of of Cy5™ labelled target was required to achieve even labelling in both 
channels. Furtheremore sequence dependant differences are more common. For this 
reason it was decided to concentrate on the indirect labelling method of incorporation of 
aminoallyl modified dUTP and secondary binding of the fluorescent tag.
Reverse transcriptase has the disadvantage of being a poorly processive enzyme 
resulting in shortening of the target produced that could lead to non-detection of some 
probes on the array slides.This is less of a problem with the arrays being used in this 
study as the majority, but not all, of probes are derived from the 3' end of the genes 
However, by careful choice of enzyme and optimisation of the reverse transcription 
reaction this problem can be reduced.
The length of the cDNA product can be increased by conditions which reduce the 
secondary structure of the mRNA. This can be achieved by using reverse transcriptases 
which are active at higher temperatures. This was used as a starting point in 
optimisation. However, no particular enzyme apeared to function significantly better at
101
Chapter 3: Labelling of Target
any particular temperature. The actual amount of dye incorporated also seemed low and 
highly variable. Thus although in many cases , the intensity of labelling as shown by the 
FOI (frequency of incorporation per 1000 nucleotides) was adequate, there was not 
enough from one reaction to hybridise on an array slide.
As aminoallyl dUTP can be inhibitory to reverse transcriptase, different ratios of 
aminoallyl dUTP to dTTP were tested and again no particular condition appeared to 
perform better than any other. In these experiments, with the exception of the dNTP mix 
provided with the kit, enough pmoles of dye were incorporated to label an array slide. 
What was noted was that in some cases, significantly less cDNA was present in Cy3™ 
labelled product than Cy5™. As both reverse transcription reactions were set up 
identically using the same master mix, it is likely that the cDNA was being lost in the 
clean up and buffer exchange steps between incorporation of the aminoallyl dUTP and 
coupling of the dye. The Microcon-30™ ultrafiltration units can leak leading to cDNA 
losses. Cleanup of the aminoallyl cDNA was attempted using column based technology, 
the QIAquick™ PCR purification kit (Qiagen) and ethanol precipitation. In this 
experiment large cDNA losses were observed in the Cy3™ labelled sample when the 
cDNA was ethanol preciptated.
The Atlas™ kit was the forerunner of the PowerScript™ kit. They both seemed to 
perform equally well although loss of the of aminoallyl cDNA can still be a problem . 
One anomaly noted with these kits was the apparent large amount of cDNA synthesis. 
Although the amount of dye incorporated into the target is good (enough for between 
two and three array slides) the FOI is very low suggesting the bulk of the cDNA is 
unlabelled. However, unlike the non-kit method and the direct incorporation of Cy™ 
labelled in the CyScribe™ (Amersham Pharmacia) kit, the Atlas™ and PowerscriptY™
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kits (BD Biosciences) use Rnase H to degrade the mRNA template. Consequently, it 
was decided to replace the Rnase H degradation with NaOH in the PowerScript™ and 
compare the characteristics of the labelled target with those of target prepared using the 
CyScribe™ Post-Labelling kit which uses NaOH to degrade the mRNA template as the 
standard protocol. This demonstrated that there was indeed a difference in the target 
prepared by the two methods.
The next step was to assess whether the method of mRNA template destruction made a 
difference to the quality of the hybridisation and to the differential gene expression 
results. Target was prepared using the PowerScript ™ kit and either destroying the 
template by Rnase H or NaOH. The number of unflagged spots on each slide was taken 
as a measure of hybridisation in combination with the mean total fluoresence of these 
spots which showed that there was no apparent difference in the slides hybridised with 
target produced by either method. Scatter plots of the Cy3™ fluorescence intensity 
against the Cy5™ fluorescence intensity for each method showed that both methods 
gave target which behaved in a similar manner; the slope of each plot is similar as is the 
deviation from the line. When the fluorescence intensity in each channel of each spot 
detected with both Rnase H and NaOH target was plotted a slope approaching 1 was 
obtained indicating no difference between the two labelling methods. The disadvantage 
in using Rnase H to degrade the template is the inability to assess the level of synthesis 
of cDNA and thereby calculate the FOI of the labelled bases and also less dye 
incorporated target is produced.
The CyScribe™ Indirect kit and the PowerScript™ kit with the modification of NaOH 
degradation of the RNA template seem to perform equally with regard to incorporation 
of the dyes. They both produce between 2 and 4 times the amount of labelled target
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from a given amount of cytoplasmic RNA. Notably, labelling in both channels was also 
more even when compared to the direct incorporation of Cy dye modified dUTP or the 
method of deRisi or the varients tryed. Together with the advantages of kit shelf life, 
which was very poor in the MICROMAX ASAP kit, and a stable cDNA target, it was 
obvious that one of these two kits would be the best choice for routinely labelling 
sample. The PowerScript kit with its modified protocol was chosen because of slightly 
shorter reverse transcription times and no quenching step.
As the Powerscript™ labelling kit with the modified removal of the RNA template gave 
such good results, it was decided to use this in all subsequent experiments.
Recently, the method has been further improved by the addition of 0.5|il of 
PelletPaintNF™ (Novagen, Merck Biosciences Ltd, Nottingham, U.K.) a non-nucleic 
acid, non-fluorescent, dye-labelled carrier to the ethanol precipitation of the amino-allyl 
cDNA. This additive colours the pellet blue reducing losses when removing the 
supernatant. It does not appear to interfere with the analysis of the probe or with the 
hybridisation to the array.
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4. Amplification of Target 
4.1 Introduction
We are interested in the pluripotent compartment of the early mouse embryo which 
contains very few cells. The pluripotent compartment of the pre-implantation blastocyst, 
the inner cell mass (ICM), at the early blastocyst stage has only about 12 cells rising to 
about 20 just before implantation (Handyside and Hunter, 1986). The whole blastocyst 
at about the 64 cell stage contains only 2ng of total RNA (Nagy, 2003) and single cells 
are generally believed to contain 10-30pg of RNA. Even after implantation on day 5.5, 
the number of cells in the expanding embryonic ectoderm is only about one hundred. 
This rises to about 550 on day 6.5 of gestation (Snow, 1976). In the previous chapter, 
we decided to use the Atlas™ PowerScript™ Fluorescent Labelling Kit which requires 
3|Xg of total RNA. The earliest microarray paper described the use of 5pg of mRNA for 
target preparation (Schena et al., 1995), the equivalent of 165-500pg of total RNA, 
assuming 1-3% of total RNA consists of mRNA. It was therefore necessary to use some 
form of amplification. This can be achieved in two ways; through increasing the 
fluorescent signal or by amplification of the input RNA.
4.1.1 Signal Amplification.
New labelling methods which can amplify the fluorescent signal post hybridisation have 
been introduced. The tyramide signal amplification method uses antibodies to introduce 
horse radish peroxidase (HRP) molecules into the array spots. The highly reactive HRP 
then oxidizes fluorescent tyramide molecules which couple to the array spots. This 
procedure can be carried out using a kit provided by Perkin Elmer and requires between 
0.5 and 1 .Opg of RNA.
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The kit produced by Genisphere, which is based on dendrimer technology (Stears et al., 
2000) claims that as little as 0.25pg of total RNA is enough to label an array. Both these 
methods suffer from the drawback that it is difficult to monitor the labelling process as 
the fluorescent molecules are applied post hybridisation. Furthermore, to acquire this 
amount of RNA, more than 100 embryos would be required for each sample. We 
therefore decided that amplification of the RNA sample would be more suitable for our 
purposes.
4.1.2 Sample Amplification.
Sample amplification has been achieved by conversion of the mRNA transcript to 
cDNA using reverse transcription followed by either the polymerase chain reaction 
(RT-PCR) (Saiki et al., 1985) or by in vitro transcription (IVT).
4.1.2a Amplification by PCR.
Reverse transcription of RNA followed by PCR (polymerase chain reaction) is a 
powerful method of amplifying rare transcripts. However, primers are required at both 
ends of the sequences to be amplified. This requires sequence information for all the 
probes on the array (Frohman et al., 1988) or a means of introducing a primer to the 5' 
end of the cDNA. A primer can be added to the 5 ' end of the cDNA by tailing with an 
oligonucleotide such as oligo-(dA) using terminal deoxynuceotidyl transferase (TdT) 
(Belyavsky et al., 1989; Tam et al., 1989). Alternatively, the inherent terminal 
transferase activity of MMLV reverse transcriptase, which on reaching the 5' cap region 
of the mRNA will add between 2 and 4 non-template C residues, can be used to add a 
template switch oligonucleotide (Chenchik, 1998). This oligonucleotide consists of a 
heel sequence with an oligo-(dG) sequence on the 3' end which base pairs with the d(C)
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sequence on the cDNA. The reverse transcriptase then switches template and continues 
replication to the end of the template thus adding the complementary template switch 
oligonucleotide to the 3' end of the cDNA (Figure 4.1). PCR can then be carried out 
using the sequence of the heel as the forward primer (Matz et al., 1999). This method 
also selects for full length transcript.
Template switchGGG
m R N A
lAAA
ccc cDNA
Template switchGGG
CCC
Figure 4.1: Diagram of template switch. When the reverse transcriptase 
reaches the cap region of the template it adds a string of non-template dCTPs to 
the cDNA. A template switch oligonucleotide with dGTPs on the 3' end is 
annealed to the dCTPs and the reverse transcriptase transcribes the template 
switch.
Although PCR is highly efficient at low RNA input levels, it does suffer from a number 
of disadvantages resulting in loss of relative transcript levels within samples and of the 
relative proportions of transcripts between samples. The process is exponential not 
linear thus high abundance transcripts will soon swamp low. Longer transcripts are less 
frequently produced than shorter by reverse transcription, and shorter transcripts are
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more efficiently amplified than long resulting in loss of maintenance of the relative 
transcript levels (Belyavsky et al., 1989; Frohman et al., 1988). Furthermore, GC rich 
sequences are less efficiently amplified by Taq DNA polymerase. To some extent the 
problem of non-proportionality can be reduced by adjusting the amount of input 
template (Seth et al., 2003) and by careful control of the number of PCR cycles carried 
out. Over-amplification contributes to serious distortion of the native ratios and it has 
been suggested that amplification should be halted one cycle before saturation of highly 
expressed genes (Endege et al., 1999). However the number of cycles suggested seem to 
vary widely from 65 cycles down to 15 (Iscove et al., 2002; Nagy et al., 2005).
Most recently, a method using a single primer for amplification (SPA) (Smith et al., 
2003) has been proposed and on the basis of identification of outliers seems to work 
well. This has been further modified to give isothermal amplification using a single 
primer (Daffom et al., 2004)
4.1.2b Amplification by IVT.
The method of Eberwine (Van Gelder et al., 1990), now used extensively in array 
analysis, was designed in the pre-microarray era to examine gene expression in single 
neural cells. The DNA dependant T7 RNA polymerase is highly specific for its 
promoter (Figure 4.2) (Chamberlin and Ryan, 1982), and is highly processive (Sousa et 
al., 1992).
+1
T AAT ACG ACTC ACT A TAGGGAGA
Figure 4.2: Sequence of the T7 promoter. The +1 base, indicated in red, is the 
first base incorporated into RNA during transcription. The underlined sequence 
is the minimum required for efficient transcription.
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Moreover, the amplification kinetics are linear. In this method the T7 RNA polymerase 
promoter is attached to cDNA transcribed from total RNA by fusing it to oligo-(dT) and 
using this as the primer to initiate reverse transcription (Figure 4.3). RNase H is used to 
degrade the mRNA and the resulting oligonucleotides are used to prime the formation 
of the second DNA strand. The second strand is polymerised by the enzyme E.Coli 
Polymerase I and the cDNA blunt ended by T4 DNA polymerase. The addition of T7 
RNA polymerase and nucleotides with an appropriate buffer allows the creation of a 
library of mRNAs without inserting the cDNA into plasmids. The enzyme binds to the 
double stranded promoter, separates the DNA strands and uses the 3'-5' strand as the 
template for synthesis of antisense RNA. Where a second round of amplification is 
required, the amplified first round RNA is reverse transcribed using random hexamers 
as primers. The RNA template is once more degraded with RNase H and a second 
strand synthesised in the presence of the T7-oligo-(dT) primer which anneals to the 
polyA tail on the second strand. In this way the T7 promoter is added to the cDNA 
allowing further synthesis of antisense RNA.
Although the original Eberwine method is used routinely to label RNA for 
Affymetrix™ hybridisation by introduction of biotinylated NTPs into the first round 
amplified RNA (also called cRNA or complementary RNA) thus providing limited 
amplification of the target, it has the disadvantage of loss of 5' complexity introduced 
by the reverse transcription step. This can be particularly problematical with 
oligonucleotide arrays. The NIA gene set used in this study is mostly made up of ESTs 
(expressed sequence tags) derived from the 3' end of the mRNA transcripts so this is 
less of a problem.
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Figure 4.3: Diagram of mRNA Amplification derived from the Eberwine 
Procedure. The T7 RNA polymerase oligo-dT promoter anneals to the poly-A tail of 
the mRNA and on reverse transcription produces cDNA with the T7 promoter attached. 
The mRNA template is destroyed with Rnase H and the cDNA double stranded with 
E.Coli Poll. Multiple copies of antisense RNA is produced by a T7 polymerase 
reaction. Where more antisense RNA is required a second round of amplification can be 
carried out by making cDNA with a poly-A tail using random hexamers as the primer. 
After destruction of the antisense RNA template with RNase H, the oligo-dT-T7 
promoter is used to prime the second strand reaction again using E. Coli Poll. The T7 
reaction will then produce more antisense RNA.
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However, an effect has still been seen in the hybridisation of SPARC where two probes 
on the array show different degrees of hybridisation, the lower hybridisation levels 
being associated with the more 5 ' probe (Fiona Mansergh, personal communication).
Another potential problem is caused by the low stringency temperature of the second 
strand reaction which can lead to mismatches. Side reactions during in vitro 
transcription result in the formation of non template dependant products (Amaud-Barbe 
et al., 1998; Biebricher and Luce, 1996). These can be minimised by optimization of the 
concentration of reagents such as primers, nucleotides and enzymes and by cDNA 
purification methods which minimize the carry over of these reagents from the reverse 
transcription and double stranding reactions.
All of these problems have been addressed by a number of workers and their solutions 
have been summarized in Table 4.1. Luo et al added a few extra 5' bases and 3' d(T)s to 
the primer in an attempt to stabilise the binding of the T7 enzyme to its promoter. 
E. Coli DNA ligase was added to the second strand reaction and the cDNA. The double 
stranded cDNA was cleaned by phenol: chloroform: isoamyl alcohol and Microcon™- 
100 to reduce carryover of primers and deoxynucleotides into the IVT reaction.
Wang approached the 3’ bias problem by selection for full length cDNA using the 
template switch strategy in the same way as for PCR amplification described above. 
The second strand extension is carried out at 75°C using Taq DNA polymerase which 
improves stringency of the second strand formation.
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Van Gelder R.N. et al, 
(1990)
Luo et al, (1999) Wang et al, (2000) Baugh et al, (2001) Scheidl et al, (2002)
*Primers Oligo20-T7-(dT) 15 0 1 igo23-T7 -(dT)2i 0 1 igo2o-T7 -(dT)i5 0 1 igoi3-T7 -(dT) 24 Oligo20-T7-(dT) 24 as 
Wang
1st Strand Reverse Transcription Reverse Transcription Reverse Transcription Reverse Transcription 
with T4gp32 protein
Reverse Transcription
Second 
Strand Primer
Fragments from 
RNaseH treatment
Fragments from 
RNaseH treatment
Template Switch 
(in 1st strand reaction)
Fragments from 
RNaseH treatment
Template Switch 
(in 1st strand reaction) 
as Wang
Template
Removal
E. coli RNaseH E. coli RNaseH E. coli RNaseH E. coli RNaseH E. coli RNaseH
Second
Strand
Reaction
DNA Polymerase I 
T4 DNA Polymerase
DNA Polymerase I 
E. coli DNA ligase 
T4 DNA Polymerase
Taq polymerase DNA Polymerase I 
E. coli DNA ligase 
T4 DNA Polymerase
Taq polymerase
Cleaning Dialysis on a 25p 
nitrocellulose filter
Phenol/Chloroform 
Microcon 100
Phenol/Chloroform 
Ethanol precipitation 
Gel filtration P6  
column
Phenol/Chloroform 
Microcon 100
Phenol/Chloroform 
Microcon 100
Amplification T7 In Vitro 
Transcription
T7 In Vitro 
Transcription
T7 In Vitro 
Transcription
T7 In Vitro 
Transcription
T7 In Vitro 
Transcription 
DNase treatment of 
aRNA
Cleaning of
amplified
RNA
Microcon 100 Trizol Microcon 100 GeneElute RNA 
Cleanup kit
Table 4.1. Steps in the process of linear amplification and the methods used by different authors.
* Primer details on Table 4.3.
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Baugh et al (2001) addressed the problem of 3' bias by addition of the phage protein 
T4gp32 which improves the processivity of reverse transcriptase.
The published methods were tested for their suitability for the amplification of our 
experimental material. When commercially produced kits became available, they were 
also tested for their ability to produce adequate amounts of amplified RNA from our 
samples.
A particular problem with all the amplification methods based on T7 polymerase is they 
are all complex and very time consuming. It takes at least three days to complete the 
two rounds of amplification minimally required by the tiny RNA samples in this 
project. Moreover, the samples are invisible and it is difficult to assess success during 
the procedure. For this reason, part of this project was devoted to trying to develop a 
method which would make use of a solid phase: magnetic beads or latex beads. The 
simplified and more effective washing procedures would reduce the carryover of 
primers and nucleotides which contribute to the non-specific products from T7 
polymerase side reactions. Not only would washing and exchange buffers be simplified 
but potentially, a reusable source of target could be produced (Figure 4.4).
Magnetic or latex beads with a spacer, to reduce steric hindrance, and oligo-(dT)
conjugated to the surface were used to capture mRNA from the total RNA samples.
Buffer exchange and washing steps were achieved by placing the tubes, in the case of
magnetic beads, in a magnetic stand which allowed easy removal of the supernatant.
Where latex beads were used, the solid and liquid phases were separated by
centrifugation. The oligo-(dT) used to capture the mRNA was then used as the primer
for reverse transcription to synthesise the cDNA strand. Addition of a template switch
oligonucleotide bearing the T7 polymerase promoter, RNase H treatment and second
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strand synthesis followed by in vitro transcription should have produced amplified RNA 
in the sense orientation. The amplified RNA produced should have a poly A tail which 
can further bind to the unsaturated oligo-(dT) on the surface of the beads. The bead 
saturated with double stranded DNA may be reusable.
m RNA
Obgo-ftfD 
conjugated oe acts
T7 promoter Tem plate switchGGG
C C C
Reverse tramcrtpDon 
cDNA
DNA double strand
Ollgo-(<JT) 
conjugated beadsT7 promoter T e m p la te  sw itchG G G  '
---------------------  ccc '  V
T em plate swttchOOO 
T em plate sw tchG C G
Tem plate switchGGG
Figure 4.4: Diagram of amplification using beads and template switch. The
polyA tail of the mRNA hybridises to the oligo-(dT) conjugated to latex or 
magnetic beads. Reverse transcription with MMLV reverse transcriptase adds a 
string of 3-4 Cs to the end of the synthesised cDNA. An oligo with a string of Gs, 
the template switch, is then used to add a RNA T7 polymerase to the sequence. 
Double stranding of the cDNA allows the production of amplified sense RNA in 
an in vitro transcription reaction.
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In an attempt to reduce steric hindrance of the bead on T7 enzyme, a streptavidin 
conjugated bead was used to bind a biotinylated oligonucleotide which was used as a 
spacer arm.
Experiments were performed to try and duplicate the results of Wang et al (2000) The 
efficiency of the reverse transcription reaction was investigated and the addition of the 
phage T4gp32 protein was used (Baugh et al., 2001) The second strand reaction was 
investigated by substituting Taq polymerase with DNA Polymerase I (Baugh et al., 
2001; Luo et al., 1999; Van Gelder et al., 1990).The methods of cleaning both the DNA 
template before IVT and the final amplified RNA product were also examined. The 
development of a solid phase method of amplification using magnetic or latex beads 
was attempted. Finally, two commercial kits both based on the Eberwine procedure 
(Van Gelder et al., 1990) were tested.
4.2 Materials and Methods
All normal precautions when handling RNA were taken (Ch2 Sect2.3)
A list of kits and chemicals is provided in Table 4.2. The following oligonucleotides 
were purchased from MWG Biotech (Table 4.3,4.4).
Where appropriate, the published protocols are reproduced in tabular form for ease of 
comparison.
116
Chapter 4: Amplification of Target
7.5M ammonium acetate Sigma
Advantage cDNA polymerase mix Promega
Anchored oligo-(dT )23 Sigma
Dithiothreatol (DTT) Invitrogen
dNTP lOOmM Set Invitrogen
Dynabeads® OHgo(dT)25 Dynal
Dynabeads®M270 Streptavidin Dynal
GenElute™ Mammalian Total RNA Miniprep Kit Sigma-Aldrich
Linear Acrylamide (0.1 pg/pl) Ambion
MEGAscript® Kit Ambion
MessageAmp™ Kit Ambion
Micro Bio-Spin Chromatograph Columns (Bio-gel P6 in TRIS) Bio-Rad
Microcon® -100 filters Amicon
Mini RNA Isolation Kit™ Zymo Research
Oligodex™ beads Qiagen
Phage T4gp32 protein USB
Phase Lock® gel tubes 5'-3' Inc
Phenol:Chloroform:Isoamyl alcohol (25:24:1) Boehringer
Mannheim
Poly(dl-dC) Poly-deoxy-inosine-deoxy-cytidylic acid Roche
QIAquick® PCR purification kit Qiagen
Random Hexamer Promega
RiboAmp™ Kit Arcturus
RNase H (2U/pl) Invitrogen
RNeasy® Qiagen
RNAlater® Qiagen
RNasin (Recombinant)40U/r 1 Invitrogen
Superscript II™ reverse transcriptase Invitrogen
Taq DNA polymerase 5U/pl Promega
TRIzol® Invitrogen
Table 4.2: Reagents and kits used
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(1990)
Wang et al (2000)
AAACGACGGCCAGTGAATTG T A AT ACG ACTC ACT AT AGGGCGT, 5
Luo et al (1999) TCTAGTCGACGGCCAGTGAATTGT A AT ACGACTC ACTAT AGGGCGT2i
Baugh et al (2001) GC ATT AGCGGCCGCG A A ATT A AT ACG ACTC ACT AT AGGGCGT 2 1 v
Table 4.3: Oligonucleotides used to prime the first strand reactions in amplification experiments. All are written in the 5' to 3' direction. 
Red letters indicates the minimal T7 promoter and the bold indicates the +1 nucleotide i.e. the first transcribed nucleotide.
Template Switch AAGC AGTGGT ATC A ACGC AG AGT ACGCGGG
20-T7Min AAACGACGGCCAGTGAATTG TAATACGACTCACTATAGGGCGGGG
9-T7Min AGTGAATTG TAATACGACTCACTATAGGGCGGGG
T7-Min TAATACGACTCACTATAGGGCGGGG
TSS T A AT ACG ACTC ACT AT AGGGCGCC AA AGAGT AGGG
Biotin Oligo *g t g g t g g t g g t 25
Pou5fl F CTTGC ACCTC AGCCTT A AG A A
Pou5fl R TGG A ACC AC ATCCTTCTCT AGC
Table 4.4: Oligonucleotides used in this study. All are written in the 5' to 3' direction. Red letters indicate the minimal T7 promoter and the 
bold indicates the +1 nucleotide i.e. the first transcribed nucleotide. Blue indicates a template switch. * indicates a 5' nucleotide modified by 
biotinylation.
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4.2.1 Amplification using the method o f Wang
The protocol is described in Table 4.5 and Table 4.6. This protocol was used as the 
starting point for testing methods both involving template switch mechanisms and
without.
1 Anneal primer 1
Mix in PCR tube: cytoplasmic RNA 
0.1pg-0.5pg 01igo2o-T7-(dT)i5 (Table 
4.3).
Nuclease free water to lOpl 
Heated to 70°C for 3min.
Cooled to room temperature.
2 Reverse transcribe
The following master mix was assembled
on ice and added to the sample
4pl of 5x SuperScriptll™ first strand
buffer,
2|xl lOOmM DTT, 
lp l Rnasin (20U/pl)
lp l Template switch oligonucleotide 
(0.1pg/pl-0.5pg/pl) (Table 4.4)
2pl dNTP nucleotide mix (lOmM),
2pl SuperScriptll™ reverse transcriptase 
(200U/pl)
The reverse transcription reaction was 
incubated for 1.5h at 42°C.
3 Second strand cDNA synthesis
Added to reverse transcription reaction: 
106pl H20
15pl lOx Advantage™ PCR buffer 
3pi lOmM dNTP 
lp l RNase H 2U/pl
3pi Advantage cDNA polymerase mix. 
Heated to 37°C for 5min to digest RNA 
template, 94°C for 2min to denature, 65°C 
for lmin for specific priming followed by 
72°C for 30min to extend the 2nd strand. 
Reaction stopped by addition of 7.5pl of 
IN NaOH, 2mM EDTA and incubation at 
65°C for lOmin.
Table 4.5: Protocol for the 1st round of amplification (Wang et a l , 2000)
continued on next page.
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Added to 2^"Strand reaction:
1 pi of linear acrylamide (0.1 pg/pl)
150pl Phenol: Chloroform: Isoamyl
alcohol (25:24:1) and mixed well. 
Transferred to phase lock gel tube and 
spun at 12,000g for 5min in a 
microcentrifuge.
Transferred aqueous phase to a fresh 
nuclease free, 1.7ml microcentrifuge tube. 
Precipitated with 70pl of 7.5M 
ammonium acetate and 1ml EtOH. Mixed 
and centrifuged immediately at 12,000g 
for 20min in a microcentrifuge. Washed 
pellet twice with 800pl of 100% EtOH, 
centrifuging at 12,000g for 8min to 
recover the pellet. Airdryed pellet and 
dissolved in 70pl H2O.
Gel-filtration column (Bio-gel P6 in 
TRIS) was prepared.
The column contents were resuspended 
by inverting several times. The end was 
snapped off the column and placed over a 
collection tube. The cap was removed 
from the column and the buffer allowed to 
drain by gravity. The column was re­
equilibrated by washing four times with 
water, each time allowing the column to 
drain by gravity and discarding the 
flowthrough. The column was then spun 
at 200g for 2min at room temperature. 
The 70pi sample was then loaded on to 
the centre of the column and spun at 700g 
for 4min.
The cleaned and desalted cDNA was then 
dried in a rotary evaporator and dissolved 
in 8pl of H2O.
Table 4.5: Protocol for the 1st round of amplification (Wang et al
2000)continued on next page.
Cleanup of double stranded
cDNA
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5 In vitro Transcription
Using the MEGAscript® kit a master mix 
was assembled at room temperature 
consisting of 2pl of each 75mM NTP 
(ATP, GTP, CTP and UTP)
2pi of reaction buffer
2pl of enzyme mix (RNase inhibitor and
T7 phage RNA polymerase)
This was added to the 8pi sample and was 
incubated at 37°C for 6h.
6 Purification of amplified RNA
To the amplified RNA sample, 1ml of 
TRIzol reagent was added and mixed 
well. 200pl of chloroform was added and 
the tube mixed by inversion. After 
standing 2-3min at room temperature the 
tube was centrifuged at 12,000g for 
15min at 4°C. The aqueous phase was 
transferred to a fresh microcentrifuge tube 
and the amplified RNA was precipitated 
by the addition of 500pl of isopropanol. 
The tube was held at room temperature 
for lOmin and then spun at 12000g for 
15min. The amplified RNA pellet was 
then washed twice in 1ml of 70% EtOH 
spinning each at 12,000g for lOmin to 
ensure recovery of the pellet. The pellet 
was airdryed and dissolved in H20.
Table 4.5 Protocol for the 1st round of amplification(Wang et al
2000)continued.
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1 Anneal primers
Combined in PCR tube:
0.5-lpg of first round amplified RNA with 
2pg random hexamer in a total volume 
11 pi of nuclease water.
Heat to 70°C for 3min,
Cooled to room temperature.
2 Reverse transcription
The following master mix was assembled
on ice and added to the sample
4pl of 5x SuperScriptll™ first strand
buffer,
lpl 01igo2o-T7-(dT)i5 (0.5pg/pl)
2pl lOOmM DTT, 
lpl Rnasin (20U/pl)
2pl dNTP nucleotide mix (lOmM),
2pl SuperScriptll™ reverse transcriptase 
(200U/pl)
The reverse transcription reaction was 
incubated for 1.5h at 42°C.
3 Second Strand Synthesis As for first round amplification
4 Cleanup of double stranded cDNA
As for first round amplification
5 In vitro Transcription As for first round amplification
6 Purification of amplified RNA As for first round amplification
Table 4.6 Protocol for the second round of amplification.(Wang et al., 2000)
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4.2.2 Amplification using Beads.
The protocols described in Table 4.7 and 4.8 were used to make sense RNA on a 
magnetic (DynaBeads® 01igo-(dT)25) or polystyrene- latex (Oligotex ®).
4.2.3 Amplification using the Message Amp™ amplified RNA Kit.
Amplification with the MessageAmp™ amplified RNA kit (Ambion) was carried out 
according to the manufacturer’s protocol (Manual Vefsion 0110).
4.2.4 Amplification using the RiboAmp™ Kit (Arcturus).
RNA was amplified according to the protocols published by the manufacturer, Version 
A and Version B.
4.2.5 Analysis o f Amplification Products Using PCR.
Preparative mixtures were contained in 500pl thin walled PCR tubes. Denaturing, 
annealing and chain extensions were performed in a Biometra® UNO-Thermoblock™ 
with a heated lid (Biometra, Thistle Scientific, Glasgow, UK) programmed according to 
the required conditions Analysis of the cDNA attached to the beads was carried out by 
adding the beads to the PCR reaction mix. The reaction mix consisted of lx 
Advantage™ PCR buffer, 0.2mM dNTPs, lOOpmol of each primer (Table 2.7), l.Opl 
Advantage™ polymerase mix and nuclease-free water to make up the final volume of 
50pl. The PCR reaction was carried out for two cycles in the presence of the beads.
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1 Prepare beads
2x Binding Buffer: 40mM Tris-HCl,pH7.5 
2.0M LiCl 
4mM EDTA 
An aliquot of Dynabeads® 01igo(dT)25 was 
washed once in 2x Binding Buffer then were 
resuspended in of 2x Binding Buffer.
2 Anneal RNA to poly-(dT) beads
lOng of cytoplasmic RNA in H2O was heated 
to 90°C for lmin then quenched on ice. The 
RNA sample was then mixed with the 
magnetic beads and allowed to bind for 5min 
at room temperature.
3 Reverse transcription
The beads were washed twice in lx binding 
buffer and once in lx first strand buffer. 
Added following reverse transcription mix: 
lpl oligonucleotide at appropriate 
concentration 
2pi 0.1M DTT
1 pi Rnasin
2 pi lOmM dNTPs
4pl 5x First Strand buffer
lOpl h 2o
2pl Superscript II reverse transcriptase 
Incubated at 42°C for 90min.
4 Second strand synthesis
Added PCR mix:
106pl H20
15 pi Advantage PCR buffer 
3pi lOmM dNTP 
lpl RNase H
3 pi Advantage Taq polymerase 
Heated to 37°C for 5min to digest RNA 
template, 94°C for 2min to denature, 65°C for 
lmin for specific priming followed by 72°C 
for 30min to extend the 2nd strand.
Reaction stopped by addition of 7.5pl of IN 
NaOH, 2mM EDTA and incubation at 65°C 
for lOmin.
5 Clean up of beads and double stranded DNA
Washed beads twice in binding buffer and 
once with in vitro transcription buffer.
6 In vitro transcription
Added in vitro transcription mix using 
MegaScript®Kit:
8 pi H20 
8pl dNTP mix
2pl 10X in vitro transcription buffer 
2pl T7 enzyme 
Incubated at 37°C for 14h.
7 Elution Where appropriate RNA was eluted from the beads with lOmM TRIS pH7.5.
Table 4.7: Protocol for the amplification of RNA using Oligo-(dT) beads(Dynal)
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1 Prepare beads
Buffer A: 0.1M NaOH, 50mM NaCl 
Buffer B: lOOmM NaCl 
Buffer B&W: 5mM Tris pH7.5, 0.5mM 
EDTA,1M NaCl
25pl of beads at lOmg/ml were washed: 
lx for 3min with Buffer A 
2x for 3min with Buffer B 
1 x for 1 min with Buffer B&W 
Suspended beads in 50pl in Buffer B&W 
Added 50|il of biotinylated oligonucleotide at 
5pmol/pl.
Incubated at room temperature for lOmin. 
Washed 2x Buffer B&W
2 Anneal RNA to poly-(dT) beads
lOng of total RNA in H2O was heated to 90°C 
for lmin then quenched on ice. The RNA 
sample was then mixed with the magnetic 
beads and allowed to bind for 5min at room 
temperature.
3 Reverse transcription
The beads were washed once in lx first strand
buffer. Added following reverse transcription
mix: lpl oligonucleotide at appropriate
concentration
2pl 0.1M DTT
lpl Rnasin
2pi lOmM dNTPs
4pl 5x First Strand buffer
lOpl h 2o
2pl Superscript II reverse transcriptase 
Incubated at 42°C for 90min. Removed the 
reaction from the beads.
4 Second strand synthesis
Added PCR mix:
42 pi H20
lOpl Advantage PCR buffer 
lpl lOmM dNTP 
0.5pl RNase H
1 pi Advantage Taq polymerase 
Heated to 37°C for 5min to digest RNA 
template, 94°C for 2min to denature, 65°C for 
lmin for specific priming followed by 72°C 
for 30min to extend the 2nd strand.
Reaction stopped by addition of 7.5pl of IN 
NaOH, 2mM EDTA and incubation at 65°C 
for lOmin.
5 Clean up of beads and double stranded DNA
Washed beads 3x in T7 reaction buffer.
Table 4.8. Amplification of RNA using streptavidin coated beads(Dynal).
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For the switch-PouSFJ oligonucleotides, the cDNA was denatured at 94°C for four 
minutes, followed by two cycles of 94°C for 2 minutes, 65°C for 1 minute to anneal the 
primers to the DNA and 75°C for 1 minute to extend the DNA chain. The synthesis was 
allowed to extend at 75°C for 5 minutes. The beads were then removed and 30 further 
cycles followed by a 5 minute extension period were carried out.
Reverse transcription followed by PCR (RT-PCR) was used to analyse amplified RNA. 
A lpl sample of amplified RNA was annealed to eitjier 0.5pg of oligo-(dT) or 2pg of 
random hexamer by heating to 70°C then holding on ice. The primer annealed amplified 
RNA was input to a reverse transcription reaction containing lx Reverse transcription 
buffer, lOOmM DTT, 8U RNasin andlmM  dNTPs. The total reaction volume was 20pl 
and the reaction was carried out at 42°C for 1.5 hours. A tenth of the reverse 
transcription reaction was subjected to PCR in a mix consisting of lx PCR buffer 
without MgCl, 200pM dNTP, 2mM MgCl, and 50pmol primer. For Pou5Fl the 
optimum cycling conditions were 94°C for 2minutes, 58°C for 1 minute and 75°C for 
1 minute.
4.3 Results and Discussion
4.3.1 Amplification using Oligo-(dT)-T7.
The method published by (Wang et al., 2000) aimed to reduce the 3' bias of the target 
and to improve specificity of the second strand. This was done by using a template 
switch oligo to select for full length mRNA and by using Taq polymerase which 
functions at 72°C to synthesise the second strand of DNA. Initially the applicability was 
tested with lOng of cytoplasmic RNA purified from the embryonic stem cell line IMT-
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11 diluted from the sample described in Section 3.2. The reverse transcription reaction 
was primed with 0.1 pg of T7-oligo-(dT). Also 0.1 pg of the template switch 
oligonucleotide was used. After the first round of amplification, 0.8|ig of amplified 
RNA was obtained, an estimated 1:2500 fold amplification. However, after the second 
round of amplification no amplified RNA was detected either by spectrophotometric 
analysis or by agarose slide gel electrophoresis.
The initiation of reverse transcription is dependant on the concentration of primers in 
the reaction and on the amount of mRNA. Reactions were carried out with 0.1, 0.2 and
t
0.5fig of each primer. To confirm that reverse transcription had occurred, an aliquot of 
the cleaned, double stranded DNA was subjected to PCR using primers for the Pou5Fl 
gene (Table 4.4.) Agarose gel electrophoresis of the PCR products showed a band of the 
expected size (259 base pairs) confirming that reverse transcription had taken place 
(Figure 4.5). The remainder of the double stranded DNA was in vitro transcribed; 
however no amplified RNA product was detected either by spectrophotometric analysis 
or by agarose slide gel electrophoresis (2.3.3 and 2.3.5).
The in vitro transcription reaction was tested by carrying out the protocol with 0.2|ig of 
the T7-oligo-(dT) and template switch primers. The formation of cDNA was confirmed 
by PCR as before (not shown) and in vitro transcription was carried out. Two control 
reactions, the first with 0.5|ig of pTRI-Xefla and one which had a mix of 0.25pg of 
pTRI-Xefla and double stranded cDNA. The control plasmid has an insert which 
transcribes the Xenopus elongation factor a .
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1 2  3 4
Fig4.5: Agarose gel of PCR product Pou5F: PCR of double stranded cDNA 
from reverse transcription of lOng of cytoplasmic RNA (round 1 of amplification).
The first strand was primed with T7-oligo-(dT) and the second strand initiated
from the Template Switch primer.
Lane 1: lOObp ladder 
Lane 2: 0.1 pg of each primer 
Lane 3: 0.2pg of each primer 
Lane 4: 0.5pg of each primer
The reactions were carried out at 4°C, 16°C and 37°C for 6h and 26h (Figure 4.6) and 
the products were run on a TAE agarose gel. The control plasmid seems to amplify well 
at 37°C and is not prevented from amplifying by addition of the sample. There is a faint 
band in lane 17 which is the IMT-11 sample amplified for 26h at 16°C. This defined 
band is not what would be expected from amplified RNA but resembles a template 
independent product produced by certain batches of T7 RNA polymerase (Biebricher 
and Luce, 1996).
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Time 6h 26h
Temperature 4*C 16“C 37°C
Sample C E  M C E M C E M 
Lane I 2  3 4 S f> 7 m  in n
4°C 16*C 3 TV
C E M C E M C E M  
12 13 14 15 16 17 18 19 20 21
Figure 4.6: Test of in vitro transcription reaction: Agarose gel of RNA product. 
In vitro transcription was tested using different conditions. Time indicates the 
number of hours for which the reaction was carried out and Temperature the 
reaction temperature. C is the amplification product from 0.5pg of the control 
plasmid pTRI-Xefa. E is the experimental sample of double stranded DNA derived 
from lOng of totalRNA. M is a mixture of 0 .2 lpg  of the control plasmid + one 
quarter of the cDNA from an experimental sample. Lanel and 12:1 OObp ladder. 
Lanes 2-10 6h amplification, lanes 13-21 26h amplification. Lanes 8, 10, 19 and 
21 shows that the in vitro transcription reaction only occurred at 37°C and is 
probably complete after 6h. Although no product is detected from the experimental 
sample (Lanes 9 and 20) it does not appear to be due to an inhibitory contaminant 
as the mixture of control and experimental sample has product (lanes 10 and 21). 
Lane 11 is empty.
Although T7 polymerase will use single or double stranded template, the promoter must 
be double stranded. Thus, the second strand reaction must copy the whole mRNA 
molecule for in vitro transcription to take place. E.Coli DNA polymerase 1 (Poll) is 
believed to be a more processive enzyme than Taq polymerase and was used by both 
(Baugh et al., 2001; Luo et al. , 1999). The amount of cytoplasmic RNA used was also 
tested. Reactions were carried out with lOng, lOOng and 900ng of total RNA (Figure
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4.7). The amount of T7-oligo-(dT) primer was fixed at 0.1 pg while the amount of 
template switch primer was varied at 0.1 jxg, 0.2pg and 0.5pg. One quarter of the 
resulting amplified RNA was run out on a 0.8% agarose gel. Only 900ng of input RNA 
appears to give any detectable amplified RNA product suggesting amplification from 
ES cells does occur but requires more starting material than for the material used by 
Wang et al (2000).
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Polymerase Tag Poll Tag Poll Tag Poll
Lane 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Figure 4.7: Agarose gel of amplification products. 10, 100, and 900ng of 
cytoplasmic RNA was put into an amplification reaction with 0.1 pg of T7-oligo- 
d(T) primer and either 0.1 pg or 0.5pg of template switch primer. The double 
stranding reaction was carried out with either E. Coli DNA Polymerase I or with 
Taq polymerase for each concentration of primer.
Lane 1: lkb+Ladder (Invitrogen)
Lane 2: lOOng total RNA, 0.1 pg template switch primer, Taq polymerase
Lane 3: lOOng total RNA, 0.5pg template switch primer, E. Coli DNA
polymerase I
Lane 4: lOOng total RNA, 0.1 pg template switch primer, Taq polymerase 
Lane 5: lOOng total RNA, 0.5pg template switch primer, E. Coli DNA
polymerase I
Lane 6: 900ng total RNA, 0.1 pg template switch primer, Taq polymerase 
Lane 7: 900ng total RNA, 0.5pg template switch primer, E. Coli DNA
polymerase I
Lane 8: 900ng total RNA, 0.1 pg template switch primer, Taq polymerase 
Lane 9: 900ng total RNA, 0.5pg template switch primer, E. Coli DNA
polymerase I
Lane 10: lOng total RNA, 0.1 pg template switch primer, Taq polymerase 
Lane 11: lOng total RNA, 0.5pg template switch primer, E. Coli DNA 
polymerase I
Lane 12: lOng total RNA, 0.1 pg template switch primer, Taq polymerase 
Lane 13: lOng total RNA, 0.5pg template switch primer, E. Coli DNA
polymerase I
Lane 14: control plasmid pTRI-Xefa.
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Experiments were also carried out to assess whether the addition of phage T4gp32 
protein to the reverse transcription reaction would improve the addition of a T7 template 
switch to the cDNA. For these experiments the first strand was primed with anchored 
oligo-(dT)23 to ensure binding at the 3' end of the message and the T7 promoter was 
added with the template switch using the primer TSS (Table 4.4). The first strand 
reaction contained 6fig of T4gp32 protein in the experimental tube. A carrier of 200ng 
of poly-(dldC) was also added to the first strand reaction. Cleaning of the cDNA was 
carried out using the QIAquick® PCR purification kit. This not only is easier, less time 
consuming and less toxic than phenol ichloroform followed by Microcon®100 filtration 
or gel filtration, but also oligonucleotides of less than 40 bases and double stranded 
DNA of less than lOObp are removed. The T7 polymerase step was carried out for 6 
hours at 37°C and the amplified RNA generated was cleaned using the QIAgen 
RNeasy® mini kit.
T4gp32 protein does not appear to make a difference to the amount of amplified RNA 
synthesised (Table 4.9). The control with no RNA template demonstrates the amount of 
non specific product which is produced in the absence of template. In this experimental 
design amplified RNA can only be made if the reverse transcription reaches the cap 
region of the mRNA so more amplified RNA could only be synthesised if more full 
length cDNA was synthesised.
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Amount of total 
RNA
template(ng)
T4gp32
protein
Yield of 
amplified RNA 
after the first 
Round
0 - 1015.2ng
10 + 753.6ng
10 - 799.2ng
Table 4.9: Yield of amplified RNA estimated 
by spectrophotometry after a single round of 
amplification.
It has been further suggested that when using the protocol of Wang et al. (2000) most of 
the second strand priming arises from the oligonucleotides produced by RNase H. An 
experiment was set up to compare the effect of the template switch oligonucleotide by 
comparing a protocol based on the method describe by (Luo et al., 1999) which has no 
template switch and that of (Wang et al., 2000).
Reactions were set up with no template, lOng of IMT-11 RNA and lOOng of an 
artificial polyA RNA which was 891bases in length as a control. Both the sets of 
reactions were primed by the T7 oligo described by both Eberwine and Wang (Table 
4.3). In the Luo reactions the second strand reaction was carried out using T4 DNA 
polymerase (Table 4.5 Step*3) and double stranded cDNA was cleaned using the 
QIAquick PCR cleanup kit. The amplified RNA was purified using the RNeasy Mini kit 
cleanup protocol. For the template switch protocol the same samples were set up and the 
first strand set up as for the non template switch. The second strand was carried out 
using Taq DNA polymerase. The cDNA was cleaned using both 
phenol:chloroform:isoamyl alcohol and the QIAquick PCR cleanup kit with the addition 
of l|xl of linear acrylamide as a carrier.
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Amount of 
template
Luo Round 1 Luo Round2 Wang Round 1 Wang Round2
0 520.8ng 388.8ng 256.8ng 139.2ng
lOng 304.8ng 556.8ng 1-17M 362.4ng
lOOng control 708.0ng 13.73|Xg 468ng 156.0ng
Table 4.10: Yield of amplified RNA after 1 and 2 rounds of amplification for 
protocols without a template switch (Luo et al,, 1999)and with a template switch 
(Wang et al., 2000). The control is an artificial polyA tail containing RNA 891 bases 
in length
Although the Luo method seems to amplify, the level of amplification is not enough and 
a third round of amplification would be required. The Wang protocol appears to have 
less after 2nd round. This is explainable if the oligonucleotide products of the RNase H 
reaction are not being used to form the second strand. Additionally the second round 
first strand synthesis is initiated by random hexamer thus it is less likely that template 
switch will be added
4.3.2 Dynabeads
The design of the experiments using oligo-(dT)25 beads requires the T7 promoter to be 
attached to the free end of the cDNA. This was achieved by adding the T7 promoter 
with a template switch. The first oligonucleotide tried, T7 Min-S (Table 4.3) consisted 
of the minimum T7 promoter with the three dG residues on the 3' end which bind to the 
non-template dC residues on the cDNA. Spectrophotometric analysis suggested 
amplified RNA was present; however nothing was visible on agarose gel 
electrophoresis.
In an attempt to stabilize the T7 promoter, oligonucleotides with 9 or 20 residues, 9- 
T7Min-S and 20-T7Min-S at the 5' end of the switch oligo were compared to the 
T7Min-S oligonucleotide. The sequence of the 9 and 20 residues added to the T7Min-S
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oligonucleotide was random and checked by BLAST to ensure there was no homology 
to known genes. All three oligonucleotides were set up at both 0.1 pg and 0.5pg per 
reaction. To check if full length cDNA was present on the bead, the beads with T7Min- 
S and 9-T7Min-S (the beads with 20-T7Min-S were lost during the procedure) were put 
into a PCR reaction using the switch oligonucleotide as the upstream primer and 
Pou5Fl as the downstream primer. The predicted band size on agarose gel 
electrophoresis is 853bp. A band of approximately this size was detected on the gel 
(Figure 4.8).
Because it proved impossible to get reliable measurements with spectrophotometry due 
to residue from the beads, the presence of amplified RNA was checked by PCR using 
PouSFl. As the input RNA is destroyed by RNase H any band generated on the gel 
must come from either the cDNA or amplified RNA. Reverse transcription was carried 
out with two control reactions, one with no reverse transcriptase which controls for 
reverse transcriptase activity in the Taq polymerase. The second control has enzyme but 
no oligonucleotide primer in the reverse transcription reaction. The absence of a band in 
both of these reactions after PCR is indicative of no cDNA contamination in the 
amplified RNA sample. The band expected would be 261 bp in size and a single band of 
about this size was detected on agarose gel electrophoresis of the RT-PCR products 
(Figure 4.9). However no RNA was detectable by gel electrophoresis.
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I 2 3
c
SOObp
Figure 4.8: Test of attachment of T7 template switch to 3' end of cDNA.
Agarose gel of PCR products. The T7Min-S and the 9-T7-Min-S template switch 
oligonucleotides were used in the formation of a first strand primed from an 
oligo-(dT) bead. The presence of full length cDNA was tested by PCR using the 
template switch as the forward, and Pou5Fl as the reverse primers. A band of 
853bp was expected.
Lane 1:1 OObp ladder 
Lane 2: T7-Min-S to PouSF l.
Lane 3: 9-T7-Min-S to P ou5F l.
A new oligonucleotide T7SS (Table 4.4) was designed; the random sequence between 
the T7 promoter and the switch sequence should allow easier diagnostics as it will be 
transcribed by the T7 polymerase enzyme. Experiments were performed to check if the 
newly synthesised amplified RNA, which should have a polyA tail, is binding directly 
to the beads on synthesis or staying in the liquid phase. To ensure the removal of all 
traces of LiCl and primers before the in vitro transcription, extra wash steps were 
inserted with lOmMTris, pH7.5, 150mM NaCl, ImM EDTA. To try to ensure no beads
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were left to interfere with spectrophotometric analysis, the beads were not only 
processed on the magnetic stand but were also spun in a microcentrifuge at 12000g for 
10 minutes.
Figure 4.9: Test for presence of amplified RNA product after IVT of bead
bound cDNA. Agarose gel of PCR products of amplified RNA for the Pou5Fl
gene.
Lane 1:1OObp ladder
Lane 2: Reverse transcription primed with oligo-dT 
Lane 3: Reverse transcription primed with dN6,
Lane 4 and 5: as 2 and 3 without reverse transcriptase.
Lane 6: no primer in reverse transcription.
Lane 7: no template in PCR
All supernatants and eluates from the beads were checked for the presence of amplified 
RNA by spectrophotometry and although large amounts of amplified RNA were 
apparently in the liquid phase, none was detected by gel electrophoresis. The 
polystyrene-latex oligo-dT conjugated beads, Oligotex®, which are a component of the
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QIAgen mRNA isolation kits, were tested to see if they were more suitable than the 
Dynal magnetic beads. The results with these beads was identical to the Dynabeads® 
Oligo (dT)25.
Finally, as it was not clear if there was inhibition of full length amplified RNA due to 
hindrance caused by the spacer and oligo-(dT), streptavidin coated beads were tried. 
These were conjugated to a biotinylated oligonucleotide consisting of a sequence of 
dNTPs and oligo-(dT )25 (BiotinOligo Table4.3). The mixed oligonucleotide sequence 
was checked on BLAST for sequence homologies and was biotinylated at the 5'end. On 
PCR neither Pou5FJ nor Switch to Pou5Fl sequence was detected.
4.3.3 Message Amp™ (Ambion) amplified RNA Kit.
This kit was used to amplify the same sample of cytoplasmic RNA as the other 
experiments. After one round of amplification the yields shown in Table 4.11 were 
obtained.
Sample No
Amount of 
Total RNA 
input to first 
round
Amount of 
amplified 
RNA input to 
second round
Yield of 
amplified 
RNA after two 
rounds of 
amplification
1 lOng L5pg 3.3pg
2 lOng 1-lPg l i n g
3 lOOng 1.7HS 2.9ng
4 lOOng 2.4flg T in s  . _
Table 4.11: Yield of amplified RNA from MessageAmp™ Kit
The whole of the amplified RNA from the first round was input into the second round 
and the amplified RNA was again analysed by spectrophotometry. The amplified RNA
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was precipitated and Ipg from sample 1 and 3 was run on an agarose slide gel (Figure 
4.10). Sample 1, lOng of input total RNA, appears to have the expected amount of 
amplified RNA. Nothing was detected from the lOOng input sample. This may be due to 
loss of the sample from the slide gel, a problem often seen. Labelling the remainder of 
this amplified RNA was attempted without success.
1 2  3  4
Figure 4.10: Agarose slide gel of lug  of amplified RNA: RNA was amplified 
from lOng or lOOng of cytoplasmic RNA from the ES cell line IMT-11 using the 
MessageAmp™ Kit to carry out 2 rounds of amplification.
Lane 1: lOng of RNA in amplification 
Lane 2: lOOng of RNA in amplification 
Lane 3: blank 
Lane 4: 1 kb-»- ladder
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4.3.4 RiboAmp™ (Arcturus) Kit
The RiboAmp™ kit (Arcturus) was used to amplify lOng and lOOng of the control RNA 
supplied by the kit, lOng of IMT-11 cytoplasmic RNA and a no template control using 
the manufacturer’s protocol described in Version A. The major difference between this 
kit and the other protocols and kits tried is that the second strand is primed by 
exogenously added primer rather than by the products from the RNase H. The amplified 
RNA is eluted in a volume of 60pl after the first round of amplification. The volume of 
the amplified RNA was reduced to 20pl by vacuum centrifugation and a lpl sample was 
diluted 1:50 for spectrophotometric analysis.
Slide gel electrophoresis was used to visualise the amplified RNA. Only lpl of each 
sample was run on the gel (Figure 4.11). Although the slide gels are very thin 
(approximately 1mm), the amount of amplified RNA loaded was below the detection 
limit of Sybergreen Gold in the case of the samples derived from lOng of total RNA.
The lane with lOOng of total RNA is very clear. Since these gels are non-denaturing, it 
is not possible to estimate the size spread of the amplified RNA. The “no template” 
control lane shows no evidence of side reactions.
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1 2 3 4 1 2 3 4
Figure 4.11: Slide gels of amplified RNA from the first round of amplification 
using the RiboAmp™ kit:10ng of IMT-11 cytoplasmic RNA and lOng and 
lOOng of the control RNA supplied with the kit were subjected to one round of 
amplification and 1 /20th of the product was run on a gel 
Gel (a) Lane 1: 1 OObp ladder 
Lane 2: lOng IMT-11 
Lane 3: lOng control 
Lane 4: no template control 
Gel (b) Lane 1: lOObp ladder 
Lane 2: lOOng control.
Lanes 3 and 4: empty
All of the amplified RNA from the lOng samples and the no template control were put 
into a second round of amplification and the amplified RNA was again analysed both by 
spectrophotometry (Table 4.12) and by slide gel electrophoresis (Figure 4.12). In both 
cases a good amount of amplified RNA was synthesised and no side reactions were
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detected in the “no template” control. This amplified RNA labelled well with the 
Clontech amino-allyl labelling kit.
Template Yield after Round 1 Yield after Round 2
0 0 0
lOng IM T-11 total RNA 200ng 42.6pg
lOng kit control 600ng 37.08pg
lOOng kit control 52.8|ig Not done
Table 4.12: Yield of amplified RNA after amplification using the RiboAmp™ 
kit.
i 2 3
Figure 4.12: Slide gel of amplified RNA: lOng of input RNA and 2 rounds of 
amplification using the RiboAmp™ kit.
Lane 1: lOObp ladder,
Lane 2: lOng IM T-11 input,
Lane 3: lOng kit control.
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To confirm that the RiboAmp™ kit (Arcturus) could not only amplify RNA diluted 
from bulk preparations, but could indeed amplify the type of material we were 
interested in, the RNA from 19 ICMs was purified using TRIzol® with the addition of
0.1 pg of linear acrylamide. After the first round, the yield of amplified RNA was 220ng 
and after the second round 7.5pg; enough for 2 labelling reactions.
Although TRIzol® purification of total RNA seemed compatible with the amplification 
procedure; the Mini RNA Isolation Kit™ produced by Zymo Research has several 
advantages. Not only is the procedure fast, simple and elutes the RNA in a very small 
volume which can be directly input into the RiboAmp™ amplification procedure 
without the need for precipitation, but there is no risk of residual phenol inhibiting down 
stream enzyme reactions.
A sample of 5 ES colonies picked from a plate of IMT-1 lp l5 and a sample of 19 ICM’s 
were purified using the Mini RNA Isolation Kit™. The remainder of the plate of ES 
cells was harvested and the totalRNA was purified using the GenElute™ Mammalian 
Total RNA Miniprep Kit and lOng was used as template in the RiboAmp® procedure. 
The yield of amplified RNA obtained after two rounds of amplification is presented in 
Table 4.13
Sample Yield
19ICM 5.22pg
5 ES colonies 1.8ng
lOng total ES RNA 89. lug
Table 4.13: Yield of amplified RNA after 
two rounds of amplification using the 
RiboAmp™ kit.
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A 0.5pg aliquot o f each sample was run on a slide gel Figure 4.13. The remainder of the 
1CM and ES colony amplified RNA was labelled with Cy3™ and Cy5™ respectively 
using the PowerScript™ labelling kit (Promega)
1 2  3 4
Figure 4.13: aRNA from two rounds of amplification. A sample of 19 ICM’s 
and 5 ES cell colonies were purified using the Mini RNA Isolation Kit™ (Zymo). 
The remainder of the plate from which the ES colonies were picked was harvested 
and the RNA isolated using a GeneElute™ Mammalian Total RNA Miniprep Kit. 
All the RNA from ICM 's and ES colonies, and lOng of RNA from the plate (bulk) 
was used as template for 2 rounds of amplification using the RiboAmp™ kit. Each 
lane was loaded with 0.5pg of amplified product.
L anel: lOObp ladder 
Lane2 ICM
Lane3 ES cell colonies
Lane4 diluted RNA from bulk culture
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The RiboAmp manufacturer’s protocol version B significantly reduced the incubation 
times for the reverse transcription and second strand reactions without affecting the 
yield of RNA or the quality. Also adjustment of elution volumes from the purification 
steps removed the need for concentration of the samples by vacuum centrifugation. 
However, two and a half days are still required to complete the procedure.
4.4 Conclusions
The purpose of the work in this chapter was to develop reliable methods of linear 
amplification for the very small total RNA samples available in this study. This chapter 
demonstrates the difficulties which can be encountered when optimising such 
complicated, multistep procedures at the limit of the sensitivity of the methods.
The published method of Wang et al (2000) was tried using lOng of total RNA which is 
about the amount which we might expect to have available. Modifications to the basic 
method as suggested by other authors were also tried. Analysis of the products of each 
step in the process suggested that the individual enzymatic reactions were working 
however, the complete procedure failed to produce amplified RNA from the 
experimental material. As significant amounts of product were produced by the first 
round when 900ng of total RNA were processed and the presence of amplified RNA 
was detected by RT-PCR when lOng were used, it could be concluded that for some 
reason the second round of amplification was not functioning. The amount of product 
after the second round of amplification was less than after the first. This suggested that 
either only non-specific products were being made as in the no template control or the 
priming of the second round was not efficiently adding the polyA tail and annealing the
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oligO20-T7-(dT)i5 primer. The ability to amplify the Pou5fl gene from the first round 
product argues against there being no specific product but if the template switch is 
added infrequently, only some of the cDNA would be expected to reach the RNA cap 
region, and there is little or no priming from the RNase H fragments then the amount of 
template which can be transcribed may be very small and the bulk of the product seen 
would be the non-specific side products which IVT produces when there is too little or 
even no template (Biebricher and Luce, 1996). Thus selection for full length cDNA may 
be impractical with the very small amounts of sample RNA used in this study. This 
belief was strengthened by the results using the protocol of Luo et al (1999) where 
amplification appears to have taken place. However the amount of amplified product 
was inadequate and would have required a third round of amplification. This would not 
have been satisfactory due to the shortening of the amplification product with every 
round of amplification leading to more severe 3' bias.
The difficulty encountered with the addition of the template switch and the necessity of 
producing full length template was probably also a major factor in the failure of the 
protocols that used beads. These protocols required the T7 promoter to be applied with a 
template switch mechanism.
Each separate enzyme reaction requires optimisation individually and with respect to 
each other. This is a task which is most probably better undertaken by the commercial 
companies. However, a measure of the difficulty of this task is the long time it has taken 
for competing companies to produce their own kits and very few of these are able to 
amplify from as low as lOng.
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The first MegaAmp® kit produced by Ambion did not work well at the very low RNA 
input levels necessary for this project (the company has subsequently produced an 
improved kit, the MegaAmpII® kit, which works with the lower amounts of RNA).
Although the protocol details are proprietary information, the RiboAmp® kit is most 
similar to the protocols of Eberwine and Luo in that no attempt is made to select for full 
length cDNA. Furthermore, instead of relying on oligonucleotides generated by the 
destruction of the mRNA template by RNase H as primers for the second strand 
reaction, an exogenous primer is used. In combination with column technology which 
efficiently cleans each reaction product before the next step, this kit produces 
approximately 50pg of amplified RNA from a lOng sample. The removal of primers 
and dNTPs before the IVT is extremely important as they can contribute to non-specific 
product.
At the time of investigation, as the RiboAmp® kit was the only one which gave 
adequate levels of amplification with the material relevant to this project; it was used in 
all subsequent experiments
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5. Optimisation of Amplification
5.1. Introduction
The process of amplification provides great opportunity for the introduction of 
systematic errors and DNA contamination of the RNA samples is a potential source of 
these. Although many workers routinely treat the RNase with DNase before 
amplification others do not. It has been suggested that reverse transcription from the 
polyA-T7 primer annealing to DNA is a rare event, and that signal from such will be 
neutral since the genome is the same in all cells (personal communication Per Lindahl) 
therefore treatment with DNase is unnecessary. As the tissue samples in this study are at 
the most only a few hundred cells, it would be advantageous to carry out as few 
procedures as possible and thus avoid loss of material through multiple purification 
steps and degradation. However we have compared DNase treatment with untreated 
samples experimentally in order to check for any contamination effects.
5.1.1 Sample Preparation
RNA can be isolated by disrupting the cells or tissues in guanidine thiocyanate buffer 
followed by phenol extraction (Chomczynski and Sacchi, 1987). Commercially 
available solutions such as TRIzol® (Invitrogen), as used in Section 4.3.4 to extract 
ICMs, combine phenol and guanidine thiocyanate in a mono-phasic solution in which 
the tissue is disrupted. Addition of chloroform separates the organic and aqueous phases 
allowing the isolation of the total RNA from the aqueous phase. Alternatively, after 
lysis in guanidine thiocyanate, the cell extract can be passed over a silica membrane in a 
column format. RNA longer than 200 bases will bind to the column and impurities are 
washed away.
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The phenol based protocols have been shown to yield amplifiable RNA even with only 
19 ICMs (4.3.4). However, traces of phenol in the RNA product could inhibit the 
downstream enzymatic reactions of amplification. Furthermore, phenol is toxic and 
produces organic waste for which disposal is difficult. Conversely, disposal of the waste 
produced from silica columns is much easier and the RNA is eluted in water. Moreover, 
as RNA less than 200 bases long is not bound to the silica but washed through with 
other contaminants, there is the advantage of enriching for mRNA: 5.8S rRNA, 5S 
rRNA and tRNA are selectively excluded. Another advantage of column technology is 
that DNase treatment can be carried out on the column if desired. Until recently the 
major difficulty with the columns available was the large elution volumes (30pl for the 
RNeasy® Mini Kit, QIAgen) necessitating concentration of the sample before 
amplification; another step where material could be lost or degraded. The introduction 
of the Mini RNA Isolation Kit™ (Zymo Research) circumvents this problem as the 
RNA can be eluted in as little as 8pl of water.
The RiboAmp™ (Arcturus) kit used in this study recommends treatment of the input 
RNA with DNase. In this experiment we ask whether treatment of our RNA with DNase 
before amplification, labelling and hybridisation to microarray slides results in a 
difference in the gene expression profile or data quality. Total RNA was extracted from 
groups of 10 ES colonies picked from a plate of IMT-11 at p i6. The sample was split 
into two and one half was treated with DNase and the remaining half left untreated. The 
samples were then amplified, labelled and applied to microarray slides printed with the 
NIA 15K gene set.
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5.7.2 Image Analysis
The aim of image analysis is to identify each spot through its unique address on the 
slide, to segment the image into foreground and background pixels and to quantify the 
spot intensities. Spot finding and segmentation was carried out using the package 
ImaGene™ (BioDiscovery). A deformable grid is placed over the array image allowing 
the spots to be assigned the unique address related to the identity of the gene probe. The 
pixels at this address are then assigned to either signal or background. First a target 
mask chosen to be larger than any spot is applied and the pixels allocated to foreground 
or background from the histogram of pixel values within the area of the mask. The 
graphics file, corresponding to the surface of the microarray, is a 16bit TIF (tagged 
image format) thus the intensity of each spot lies between 0 and 65,536 (216).
5.2.3 Normalisation and Data Analysis
When analysing two colour arrays relative levels are being measured and thus the two 
channels need normalising. Furthermore, microarray images are rarely perfect, 
particularly from non-commercial sources. Usually, they suffer from spatial bias, print 
tip bias and dye bias. Moreover, low intensity spots have more noise than high. Global 
normalisation by scaling in the same manner as for Northern blotting is the simplest 
normalisation using all the gene spots on the array. This does not take into account 
intensity dependant bias which shows on the MA plot as a curve. The most frequently 
used normalisation procedure is loess (also known as Lowess, locally weighted 
polynomial regression). Loess normalisation assumes that most of the spots on the array 
are not differentially regulated and consequently would be unsuitable for arrays where 
this would not be the case such as the so called boutique arrays. Loess takes a 
percentage of the spots and fits a curve to these spots. The larger the number of spots
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(or window) the smoother the fitted curve. Print tip Loess, where a Loess curve is fitted 
to each print tip field, is often used as a proxy for spatial normalisation. Loess curves 
are fitted for each print tip (Yang et al., 2002b).Variation between slides also needs to 
be considered.
Normalisation and analysis was carried out using both GeneSight™ (BioDiscovery) and 
Limma (BioConductor). GeneSight™ is a commercial package for the analysis of 
microarray data. It is generally simple to use providing pull down menu options for 
processing data. However, it is a “black box” package with limited options for data 
normalisation and processing. In particular, only global normalisation procedures are 
provided and considerable bias due to print tip variation and spatial variation can be left. 
It does have the advantage of being specifically designed for ImaGene data files which 
produce the two channel data in separate files. There is also flexibility in the spots 
which are included in the normalisation process; landmarks and other non-data spots 
such as spiked in controls can be removed from the normalisation process. Limma, on 
the other hand, is an R based package (http://www.r-project.org/) provided by the open 
source, open development project designed experiments and the assessment of 
differential expression. It has the disadvantage of being command line software but 
provides more options for normalisation and visualisation in analysis. In particular 
Limma produces an MA plot which is similar to a scatter plot but instead of the logged 
intensities for the two channels of a spot being plotted against each other, the log ratio 
of each spot (M) is plotted against its total intensity (A). This has the advantage of 
spreading out low intensity spots allowing better visualisation. However, Limma does 
not read flag information from ImaGene files thus all spots including landmarks and 
blanks are included in the normalisation process.
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The effect of various background removal procedures was examined using Limma. 
Background removal by local background subtraction is not generally recommended. 
Firstly, it tends to increase the variance of the intensity values. Secondly, the 
background around a spot does not reflect the background under the spot. Finally, 
simple subtraction of the local background tends to result in many negative intensity or 
zero values leading to loss of data and interference with normalisation between arrays. 
Other methods of background correction which do not result in negative signal values 
are provided in Limma. The most used procedure is ‘normexp’ which by fitting a 
normal distribution to the background and an exponential model to the foreground, the 
expected background removed is calculated on the basis of the foreground observed. 
This results in all foreground intensities being positive. Adding a constant to all 
intensities reduces the variation of low intensity spots bringing the log ratios closer to 
zero.
In addition to within array normalisation, Limma provides methods of between arrays 
normalisation. Between arrays normalisation is applied after within array normalisation. 
Variation between arrays often arises due to differences in print quality or from 
differences in the scanner settings. The simplest and often the most useful method is 
scale normalisation which simply applies the same scale to all the M-values (Yang et 
al., 2002b). The method "A quantile" ensures that the A-values (average intensities) 
have the same empirical distribution across arrays leaving the M-values (log-ratios) 
unchanged.
Limma provides a list of differentially expressed genes using the functions “topTable” 
and statistical function “eBayes” which outputs a number of summary statistics. Instead
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of a normal t-statistic a moderated t-statistic is provided. This is interpreted in the same 
way as the normal t-statistic but borrows information from all the genes on the array.
The B-statistic is the log-odds that the gene is differentially expressed thus a B-statistic 
of zero records a 50:50 chance that the gene is differentially expressed. The moderated 
t-statistic and B-statistic should give the same ranking of differentially expressed genes, 
however as these tests are based on different assumptions about the data, this may not 
be the case. In particular, the B-statistic depends on an estimate of the expected level of 
differential expression
A feature of microarray analysis is that many tests are being carried out in parallel. For 
an experiment where for example 10,000 genes were being tested and the critical p- 
value was 0.05, then 500 significantly differentiated genes would detected by chance 
even if none are actually differentially regulated. Thus a false discovery rate algorithm 
is applied to the p-values to control the number of false positive results. If an algorithm 
which is too stringent is applied true positives will be lost. For microarray data, the one 
most frequently used is ‘fdr’ (Benjamini and Hochberg, 1995).
The scanned images of the microarray slides were subjected to image analysis using 
ImaGene™ 5.5.3 (BioDiscovery). The raw intensity data was examined using Excel to 
provide information about the dynamic range of intensities and the number and quality 
of features detected on the array. The data was input into both GeneSight™ 3.5 
(BioDiscovery) and Limma (BioConductor) and the raw data displayed in a number of 
ways. Various background correction and normalisation procedures were applied and 
differential expression between DNase treated and untreated samples examined.
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5.2. Materials and Methods
5.2.1 Target Preparation
A plate of the ES cell line IMT-11 at passage 16 was washed twice in DPBS-A and 
colonies were picked from a plate using a glass capillary. Groups of ten colonies were 
put into microcentrifuge tubes in a minimal volume of DPBS-A and 200pl of Zymo™ 
RNA Extraction Buffer was added. Samples were stored at -70°C until extraction. The 
RNA was extracted from two samples (20 colonies) according to the manufacturer’s 
protocol (2.3.1b). The two purified total RNA samples were then pooled and divided 
into two aliquots. One aliquot was then treated with DNase (provided in kit) and 
cleaned using the DNA Free RNA kit™ (Zymo) according to the manufacturer’s 
protocol. The other aliquot was left untreated. The whole amount of both the control
TMand DNase treated samples were then amplified for 2 rounds using the RiboAmp HS 
RNA Amplification kit (Arcturus Bioscience Inc, California, USA). A 500pg kit control 
sample was also amplified. The amplified RNA was analysed by spectrophotometry and 
by denaturing agarose gel electrophoresis.
A 5pg aliquot of the amplified RNA, both control and experimental was then labelled 
according to the modified Atlas™ PowerScript™ Fluorescent Labelling Kit (BD 
Biosciences) labelling described in Table 3.9 and Step 3*. Precipitation and recovery of 
the aminoallyl conjugated cDNA was enhanced by the addition of 0.5|il of 
PelletPaintNF™ (Novagen, Merck Biosciences Ltd, Nottingham, U.K.), Section 3.4.
A 15pmol aliquot of each Cy labelled target was combined and the non specific binding 
sites blocked with human COT-1 DNA (Invitrogen) and Poly-dA30 (MWG) as described
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in Section 2.4.3. After denaturation, an equal volume of two times concentrated 
hybridisation buffer (Section 2.4.3) was added to the target.
5.2.2 Slide Preparation and Hybridisation
Each slide was blocked as described in Section 2.4.2 and the prepared target applied to 
the slides under Hybri-slips (Sigma) forl8h at 42°C according to the experimental 
design described in Table 5.1.
Slide Number Cy3 Cy5
11 DNase control
12 DNase control
13 control DNase
14 control DNase
Table 5.1: Design of experiment.
After washing and drying in accordance with the conditions described in Section 2.4.4, 
the arrays were scanned in a ScanArray® Express HT (PerkinElmer™) equipped with 
red (X=633nm) and green(X=543nm) lasers. The slides were scanned at a resolution of 
IOjli run at full speed. The pmt gain was set at 65% and the laser power at 95%.
5.2.3 Image Analysis
Spot finding and segmentation were carried out using the ImaGene™ 5.5.3 image 
analysis program (BioDiscovery). Screen shots of the settings used are provided in 
Figure 5.1. As there were no negative spots, visible as darker spots on the slides, this 
option was left deselected. The grid constraints were enforced and the global flexibility 
set as shown such that the spot finding did not misidentify contamination as spots. 
Automatic segmentation was used with the shown buffer and background settings as 
these gave the least number of incorrectly flagged spots.
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Figure 5.1: Screen shots of the settings for image 
analysis
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Doughnut shaped spots were not allowed although this was not a problem on these 
slides. The threshold for empty data spots was set using the blank spots printed on the 
slides and adjusting till all were flagged as empty (Flag2). A spot was flagged as empty 
only if there was no signal above the threshold in both channels.
Negative spots were flagged using the same constraints. Spots which failed the quality 
checks were flagged if either channel failed. All non-data spots; Landmarks, controls, 
blank (printed with buffer only) and empty (not printed) spots were manually flagged as
1. Histograms and scatter plots of the raw data were generated. The text files generated 
by ImaGene™ were opened in Excel, the data was filtered and statistics for each slide 
were generated.
5.2.4 Normalisation and Analysis
Normalisation and analysis was carried out using both GeneSight™ 3.5 (BioDiscovery) 
and Limma (BioConductor).
5.2.4a Normalisation and Analysis using GeneSight™3.5 (BioDiscovery)
Data was loaded into GeneSight™3.5(BioDiscovery) according to the method shown in 
Figure 5.2. The data was processed in the sequence: omit flag types (selected for 
individual analyses, floor values to 20 (this raises the value of all intensities less than 
twenty to twenty avoiding negative values and ratios with zeros), log2 transform the 
intensities, normalise with loess then subtract the log2 green from the log2 red values 
(M value) and combine the data for each array. Histograms and scatter plots were 
generated. Differentially regulated genes were identified by first finding the spots more 
than 2-fold up or down regulated. A confidence analysis test to identify the statistically 
significant genes at the 99% level was then carried out.
158
o s z c c s n
JZLED.B.Q.Q.QQRQ.Q.
N Q ® '® S 1
£}
WartatiUaal
ircr
F 3 -----------------
j H
Cw
J?J
U S H H M K ^  jej
>»v!(»»»j(#P#h5<at^j t-)»wi» W^C* ■ OtwM9 d
f>0
-«J
MtaMnrwwMwtow
n
l< « * ii 'le H i)  
>K»r»ig SriM l ^>£7
S 3
zJ
Figure 5.2: Screenshots of settings used for processing the data.
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5.2.4b Normalisation and Analysis using Limma
The raw data text files were loaded into Limma using the commands in Appendix 3. 
Diagnostic plots of the raw data were generated. Various background correction and 
normalisation protocols carried out and diagnostic plots again generated to assess the 
consequences. A linear model was fitted to the data and eBayes statistics produced. 
Statistically significant regulated genes were identified from the top table.
5.3 Results and Discussion
5.3.1 Amplification and Labelling
After two rounds of amplification the amplified RNA was analysed by 
spectrophotometry (Table 5.2) and denaturing agarose gel elecrophoresis (Figure 5.3).
Treatment of TotalRNA Yield of amplified RNA
DNase + 57.3pg '
DNase- 94.0pg
Mean 75.65pg
SD 18.35pg
Table 5.2: Yield of amplified RNA after 2 rounds of amplification.
Although the DNase treated aliquot does appear to have a lower yield than the untreated 
aliquot the difference is not significant being within two standard deviations of the 
mean. Samples of the amplified RNA were labelled with either Cy3™ or Cy5™ and the 
labelled products were analysed by spectrophotometry (Table 5.3) and by slide gel 
electrophoresis (Figure 5.4).
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I 2 3 4 5
Figure 5.3: Denaturing agarose gel of lpg  amplified RNA
Lanel: RNA ladder.
Lane2: Kit control lOng amplified in parallel with samples 
Lane3: DNase treated sample.
Lane4: Untreated sample.
Lane 5: RNA ladder (Sigma)
Treatment of 
totalRNA
Yield of cDNA(pg) pmol of Cy dye 
incorporated
FOI
Cy3 Cy5 Cy3 Cy5 <v3 Cy5
DNase+ 440.3 407 28.0 18.0 20.6 18.0
DNase- 754.8 821.4 28.0 32.4 12.0 12.8
Table 5.3: Yield of labelled target and incorporation of dye molecules.
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Again, the difference between the DNase treated and untreated are not significantly 
different. The apparent increase in the amount of cDNA synthesised with the same 
amount of dye incorporation suggests inaccuracy in the quantification of the input 
amplified RNA. Examination of the denaturing gel (Figure 5.3, Lanes 3 and 4) confirms 
this.
1 2  3 4
Figure 5.4: Slide gel of labelled amplified RNA target. 
Lane 1: lOObp ladder, Cy3™ labelled.
Lane 2: untreated sample, Cy3™ labelled.
Lane 3: DNase treated sample, Cy5™ labelled.
Lane 4: DNase treated, Cy5™ labelled.
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5.3.2 Analysis 
5.3.2a Image Analysis
After filtering out all the landmarks, empty, blank and scorecard spots, the number of 
good, empty and poor spots detected were recorded (Table 5.4).
Slide
Number
Good Spots Empty Spots Poor Spots Non Data Spots
Number
%of
total
printed
Number
%of
total
printed
Number
%of
total
printed
Number
%of
total
printed
11 11114 68.91 3200 19.84 933 5.78 881 5.46
12 11848 73.46 2517 15.61 882 5.47 881 5.46
13 13049 80.91 1316 8.16 882 5.47 881 5.46
14 12013 74.48 2369 14.69 865 5.36 881 5.46
Mean
SD
12006
690.75
2350.5
674.52
890.5
25.5
Table 5.4 : Number and quality of spots found by ImaGene on each s lide.
All four slides were very similar with no real difference in the dye reversed pair. The 
maximum and minimum intensity of the spots show that the data is within the linear 
range of the assay, none of the spots are below zero (negative spots) and none are over 
65,536; the maximum detection limit of the scanner 216 (Table5.5).
However, some of the lower intensity spots should be disregarded as they are lower than 
the mean background intensity + 2 standard deviations.
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11 12
Cy3 DNase Cy5 Control Cy3 DNase Cy5 Control
Signal Background Signal Background Signal Background Signal Background
Total 39719697 2874733 31469286 2836929 43531501 2653556 30767081 2695366
Maximum 52429.19 1968.7 49507.96 1013.295 49866.72 7818.427 50975.3 5521.066
Minimum 155.9058 140.7585 159.4688 140.5767 139.7211 130.6407 155.3575 136.6654
Mean Spot 2774.885 200.8337 2198.497 198.1926 3030.386 184.7237 2141.809 187.6343
SD 5442.502 39.12995 4550.162 30.49111 5654.837 87.52242 4392.979 49.67983
Slide Number 13 14
Cy3 Control Cy5 DNase Cy3 Control Cy5 DNase
Signal Background Signal Background Signal Background Signal Background
Total 26689105 2924201 65726756 3592284 26596318 2918505 44686411 3337158
Maximum 47101.77 1784.457 53177.62 2644.202 51842.26 8090.993 54010.8 13874.29
Minimum 161.9427 154.9125 193.5648 177.2587 167.0465 146.9656 186.6628 168.9225
Mean 1857.926 203.5643 4575.479 250.072 1849.407 202.9417 3107.323 232.0532
SD 3755.291 33.75438 7517.186 44.64857 3771.753 69.87828 5723.164 119.1988
Table 5.5: Foreground and background signal intensities for each array slide.
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Examination of the histograms and scatter plots (Figure 5.5 and 5.6) suggests that some 
spatial and between array slide normalisation is required. The distinct banana shaped 
scatter plot from Slide 13 shows strong evidence of intensity dependant dye bias. Spots 
from the scorecard which have hybridised with the target are evident as both a shoulder 
on the histogram and a low intensity group on the scatter plot. This is also present on 
slide 14 to a lesser extent. As the dyes are reversed with respect to slides 11 and 12, this 
is evidence of dye bias. However, the dye swap should be sufficient to counteract this.
5.3.2b GeneSight™ (BioDiscovery)
The analysis package GeneSight™ is designed for full integration with the image 
analysis program ImaGene™ and can be used to remove spots from the normalisation 
process by utilising the spot quality flags. It provides a number of tools with various 
options for the processing of microarray data. After processing the data scatter plots 
were produced. To assess the impact of non-data spots on normalisation and detection 
of differential expression analysis was carried out using various categories of spots 
(Figure 5.7).
The slope of the regression line under all three analysis conditions is very close to 1 
indicating very little difference in the two samples being examined. The inclusion of 
empty data, poor or non-data spots seems to have little impact on the relationship 
between the samples. The R2 value, also very close to 1, indicating the goodness of fit.
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(a) Slide 11: Untreated Cy5 ™ 
DNase Cy3™
(b) Slide 12: Untreated Cy5™ 
DNase Cy3™
(c) Slide 13: DNase Cy5
Untreated Cy3™
(d) Slide 14: DNase Cy5™
Untreated Cy3™
Figure 5.5: Histograms of the raw data Cy5™intensity/Cy3™ intensity The
ratio of two channels is plotted on the x-axis and the frequency plotted on the y- 
axis.
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(b) Slide 12: Untreated Cy5™ 
DNase Cy3™
(c) Slide 13: DNase Cy5™
Untreated Cy3™
(d) Slide 14: DNase Cy5™
Untreated Cy3™
Figure 5.6: Scatter plots of raw data. x-axis=control, y-axis=DNase treated. The 
spot marked red is a landmark for orientation.
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Figure 5.7: Scatter plots of analysis of data after normalisation. Red spots indicated regulated genes. Plots in column (l) show spots 
more than 2-fold regulated. Plots in column(2) are 2-fold regulated at the 99% confidence limit. 
x=amplified RNA from untreated total RNA, y= amplified RNA from DNase treated total RNA.
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Spot Types 
Omitted
Genes more 
than 2-fold 
different
Genes more 
than 2-fold 
different at 
99% 
confidence 
level
Identity
Non-data,
Poor 42 2
H3056D06-3
H3065A01-3
Non-data,
Empty
Poor
46 4
H3056D06-3
H3065A01-3
H3072A07-3
H3105C08-3
none 33 1 H3056D06-3
Table 5.6: Genes detected as differentially detected by GeneSight™
If DNase treatment had a significant effect in a gene specific manner, a number of genes 
might be expected to be differentially detected. This does not appear to be the case 
(Table 5.6).
On examination of the spots identified by these analyses, H3072A07-3 and H3105C08- 
3 are flagged as empty (Flag2) data spots on three of the slides out of the four and 
H3065A01-3 is very low intensity. The spot detected in all analyses, H3056D06-3, is of 
low intensity but by visual inspection is not an artefact such as dirt on the slide. 
Searches of sequence data bases show the probe sequence to be an unknown EST. Thus 
only one gene appears to be affected by DNase treatment.
5.3.2c Analysis using the Package Limma (BioConductor)
Before any normalisation procedures were undertaken, the unmanipulated data was 
scrutinised using the various plotting tools available in Limma. Examination of the red 
and green background image plots showed that these slides had few background 
problems (Figure 5.8). There is however, an area of higher background on metagrid
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(2,4) and in the corner (12,4). This is not so easy to see in the print tip loess image 
although the need for normalisation is clear (Figure 5.9(a).).
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(a) (b)
Figure 5.8: Example of image plots of the background obtained from the 
raw data from slide ll.(a) Cy5 background (b) Cy3 background.
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Figure 5.9: Example of print tip loess plot of the data from slide 11
(a) before normalisation and (b) after printtip loess normalisation.
Figure 5.10 shows the MA plot for each slide before normalisation.
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Figure 5.10: MA plots of the microarrays before background subtraction or 
normalisation. The x-axis is A where A= 0.5(log2Cy5™+log2Cy3™) i.e. the 
total spot intensity and M is the y-axis where M=log2Cy5™/Cy3™ i.e. the fold 
change in intensity.
Background is removed from the foreground intensity before within array 
normalisation. The default procedure for Limma is to subtract the local background and 
carry out print tip Loess normalisation. First the data was normalised by print tip Loess
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with no background correction. The normalisation procedure was then repeated using 
the “normexp” function with an offset of 50 for background adjustment. The data was 
finally normalised using no background correction and global loess as a comparison 
with GeneSight. All the normalised slides show clearly the correction of the higher 
intensity in the red channel (Table 5.5) and compensation for the intensity dependant 
component. The slides where no background correction was applied before 
normalisation appear to have compression of the signal intensity For the Limma 
analysis it was decided to use normexp with an offset value of 50 with the command 
printtip loess.
Box plots and density plots of the arrays, before and after between slide normalisation, 
were generated (Figure 5.11). Both the box plot and the density plots show that 
although very similar, some between array normalisation could be beneficial. The 
density plot shows very little variation between channels (this is after within slide 
normalisation) and some between slides. Scale normalisation and A-quantile 
normalisation were compared. A-quantile appears to give a better result.
A linear model was designed (Appendix 3) as shown in Table 5.7.
Array DNase
1 -1
2 -1
3 1
4 1
Table 5.7: Design matrix of linear model.
Coefficients used to model data for this simple dye swap experiment. 
Cy5™/Cy3™= -l(Cy3™ /Cy5™ )
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Figure 5.11: Box plots and density plots of (a) the four print tip loess normalised slides before between array 
normalisation (b) after scale normalisation (c) after A quantile normalisation and (d) with no background correction 
before print tip Loess A-quantile normalisation.
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The linear model was fitted to the data, and the eBayes statistics generated. The 
TopTable command is used to output the data. When the data was only subjected to 
global normalisation, no significant genes were found, only landmarks and Scorecard 
spots were significant.
Method BackgroundCorrection
Within Array 
Normalisation
Between
Array
Normalisation
Genes
Found
1 None Printtip Loess None 6
2 normexp Printtip Loess None 9
3 normexp Printtip Loess Scale 0
4 normexp Printtip Loess A-quantile 9
5 None Printtip Loess A-quantile 6
6 None Global Loess None 0
Table 5.8: Summary of the analysis of the data processing and 
the number of genes differentially detected.
The nine genes found as being differentially detected by methods 2 and 4 (Table 5.8) 
are identical both in rank and identity. The six genes found by Method 1 are the first six 
genes in the list of nine albeit in a slightly altered rank order. The six genes found by 
method 5 are the same as those found by method 1 with only the last two genes in 
reverse order compared to Method 1. Methods 3 and Methods 6 both yield no spots.
As this data is unfiltered and includes spots with a signal less than the background mean 
plus two standard deviations, intensity data for the nine spots were examined in Excel. 
Seven of these genes had intensities greater than the background mean + 2 standard 
deviations in both channels of all four slides. Two of the genes had one slide where one 
channel was below this cut-off value. Examination of the M-values for these genes 
reveals only the three were more than 3-fold different. One was just under 3-fold 
different. The remaining five were only marginally over 2-fold different (Table 5.9)
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Field Meta. Row Meta.Column Row Column Gene. ID Status M A t P. Value B
6493 A 5 4 6 4 H3050H04-3 gene -1.771 8.86 -13.77 0.0169 5.02
8105 A 7 1 2 20 H3019A12-3 gene 1.625 9.52 10.67 0.0488 3.84
10240 A 8 3 8 13 H3079C09-3 gene -1.429 10.61 -9.94 0.0488 3.48
13256 A 10 4 8 5 H3075D05-3 gene 1.148 13.07 9.29 0.0488 3.12
13494 A 11 1 3 12 H3027A03-3 gene 1.146 11.46 9.16 0.0488 3.04
13040 A 10 3 13 20 H3135C05-3 gene 1.119 12.96 9.08 0.0488 3
9899 A 8 2 8 8 H3073B10-3 gene -1.13 8.41 -9 0.0488 2.95
5156 A 4 4 6 11 H3056D06-3 gene -1.857 11.11 -8.87 0.0488 2.87
1355 A 2 1 1 11 H3006A09-3 gene -1.17 11.72 -8.81 0.0488 2.83
14376 A 11 3 13 12 H3131C03-3 gene 0.983 10.37 8 0.0771 2.29
Table 5.9: Table of top ten differentially expressed genes. The data was processed by removing the background with normexp Offset=50, 
normalisation within arrays by printtip Loess and normalisation between arrays by A-quantile or with none. Only the first 9 genes are
statistically significant. p< 0.05. When processed by within array printtip loess and without background removal or between array normalisation
only the first six genes, highlighted in yellow are found to be significantly different at p<0.05.
Note actual p values of yellow list are different.
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The gene H3056D06, which is the only gene detected by GeneSight™ (BioDiscovery), 
is also on the list of 9 genes and has the highest M-value (-1.857)
5.4 Conclusions
The purpose of the work presented in this chapter was to assess the impact of DNase 
treatment on the outcome of array analysis and to examine some of the statistical 
methods available.
Treatment of the RNA samples before amplification with DNase had little effect on the 
yield of amplified RNA and its subsequent labelling. Furthermore, the detection profile 
of the genes was only very slightly altered. As two samples, Dnase treated and 
untreated, were being compared and few differences between the treatments were 
expected, a direct comparison was made with reversed dyes to allow for any dye bias. 
The histograms of the raw data demonstrate the necessity for the dye swap design.
Analysis with GeneSight™ was used to assess the impact of the different categories of 
spots on the finding of differential detection. The non-data spots, in particular the 
Landmarks might be expected to have the largest impact on identification of 
differentially detected genes but their removal resulted in the detection of one extra 
gene (2 in total) in comparison to analysis where no spots were removed from the 
normalisation process. However, this spot (H3065A01-3) is of very low intensity and 
would normally be eliminated from the analysis. The further two spots assigned as 
differentially detected when the empty spots (flagged by ImaGene™) are removed from 
the normalisation process are also empty spots. This leaves a single gene (H3056D06-3) 
as potentially affected by DNase treatment.
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The extensive plotting tools in Limma allowed closer scrutiny of the slides before any 
statistical procedures were applied and the affects of these could be assessed. Under the 
most stringent analysis conditions, a maximum of nine genes are shown to be 
differentially detected. However most of the genes detected would be described as 
marginal. Subsequently, the genes detected have been analysed by semi-quantitative 
RT-PCR (Hunter et al.). The gene H3056D06-3, was detected by both GeneSight™ and 
Limma when background correction was carried out by “normexp”, printtip Loess 
within array normalisation, and with either no between array normalisation or with “A- 
quantile” between array normalisation. Although very clear on the arrays, it proved to 
be a false positive when checked by semi-quantitative RT-PCR. The two genes 
H3050H04-3 and H3073B10-3 were confirmed as being differentially detected by semi- 
quantitative RT-PCR. These two genes were not detected at all by GeneSight™ and 
both were only detected by Limma when “normexp” was used for background 
correction, with printtip Loess and either no “between array” normalisation or A- 
quantile “between array” normalisation. Thus methods 2 and 4 (Table 5.8) yield two 
positive results and seven false +ves, while methods 1 and 5 detect only 5 false 
positives at the cost of losing one positive result. Methods 3 and 6 yield no false 
positives but at the expense of losing the positive results.
This data demonstrates how sometimes a decision must be made whether it is more 
important to detect all differentially regulated genes at the expense of more false 
positives.
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6. Embryonic stem cells and transcriptomic analysis 
6.1 Introduction
ES cells are the cells of the pluripotent compartment of the embryo isolated into culture 
(Evans and Kaufman, 1981; Martin, 1981). Their ability to integrate into an embryo and 
contribute to chimaeric animals (Bradley et al., 1984; Nagy, 2003) and the expression 
of the pluripotency associated markers; nanog (Chambers et a l , 2003; Mitsui et a l , 
2003), Pou5f1 (Oct3/4) (Nichols et al., 1998) and Zfp42 (Rexl) (Pelton et al., 2002); 
argues identity with the pre-implantation ICM. However, protein expression profiling 
using two-dimensional electrophoresis indicates a later phenotype, that of the 
embryonic ectoderm (Lovell-Badge and Evans, 1980). Gardner et al (1985) (Gardner et 
al., 1985) injected ICM cells from blastocysts up to Day 5 early implanting stage and 
obtained chimaeras. Injection of cells from embryos more advanced than this failed to 
produce chimaeras. Furthermore cells from the ICM of blastocysts undergoing 
lactational delay or reactivated delayed blastocysts did not produce chimaeras even 
though these can implant and develop to term. Lawson et al (1991) by injecting the 
lineage marker HRP into a single cell of the post-implantation ectoderm showed that 
after in vitro culture these cells could contribute to mesoderm thus confirming the 
ability of these cells to contribute to multiple cell lineages.
Development of the embryo has been described in terms of progressive loss of 
totipotency. The fertilised egg is fully totipotent, on reaching the blastocyst stage the 
embryo is subdivided into two restricted tissues, the inner cell mass (ICM) and its 
trophectoderm. The trophectoderm is restricted to contributing to the Reichert’s 
membrane and placenta while the ICM develops further to produce a layer of primitive
179
Chapter 6: Embryonic Stem Cells and Transcriptomic Analysis
endoderm. This primitive endoderm migrates round the inner surface of the 
trophectoderm to form the parietal endoderm while the endoderm which remains in 
contact with the ICM becomes the primitive visceral endoderm. Over this peri- 
implantation period the ICM is proliferating and is often at this stage referred to as the 
epiblast. Signals from the visceral yolk sac endoderm, the layer of endoderm which 
remains in contact with the ICM, trigger the epiblast to form a pro-amniotic cavity and 
to transform into a pseudo-stratified epithelium; the embryonic ectoderm.
Over this period the ICM, epiblast and embryonic ectoderm have the same potency in 
vivo and will give rise to the whole foetus. They also will all form teratocarcinoma, a 
tumour consisting of both differentiated and stem cells (Section 1.1.1) However ES 
cells have so far only been derived up to the late blastocyst stage. ES lines have not 
been derived from early embryonic layers once the embryonic ectoderm has been 
formed. Although cell lines known as EpiSCs which share some features of ES cells 
have been isolated from pre-gastrulation stage embryonic ectoderm (Brons et al., 2007; 
Tesar et al., 2007) these cells, in common with human ES cells, do not depend on LIF to 
maintain their undifferentiated state and furthermore, like EPL cells do not contribute to 
chimaeras. The unique gonadal tumours, teratocarcinomas, may hold a clue to the origin 
and in vivo homology of ES cells. Testicular teratocarcinomas spontaneously arise in 
the gonads of strain 129 mice by proliferation of germ cells in the genital ridge of male 
mice (Stevens, 1967) and can be induced experimentally by the transplantation of 
Day 11.25-12.5 genital ridge to an ectopic site (Stevens, 1964). However, an embryonic 
origin for these cells has also been postulated. This was tested by transplantation of 
embryos to ectopic sites (Stevens, 1970) and it was shown that teratocarcinomas were 
formed from pre-implantation embryos. Furthermore, from post-implantation embryos
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up to gastrulation stage, only fragments which included embryonic ectoderm would 
form teratocarcinomas (Diwan and Stevens, 1976).
A transplantable teratocarcinoma generated from a preimplantation embryo by Stevens, 
was used to derive clonally isolated cell cultures which were shown to be pluripotent 
both in vivo by forming teratocarcinomas on injection into mice (Evans, 1972), and in 
vitro via embryoid bodies (Martin and Evans, 1975a; Martin and Evans, 1975b). These 
cells were shown to be able to contribute to chimaeras. Subsequently, ES cells were 
derived from delayed blastocysts without the in vivo tumour step (Evans, 1972; Evans 
and Kaufman, 1981). These cells share with EC cells the ability to grow indefinitely in 
culture, to differentiate in vivo as teratocarcinomas and in vitro as embryoid bodies. 
Furthermore, when injected into a blastocyst, they not only contribute to the somatic 
tissues of the animal but also to the germ line.
The central question to this thesis is whether ES cells have any homology to the 
pluripotent compartment of the mouse and to what degree they are an artefact of culture. 
Molecular phenotyping using techniques for profiling the expression of individual genes 
such as Northern blotting, PCR and in situ hybridisation have provided much 
information but fail to give a wider picture. Expression of individual genes associated 
with the pluripotent state in EC and ES cells such as Oct3/4 have been investigated in 
the embryo and their function in vivo studied via knockouts of the genes. A functional 
genomics approach using microarrays would be expected to show this broader picture 
as well as yield information on individual genes. Although the proteome can be argued 
to be more representative of the state of a cell than the transcriptome, not all mRNA is 
translated into protein; the ability to carry out comparisons is restricted by the amount 
of material available. While the amount of material available for comparisons between
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ES and EC cells is limited only by the number of vessels they can be grown in, the 
amount of material from the pluripotent compartment of the embryo is very small. It is 
possible to amplify the transcriptome while maintaining complexity and without loss of 
the original transcript levels.
Microarrays are uniquely able to provide expression data for thousands of genes in 
parallel and thus provide a snapshot of gene activity. This, in combination with the 
ability to amplify RNA, can be utilised to compare ES cells to the pluripotent 
compartment of the embryo at various stages. The data thus obtained can be used to 
identify which developmental stage ES cells most resemble and perhaps reveal 
pathways to specific fates. The NIA 15k cDNA gene set is derived from libraries of 
ESTs from embryonic tissues making it a valuable resource for studies such as these. 
This clone set consists of 15,247 clones which represent approximately 12,000 unique 
transcripts. It was assembled from cDNA libraries of pre-implantation embryo stages, 
day 7.5 embryonic and extra embryonic portions, ovary/mesonephros from Day 12.5 
embryos and ovary from newborn pups (Carter et al., 2003). Furthermore, the clones are 
ESTs and thus the 3r bias and reduced transcript length of the amplified target is less 
problematic than for oligonucleotide arrays.
In this study ES cells were compared to various pluripotent cells of the peri- 
implantation embryo namely the Day 3.5 ICM, Dy4.5 ICM and the early post­
implantation embryonic epiblast and ectoderm on Day5.5 and Day6.5 of gestation 
respectively. In addition, ES cells were compared with ICMs from delayed blastocysts 
(Section 1.1.2) on the equivalent day of gestation (EDG) 6 and 8. Frequently ES cell 
lines are isolated from such blastocysts. Furthermore, at these developmental stages, 
unmanipulated embryos would normally have implanted.
182
Chapter 6: Embryonic Stem Cells and Transcriptomic Analysis
6.1.1. Design o f Experiment
The design of a microarray experiment is not always obvious and many features have to 
be considered if the primary aim of the experiment is to be achieved. Balanced dye loop 
designs have the advantage of economy; they usually require less array slides and have 
lower variances, as the number of conditions being compared increase, the paths 
between the comparisons increase leading to increased variances. This can be overcome 
by using an interwoven loop design. However, as the number of conditions being 
compared increases, the experiments become more complex with greater capacity for 
operator error.
A-CpNinriHy S am  tar Oontr—to: Tr[ hrQCX) ] -  3.7143.
Nr ol array*-2 4 . M’a4aanMani-7
Figure 6.1: Balanced dye loop design with reference sample. The reference 
sample in this case would be ES cells. This design was produced using the 
online tool http://exaen.ma.umist.ac.Uk/R public/ExpDes v2.htm with the help of 
Ben Routley. This design uses both an interwoven loop without dye reversal 
and a common reference with the reference sample being of biological 
significance. The common reference slides require dye reversals to be carried 
out. This design would require 24 slides for 7 samples.
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The addition of the common reference design to the interwoven loop design minimises 
the variances but for example shown in Figure 6.1 with seven samples twenty-four 
slides are required. Furthermore, the failure of any individual array becomes more 
critical.
A reference design does require more array slides and, as most or all of the comparisons
are indirect (on separate slides); the variances are higher than for a direct or a loop
design. However, the reference design is more flexible (Figure 6.2). If desired, more 
conditions can be added to the experiment. Furthermore, loss of a slide due to breakage 
or hybridisation failure is recoverable as long as there is enough RNA sample. Analysis 
of the comparisons of interest is also simpler.
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Figure 6.2: Two examples of experiment designs using a common 
pool. In (a), a common reference pool of no intrinsic interest is used 
requiring three array slides to compare the three samples of interest with 
indirect comparisons. In (b), four slides are required as dye swaps have to 
be performed. Although the comparison between the ICM samples and 
ES cells are direct, the difference between the two ICM samples can be 
estimated indirectly.
Although an important factor in the choice of reference is abundance, whether the 
choice of reference could also be a sample of interest, should also be considered. On
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one hand, if the reference sample is of no interest, then half the possible information on 
the slide is of no interest. On the other hand, when the common reference is also a 
sample, gene specific dye effects must be taken into consideration so more slides have 
to be used. Another concern is the number of spots detected by the reference sample. 
Ideally all the spots on the array should be detected by the reference sample otherwise 
there will loss of data. Consequently, for small arrays, the library represented by the 
spots is often used as a reference sample.
The ease with which ES cells can be genetically manipulated has led to the belief that 
the DNA is open and that transcriptional control is leaky (Evans et al., 1997). Recently, 
the DNA from ES cells has been shown to be in a more open configuration (Meshorer et 
al., 2006). If this does indeed lead to expression of all transcripts albeit at a very low 
level, ES cells could be unique as a universal reference sample in two colour arrays. 
Alternatively, a pool of all the tissues which were used to compile the gene libraries 
represented on the arrays can be used as a common reference. The pool strategy has the 
advantage that no dye swaps are required since the comparisons of interest are all 
labelled with the same dye. The disadvantage is that all the comparisons of interest are 
indirect, leading to increases in the variances.
A pilot experiment was undertaken to test the usefulness of ES cells as a universal 
reference before making a reference pool.
The reference pool consisted of the embryos and tissues which were used to construct 
the libraries from which the NIA 15k gene set was derived (Carter et al., 2003). 
(Section 6.2.2, Table 6.1)
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6.1.2. Image Analysis
Image analysis was carried out using the commercial packages ImaGene™ 
(BioDiscovery) and Spot (CSIRO). ImaGene™ (BioDiscovery) uses histograms to 
segment the image pixels into foreground and background. Although this appears to 
function well, it suffers from the drawback that the version of the program held by this 
institution does not process batches of slides thus every slide must have the grid applied 
and adjusted individually. Furthermore, the local background measurement in most 
cases can not simply be subtracted from the foreground as this often produces too many 
zero or negative values which not only compromises “between array” normalisation but 
leads to loss of data. The variance in the data can also be increased leading to loss of 
data especially with low intensity spots (Yang et al., 2001). Spot software is implemented 
as a package within R (http://www.r-proiect.org/) allowing the powerful suite of R tools, 
particularly the package limma (BioConductor) to be used directly on the results produced by 
Spot software. Spot is an adaptive shape segmentation method which uses seed points 
from which regions grow outwards preferentially according to the difference between a 
pixel’s value and the running mean of values in an adjoining region. This software has 
the big advantage of being able to use a template to automatically process a batch of 
slides thus reducing the amount of user intervention required. It also accommodates 
irregular shaped spots. The background measurement method ‘morph’ has the effect of 
smoothing and damping the variance of the background and usually returns a lower 
background than ImaGene™. It allows simple background subtraction without 
generation of many zero or negative values.
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6.1.3. Analysis
The image files generated by either ImaGene™ (BioDiscovery) or Spot (CISRO) were 
input to either limma using limmaGUI version where appropriate and the data was 
normalised. The Bayesian statistics were generated in limma and tables of the highest 
differentially expressed genes were generated.
The BioConductor package limma is an excellent tool for both quality control and 
normalisation of data. A drawback, however, is the difficulty in retrieving the 
manipulated data for analysis in other software packages. The GUI (Graphical User 
Interface) version of limma handles data and performs in the same way as the command 
driven version though with more restricted options. However, it is very easy to extract 
the normalised M and A data to Excel files from which it is easy to calculate 
normalised, log2 red and green intensity values which can be used in other tools such as 
the online NIA Array Analysis tool (http://stemcell.biosi.cf.ac.uk/ ). This suite of tools 
can be used to carry out ANOVA and produce lists of differentially regulated genes as 
well as hierarchical clustering.
6.1.4. Characteristics o f  the Embryonic Stages.
The collection of the embryonic material for the experimental comparisons was carried 
out such that the groups were not only collected by the estimated time of development 
but by morphological landmarks (Figure 6.3, 6.4, 6.5 and 6.6). The blastocysts 
harvested between 86 and 86.5h.p.c. were selected on the basis that they had a 
blastocoel and retained the zona pellucida. The initiation of fluid accumulation begins 
towards the end of the fifth cleavage division when the embryo has 27-29 cells (Smith 
and McLaren, 1977). All morulae, defined as having no fluid accumulating cells, all
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very early blastocysts, defined as having a blastocoel cavity of less than half the volume 
of the blastocyst and all hatched blastocysts, defined by having no zona pellucida were 
discarded. Thus the majority of ICMs in this group would not have primitive endoderm 
on the blastocoelic surface. Furthermore, if explanted into culture they would regenerate 
TE or if injected into a host blastocyst would be expected to be capable of contributing 
to all tissues of the conceptus, including the trophectoderm (Handyside, 1978; Hogan 
and Tilly, 1978).
The blastocysts harvested between 103 and 107h.p.c. were only selected when hatched. 
Some of the embryos in this group, particularly from the later harvest times had 
evidence of endometrial cells adhering to the TE indicating the initiation of 
implantation. Isolated ICMs from this group would be expected to have lost the ability 
to form trophectoderm both in vitro and in vivo. They would also be expected to have 
primitive endoderm and perhaps some parietal endoderm starting to migrate around the 
inner surface of the mural trophectoderm (Enders, 1971; Nadijcka and Hillman, 1974; 
Snell and Stevens, 1966). No attempt was made to remove the endoderm from these 
ICMs after immunosurgery. Immunosurgery was used to isolate the ICM from 
blastocysts.
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Figure 6.3: Examples of embryos from which ICMs collected (a)early 
blastocysts flushed 88hpc (b) morulae and early blastocysts from the 
same group as (a) but rejected from immunosurgery. (c) late blastocysts 
flushed 105hpc (d) delayed blastocysts 136hpc,arrow indicates collapsed 
blastocyst this would re-expand in culture (e) delayed blastocysts 180hpc 
Bar is 200mm.
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As the cells of the trophectoderm are held by tight junctions, the blastocysts can be 
exposed to antibodies which will bind to the trophectoderm but be unable to reach the 
ICM. After washing to remove unbound antibody, the blastocysts are exposed to 
complement and the trophectoderm is lysed leaving the ICM intact (Solter and 
Knowles, 1975). Embryos isolated at the 132-135h.p.c. time point were the most 
difficult to detect, harvest and dissect. At this time point, in some cases, there was little 
evidence of segmentation of the early egg cylinder and no formation of the pro-amniotic 
cavity (pac) so some contamination of the embryonic ectoderm with extra-embryonic 
ectoderm is likely. This group included embryos with an early pac but without the pac 
extending into the extra-embryonic region (Figure 6.4).
The embryos at the 150-154h.p.c. time point were both easy to see in the uterus and to 
harvest. They were significantly larger with a well defined embryonic and extra- 
embryonic boundary (Figure 6.5 and 6.6).
The delayed blastocysts were very uniform when flushed from the uteri. As all would be 
expected to have hatched, any unhatched embryos were discarded. There were no signs 
of implantation having initiated in any of these embryos.
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200um
ExEmEct 
Early PAC
RM 
EmbEnd
Maternal Cells
Figure 6.4: Examples of the isolation of the embryonic ectoderm from 
130h.p.c. embryos. The top row (a) shows a sample of intact embryos. Reichert’s 
membrane was removed with tungsten needles where necessary. The embryo was 
then incubated in pancreatin-trypsin and the endoderm peeled off (b) left hand 
embryo, (c) The embryonic portion was then isolated with tungsten needles. 
ExEmEct:extra-embryonic ectoderm, PAC: pro-amniotic cavity, EmEnd:
embryonic endoderm, RM: Reichert’s membrane.
200jim
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Figure 6.5: Embryo 152hpc (a) intact, (b) dissected into embryonic and extra- 
embryonic parts. EPC: ectoplacental cone, ExEmEnd: extra-embryonic endoderm 
ExEmbEnd: extra-embryonic ectoderm, PAC: pro-amniotic cavity, EEct: 
embryonic ectoderm, EmEnd: embryonic endoderm, RM: Reichert’s membrane.
f t
\
200pm
*
(a) Intact embryos
100pm
(b) Embryonic portion
&
100pm
(c) Embryonic endoderm
4
100pm
(d) Isolated embryonic
Figure 6.6: Example of the isolation of the embryonic ectoderm from 152hpc 
embryos. First Reichert’s membrane is removed with tungsten needles and the 
embryonic portion (b) is incubated in pancreatin-trypsin. The embryonic 
endoderm, (c) is then peeled off leaving the embryonic ectoderm (d).
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6.2. Materials and Methods
6.2.1. Cell Culture.
The embryonic stem cell line IMT-11 was cultured according to the protocol in Section
2.1. A plate of IM T-11 at passage 16 was washed twice in DPBS-A, groups of ten 
colonies were picked from the plate using a glass capillary, put into microcentrifuge 
tubes in a minimal volume of DPBS-A and 200pl of Zymo™ RNA Extraction Buffer 
was added. Samples were stored at -70°C until extraction. RNA was purified according 
to the manufacturer’s protocol (2.3.1b).
6.2.2. Reference Pool
Embryos and tissues, as per Table 6.1, were isolated according to the protocols in 
Section 2.2a and b and stored at -70°C in Zymo™ RNA extraction buffer. In the case of 
the pre-implantation embryos, pools of approximately 40 embryos were made in 200pl 
of Zymo™ extraction buffer and the RNA purified with the Mini RNA Isolation Kit 
(Zymo) according to the manufacturer’s protocol. The isolated RNA was subjected to 
two rounds of amplification using the RiboAmp™ Kit (Arcturus) according to the 
manufacturer’s protocol Version C. In the case of day 7.5 embryos, the 
ovary/mesonephros isolated from Day 12.5 embryos and newborn ovary, groups of 
eight embryos and tissues fragments were collected and the RNA isolated as for the pre­
implantation embryos. When amplifying these larger tissues, to avoid saturation of the 
second round of in vitro transcription, the amount of amplified RNA produced by the 
first round of amplification was measured by spectrophotometry. The second round of 
amplification was then initiated with 0.5 pg of amplified RNA from the first round of 
amplification.
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Tissue Day of Gestation Harvested hpc
oocytes 0.5 7-7.5
1 cell 0.5 7.5-8.5
2 cell 1.5 32-35
3-4 cell 2.0 45-46.5
4-8 cell 2.5 55.5-58
8-16 cell 3 67-68
Late morulae-early blastocysts 3.5 80-84
Whole embryo, mid-streak stage 7.5
Ovary+mesonephros 12.5
Ovary Newborn
Table 6.1: Composition of the common pool.
Three separate pools, each composed of 5pg of amplified RNA from each tissue 
sample, were made and a 5pg sample from each pool was labelled with Cy5™. A lpl 
sample of each labelled pool sample was run on a slide gel (Section 2.3.5). A grand pool 
made up of 50pl each of the labelled pools Pool 1, 2 and 3 was made. A 15pmol sample 
of each Pool 1, 2, 3 and the grand pool was combined with 15pmol of Cy3™ labelled 
IMT-11 ES cell amplified RNA. The volume adjusted, combined samples were heated 
with human COT1 DNA (Gibco BRL) and Poly-dA30 (MWG Biotech) oligoA before 
adding an equal volume of two times concentrated hybridisation buffer (2.4.3). The 
samples were then applied to blocked microarray slides (2.4.2) and covered with Hybri- 
slips (Sigma) (2.4.3). Hybridisation was performed at 42°C overnight followed by 
washing as in Section 2.4.4. Slides were then scanned with the ScanArray® Express HT 
(Perkin Elmer) with 65pmt, 5pm resolution and half speed. After ensuring the 
individual pools labelled well and hybridised to the slides, the amplified RNA was 
pooled, the volume adjusted and random hexamers were added to a final concentration 
of lOOpM. This was then stored in aliquots ready for labelling. Labelled (Cy5™) 
aliquots were pooled and redistributed in 15pmol aliquots (a single hybridisation) and
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stored frozen at -20°C ready for combination with the labelled experimental samples 
(Cy3™). All samples were labelled using the method developed in Chapter 3.
6.2.3 Collection o f Tissues
Embryos were harvested from animals and tissues isolated according to the protocols in 
Section 2.2 (Table 6.2.).
Tissue Embryo Stage Time hpc
ICM Day 3.5 86-86.5
ICM Day4.5 103-107
Delayed ICM EDG6 134-138
Delayed ICM EDG8 179-180.75
Embryonic epiblast Day5.25 132-135
Embryonic ectoderm Day6.5 150-154
Table 6.2: Tissue samples being compared by microarray
6.3. Results and Discussion
6.3.1 ES Cells as Reference
As part of a preliminary experiment, the amplified RNA from colonies of the ES cell 
line IMT-11 at passage 16 was hybridised according to the plan in Table 6.3. For this 
experiment the slides were scanned with the LSIV scanner (Genomic Solutions) and 
analysed with ImaGene™ (BioDiscovery). The mean foreground and background 
intensities were exported to Excel (Microsoft) and the number of spots with foreground 
intensity greater than the mean local background intensity plus two standard deviations 
(SD) was counted. Since the Cy3™™ and Cy5™™ labelled samples of IMT-11 were 
pooled after labelling 5pg aliquots of amplified RNA, and the developmental stages are 
six different tissues, the SD of the number of spots for IMT-11 should be lower than for 
the developmental stage tissues and this is in fact the case.
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Slide Number Cy3™ Cy5™
1 IM T-11 ICM ~86hpc
2 IMT-11 ICM ~86hpc
3 IM T-11 ICM ~105hpc
4 IMT-11 ICM ~105hpc
5 IMT-11 Embryonic epiblast ~133hpc
6 IMT-11 Embryonic epiblast ~133hpc
7 IMT-11 Embryonic ectoderm ~152hpc
8 IMT-11 Embryonic ectoderm ~152hpc
9 IMT-11 Delayed ICM ~136hpc
10 IMT-11 Delayed ICM ~136hpc
11 IMT-11 Delayed ICM ~ 180hpc
12 IMT-11 Delayed ICM ~180hpc
13 ICM ~86hpc IMT-11
14 ICM ~86hpc IMT-11
15 ICM ~105hpc IMT-11
16 ICM ~105hpc IMT-11
17 Embryonic epiblast ~133hpc IMT-11
18 Embryonic epiblast ~ 133hpc IMT-11
19 Embryonic ectoderm ~ 152hpc IMT-11
20 Embryonic ectoderm ~152hpc IMT-11
21 Delayed ICM ~ 136hpc IMT-11
22 Delayed ICM ~136hpc IMT-11
Table 6.3: Hybridisation plan of ES cells compared with ectoderm from various
developmental stages.
Although the number of spots detected as two standard deviations above the mean 
background fluorescence intensity on these slides is very low, there is no evidence that 
ES cells hybridise with more spots than any of the tissues tested. Student’s two tailed t- 
tests for heteroscedastic samples (samples of unequal variance) were carried out. The 
only slide set with a significant difference (p<0.05), more spots were detected in the 
developmental stages.
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ES
cellsCy3™
Developmental 
Stages Cy5™
ES cells 
Cy5™
Developmental 
Stages Cy3™
ES cells 
combined
Developmental
Stages
combined
No
of
Spots
1392.25 2859.92 1489.80 973.40 1436.59 2002.41
sd 976.84 1659.01 841.43 536.26 919.05 1585.68
n, p n=12, p=0.02 n=10, p='0.14 n=22, p=0.17
Table 6.4: Mean number of spots per slide above background fluorescence intensity+
2sd.
An obvious problem with this experiment is the very low number of spots detected. 
There are 15,240 data spots on this particular slide batch and at best only 18.76% of the 
spots were detected as the mean+ 2SD above the global background. This was probably 
due to the batch of slides being of sub-optimal quality.
6.3.2 Pooled Embryonic Tissues as Reference
A further experiment was initiated with a new array slide set. The slides used in this 
section, which compare the ES cells to the common pool, are part of the larger 
experiment described in Section 6.3.4. They have been used in this section used to ask 
the question as to whether the ES cells are suitable as a reference sample and yet again 
in Section 6.6.3 to compare ImaGene™ with Spot.
Table 6.5 shows the number of spots detected in the two channels of the ES cells against 
the array. This slide set has 15248 data spots on each slide. In these calculations the 
poor quality spots were removed from the data. This is also a conservative estimate of 
spots above background as local background was used as the estimate of background. 
Thus 87.56% and 88.81% of spots on the slides were hybridised to the target from ES 
cells and the pooled reference respectively. This suggests that ES cells may indeed
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make a good universal reference at least for amplified material where very low 
expression levels are more reliably detected (Polacek et al., 2003) The embryonic stem 
cells may only make a good reference with embryonic genes.
ES cells Cy3™ Pool Cy5™
Mean Number of Spots 13351.17 13541.33
SD(n=6) 387.83 369.22
Table 6.5: Mean number of good spots per slide detected above 
background fluorescence+2sd.
6.6.3 Comparison o f  ImaGene™ and Spot
In this study, much of the image analysis was carried out using ImaGene™. However, it 
became clear as more data was generated; an image analysis program which required 
less user intervention was necessary. The image analysis program Spot, not only uses 
the seeded growth method of spot detection and segmentation, which has the advantage 
of being able to segment irregular spots, but also can be used to process a whole batch 
of slides which for our printer is fifty slides (Figure 6.7)
Since each slide is analysed individually more “between slide” variation in data may be 
acquired from ImaGene™ analysis, and consequently noisier data might be expected. 
Furthermore, ImaGene™ files are handled differently from Spot files in limma in 
particular with regard to background correction. A set of slides hybridised with IMT-11, 
labelled with Cy3™ and the reference pool labelled with Cy5™, were analysed using 
both ImaGene™ and Spot. The data were then scrutinized for discrepancies.
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Figure 6.7: Example of a microarray analysed with Spot (CISRO) Left is whole 
array and right column is one example grid. Top unprocessed, middle with 
addressing grid applied and bottom segmented. In the pseudo colour images red is 
higher expression in the Cy5™, green is higher in Cy3™ and yellow is equal in 
both channels.
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The first difference detected is in the range of intensities found (Figure 6.8).
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Figure 6.8: MA plot of sample slide and density plots for the raw Iog2 
transformed red and green intensities. Left column ImaGene™ and right 
column Spot. M is log2Cy5™-log2Cy3™ i.e. the fold change for each spot and A 
is the 0.5(log2Cy5™+ log2Cy3™) i.e. the total intensity for each spot. The 
density plots show that two of the slides have a slightly different distribution of 
intensity in the green (Cy3™) channel
Examination of the MA plot of the raw log2 red and green intensity values shows that 
the lowest intensity spot was greater than 6 when analysed with Spot and less than 5 
when analysed with ImaGene™ suggesting greater discrimination at lower spot 
intensity for the program Spot. This is not surprising as the histogram method of 
segmentation uses the mean pixel values between two high percentiles, usually the 80th 
and 95th. The MA plots of the ImaGene™ and Spot red and green intensities (top
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graphs, Figure 6.8) also show the ImaGene™ data does have greater variance than for 
Spot particularly for low intensity spots. Examination of the density plots for this data, 
(bottom graphs, Figure 6.8) shows the need for “within array” normalisation as two 
slides have a noticeably different distribution in the green channel. There is also a 
noticeable difference in the distribution of intensities over the slides with ImaGene™ 
showing a double peak rather than the single peak from Spot. Image plots of the red and 
green background shows that the background generated by ImaGene™ is much more 
uneven than that generated by Spot (Figure 6.9).
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Examination of the density plots of the within slide normalised data for Spot, which 
have not been background subtracted (Figure 6.10) show that these slides require very 
little “between array” normalisation. Unfortunately, it was not possible to put these 
plots on the same scale making comparisons more difficult. Thus it was not possible to 
say if background subtraction increased the variance between slides, a phenomenon 
often seen (Yang et al., 2002a). However it appears that the simple subtraction of morph
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background function followed by A-quantile “between array” normalisation gives 
excellent normalisation of Spot image analysed data.
s
o
oo
5 to IS 30
o
o
©
S 10 15 70
5e
©
©
oo
5 10 30
I 5
g
8o
88 10 16 18M
(a) No between array 
normalisation
8
*e
8
8
©
8©
|
6 10 14 16 18
(b) Scale 
normalisation
©
8©
6 6 10 12 14 16 18
(c) A-quantile 
normalisation
Figure 6.10: Density plots of data with image analysis using Spot. The top row
shows the effect of (a) no between array normalisation, (b) scale between array 
normalisation and (c) A-quantile between array normalisation on data which has 
not had any background removed before print tip loess “within array” 
normalisation. The bottom row has had the Spot generated value “morph” 
removed before print tip loess normalisation within the arrays followed by 
between array normalisation as for the top row.
Examination of the ImaGene “within array” normalised data (Figure 6.11) suggests that 
background subtraction in this case does increase the between slide variances and 
magnifies anomalies in intensity distribution.
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Figure 6.11: Density plots of the data obtained from the image analysis 
program  ImaGene™ Column 1: no between array normalisation. Column2: scale 
between array normalisation.Column3: A-quantile between array normalisation. 
Row (a): no background subtraction, Row (b):“subtracf\ Row(c): “ha lf’ 
background subtraction. Row (d): “normexp, offset=50“ background subtraction.
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Also application of “between array” normalisation appears to be less effective and 
because “between array” normalisation acts on the individual array channels this results 
in some loss of normalisation within arrays. The best normalisation for the ImaGene™ 
generated data appears to be no background subtraction followed by print-tip Loess and 
A-quantile normalisation.
To assess the impact of these normalisation methods on the detection of differentially 
regulated genes, the top ten returned genes ranked for each method was examined 
(Table 6.6 and 6.7). For ease of comparison, the grid number of the probe was used in 
these tables. The method of background subtraction has a small impact on the rank 
order of the top differentially regulated genes with all ten genes being the same albeit in 
a slightly different order. Normalisation by A-quantile method does not change the gene 
list order. On the other hand scale normalisation changes the rank order more 
substantially and is sensitive to the background correction method. However, these 
differences are not large as all these genes have very high and similar p values.
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Rank Probe Number
1 8162 6997 8162 8162 2601 8162 8162 2601 8162 8162 8889 8162
2 13651 4293 13651 1485 8889 1485 1485 8889 1485 5639 2601 5639
3 5639 5088 5639 8278 8162 8278 8278 8162 8278 1485 6997 1485
4 6866 15761 6866 15296 3946 15296 15296 3946 15296 8278 7985 8278
5 15457 7985 15457 5639 1485 5639 5639 1485 5639 3946 8162 3946
6 3946 8889 3946 3946 6997 3946 3946 6997 3946 15263 1485 15263
7 91 6897 91 9914 10567 9914 9914 10567 9914 9914 4293 9914
8 2547 6993 2547 15263 12959 15263 15263 12959 15263 15296 15263 15296
9 15263 2783 15263 14937 7985 14937 14937 7985 14937 13651 9337 13651
10 13441 2927 13441 2601 15296 2601 2601 15296 2601 2601 3946 2601
Background
correction none subtract half normexp
Between
Array
correction
none scale Aquantile none scale Aqantle none scale Aquantile none scale Aquantile
Table 6.6: Top ten differentially expressed genes from slides analysed with ImaGene™.
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Rank Probe Number
1 8162 8889 8162 8162 8889 8162
2 5639 6534 5639 5639 6534 5639
3 15263 2601 15263 13651 8162 13651
4 15687 15761 15687 15263 2601 15263
5 13651 13455 13651 15687 2547 15687
6 1257 8162 1257 6866 6972 6866
7 2547 1485 2547 1257 1485 1257
8 5643 2547 5643 4211 12959 4211
9 6866 2819 6866 5643 8684 5643
10 4211 6972 4211 2547 9521 2547
Background
Correction none morph
“between
array”
Normalisation
none scale A-quantile none scale
A-
quantile
Table 6.7: Top ten differentially expressed genes from Spot analysed 
slides. “Morph” is the method of smoothing the background variances 
before subtraction used by Spot.
The rank order by p-value for the slides analysed with ImaGene™ is significantly 
different from the order found after Spot analysis. When the returned genes for Spot and 
ImaGene™ which have been analysed by the same method are compared (morph in 
Spot is the same as subtract in ImaGene as both simply subtract the background as is 
measured by the image analysis program) the number of genes in common (Table 6.8) 
are at best four out of ten.
Background correction None Subtract/Morph
Between array correction None Scale A quantile None Scale A quantile
Common genes 4 2 4 1 4 1
Table 6.8: Number of common genes in top ten diflerentia ly expressed genes
comparing Spot and ImaGene™ image analysis.
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Both data sets, irrespective of the image analysis program used, show that background 
correction has an impact on the top ten genes returned and that this impact is greater in 
slides analysed using ImaGene™. Furthermore, scale “between array” normalisation 
changes the top ten returned genes irrespective of the method of background correction 
while the lists returned when either no “between array” or A-quantile “between array” 
normalisation was applied are identical.
When the genes lists for the ImaGene™ slides analysed using no background 
subtraction and A-quantile “between array” normalisation are compared to Spot 
analysed data using morph background correction and A-quantile “between array” 
normalisation, the methods which give the best normalisation by examination of the 
density distribution, the number of common genes rises to six.
The Spot and ImaGene™ data were reanalysed using limmaGUI. In both cases they 
were analysed in the sequence: background subtract by the method “subtract”, “within 
array” normalisation by the method print-tip loess, and “between array” normalisation 
by the method A-quantile. The M and A values were then exported to Excel (Microsoft). 
The green and red intensities were calculated using the formulae below (Boxl). The 
derivation of the formulae is presented in Appendix 4.
Log2 Cy3™ Intensity=A-M/2 
Log2 Cy5™ Intensity=A+M/2
These intensities were put into a format suitable for the NIA Array Analysis tool and 
loaded. The data was analysed using the maximum of averaged and actual error 
variance model which is the most conservative reducing the number of false positives.
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The standard deviation should vary with the log intensity and for the Spot data does but 
shows a peak with the ImaGene™ data (Figure 6.12). The correlation matrix of 
intensities (Figure 6.13) shows a slightly better correlation between repeats with 
ImaGene™ than Spot although the correlation in both cases is high. The data presented 
here suggests that Spot performs well at segmenting the images in these slides. It does 
suffer from the disadvantage that the individual spots cannot be adjusted so some losses 
do occur (Figure 6.6 bottom right panel). However, the measurement of background for 
Spot is much less noisy and results in less loss of data.
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Figure 6.12: E rro r plot for (a) Spot and (b) ImaGene™ analysed slides.
Log-intensity (x-axis) is plotted against the Standard Deviation (y-axis)
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Figure 6.13: Correlation matrix of intensities for (a) Spot and
(b) ImaGene™. The darkest red indicates the highest correlation, 1 being the 
maximum, shading orange for correlation coefficients between 0.900 and 0.999 
and yellow for between 0.800 and 0.899.
6.3.4 Comparison o f  ES Cells with Pluripotent Embryonic Tissue
The data produced by this experiment has been lodged with GEO.
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GEO Accession: GSE8881:
http://www.ncbi.nlm.nih.gov/proiects/geo/querv/acc.cgi?acc=GSE8881
The ES cell line and various pluripotent embryonic tissues were labelled with Cy3™ 
and hybridised against the common pool reference sample labelled with Cy5™ (Table 
6.9). After scanning on the ScanArray® ExpressHT the images were analysed with Spot 
and loaded into LimmaGUI. The data was normalised using the sequence: background 
subtract by method subtract, “within array” normalise with print-tip loess and “between 
array” normalise with the method A-quantile. The normalised M and A values were 
exported to Excel (Microsoft) and converted to normalised log2 red and green intensities 
as before (6.3.3). This manipulated data was then input to the NIA Microarray Analysis 
tool and analysed. Examination of the correlation matrix suggested that some of the 
slides were not good enough and visual inspection showed them to be smeared. These 
were eliminated from the analysis namely slides 11, 12, 30 and 42. However, the 
correlation coefficients for each tissue were very high. The most difficult tissue to 
isolate and dissect was the Day 5.5 epiblast and this might be expected to be the most 
variable, however the correlation coefficients for the biological repeats lay between 
0.935 and 0.975 showing the degree of reproducibility in sample collection and 
processing was very high. Furthermore, this suggests a high degree of similarity in gene 
expression within the groups of embryos staged by morphological criteria.
A wealth of data has been generated by this experiment and is beyond the scope of this 
thesis to examine it all. The analysis examined here is aimed at investigating the 
homology of embryonic stem cells with the pluripotent embryonic portion of the 
conceptus.
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Slide
Number
Cy3™  labelled Tissue Number 
in sample
Yield amplified 
RNA(pg)
1 IMT-1 1 colonies Sample 1 10
2 IMT-1 1 Sample 1
3 IMT-1 1 Sample2 10
4 IMT-1 1 Sample2
5 IMT-1 1 Sample3 10
6 IMT-1 1 Sample3
7 ICM 86hpc Sample 1 25 43.9
8 ICM 86hpc Sample 1
9 ICM 86hpc Sample2 34 94.08
10 ICM 86hpc Sample2
11 ICM 86hpc Sample3 27 60.24
12 ICM 86hpc Sample3
13 ICM 105hpc Sample 1 28 109.4
14 ICM 105hpc Sample 1
15 ICM 105hpc Sample2 35 107.16
16 ICM 105hpc Sample2
17 ICM 105hpc Sample3 34 73.2
18 ICM 105hpc Sample3
19 D elayed ICM 136hpc Sample 1 16 63.5
20 Delayed ICM 136hpc Sample 1
21 Delayed ICM 136hpc Sample 2 33 84.06
22 Delayed ICM 136hpc Sample 2
23 Delayed ICM 136hpc Sample 3 31 46.56
24 Delayed ICM 136hpc Sample 3
25 Delayed ICM 180hpc Sample 1 30 20.82
26 Delayed ICM 180hpc Sample 1
27 Delayed ICM 180hpc Sample2 26 21.36
28 Delayed ICM 180hpc Sample2
29 Delayed ICM 180hpc Sample3 37 31.26
30 Delayed ICM 180hpc Sample3
31 Em bryonic epiblast Day5.5 Sample 1 3 36.24
32 Em bryonic epiblast Day5.5 Sample 1
33 Em bryonic epiblast Day5.5 Sample2 5 27.72
34 Em bryonic epiblast Day5.5 Sample2
35 Em bryonic epiblast Day5.5 Sample3 2 27.7
36 Em bryonic epiblast Day5.5 Sample3
37 Em bryonic ectoderm Day6.5 Sample 1 2 33.9
38 Em bryonic ectoderm Day6.5 Sample 1
39 Em bryonic ectoderm Day6.5 Sample2 3 107.28
40 Em bryonic ectoderm Day6.5 Sample2
41 Em bryonic ectoderm Day6.5 Sample3 2 53.7
42 Em bryonic ectoderm Day6.5 Sample3
Table 6.9 continued: Plan of hybridisation. Highlighted s ides were removed
from the analysis.
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Pairwise comparisons of the means were carried out and plots of log ratio against log 
intensity were made (Figure 6.14). With respect to the number of genes up and down 
regulated, the ES line IMT-11 is most similar to the epiblast portion of the day 5.5 
embryo. Only 97 genes are detected as differentially regulated between the ES sample 
and this embryonic tissue. Also very interesting but not pertinent to this thesis is the 
similarity between the early (88h.p.c.) and late (105h.p.c.) ICM and the late ICM 
105h.p.c. with the delayed ICM, 180h.p.c.The number of regulated genes in each pair 
wise combination is shown (Table 6.10)
Comparison Number Up 
Regulated
Number Down 
Regulated
Total
IM T-11 v ICM 88hpc 1344 984 2382
IMT_11 v ICM 105hpc 2022 1807 3829
IMT-11 v delayed ICM 136hpc 530 307 837
IM T-11 v delayed ICM 180hpc 1708 1879 3587
IM T-11 v epiblast Day5.5 31 66 97
IM T-11 v embryonic ectoderm 
Day6.5
959 1124 2083
Table 6.10: Number of differentially regulated genes for the comparisons 
between the ES cells, IMT-11 and embryonic tissues.
Figures 6.15 to 6.20 present the data for each comparison of the ES cells against with 
the top ten up-regulated (in red) and down-regulated (in green) genes.
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Figure 6.14: Plots of all pairwise comparisons extracted from ANOVA. The
number under each graph is the numbers of regulated genes in each comparison.
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Log-ratio
Legend
♦ Siginificant 
over-expressed 
genes
♦ Highly variable 
over-expressed 
genes
♦ Siginificant 
under-expressed 
genes
♦ Highly variable 
under-expressed 
genes
L o g - i n t e n s i t y
Featureid M ean(IM T_11) M ean(IC M _88hpc) LogRatio FoldChng P FDR Noisy Symbol
H 3023H 12-3 4.1602 2.51361 1.64659 44.319 0 0 0 Ldh1
H3027E 07-3 4.0391 2.6652 1.3739 23.653 0 0.0001 0 Eno1
H3027E 09-3 4.0516 2.69611 1.35549 22.672 0 0.0001 0 Eno1
H3051D 10-3 3.4279 2.1131 1.3148 20.644 0.0002 0.0035 1
H 3023D 06-3 4.2699 2.95791 1.31199 20.511 0 0.0001 0 Pgk1
H3025D01 -3 3.6912 2.4048 1.2864 19.337 0 0.0001 0 Rex3
H 3026E 09-3 3.4348 2.1803 1.2545 17.968 0 0.0005 0 Ttc19
H 3022H 02-3 3 .9374 2.72591 1.21149 16.273 0 0.0002 0 Eno1
H 3103E 02-3 3.5722 2.3897 1.1825 15.222 0 0.0012 1
H 3091B 05-3 3.2602 2.0799 1.1803 15.146 0 0.002 1
H3048A07-3 2.7392 4.0058 -1.2666 18.475 0 0.0006 0
H3033G02-3 3.1418 4.3762 -1.2344 17.155 0 0.0006 0 Bhmt
H3099G12-3 2.3257 3.5315 -1.2058 16.062 0 0.0002 0
H3078G11-3 2.6747 3.8408 -1.1661 14.658 0.0003 0.0042 1
H3079G10-3 2.322 3.38759 -1.06559 11.63 0 0.0014 0
H 3081G02-3 2.737 3.79789 -1.06089 11.505 0 0.0002 0
H3030A12-3 2.7386 3.7904 -1.0518 11.266 0 0.0001 0 Glrxl
H3115A08-3 2.7885 3.81579 -1 .02729 10.648 0 0.0001 0 Ly6a
H 3048G 12-3 3.0486 4.07449 -1.02589 10.614 0 0.0009 0 Ndp52
H3030E02-3 3.2046 4.19899 -0.99439 9.871 0 0.0007 0
Figure 6.15: IM T-11 vs. ICM 88hpc. Top ten up regulated genes in red and down 
regulated genes in green below scatter plot.
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Legend
♦ Siginificant 
over-expressed 
genes
♦ Highly variable 
over-expressed 
genes
♦ Siginificant 
under-expressed 
genes
• •  •  •
-* - • ♦ Highly variable
under-expressed 
• genes
2  2 .9  3 3.9  «  4 .9
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Featureid Mean(IMT_11) Mean(ICM_105hpc) LogRatio FoldChng P FDR Noisy Symbol
H3051D10-3 3.4279 2.2399 1.188 15.417 0.0002 0.0018 1
H3107G09-3 3.4113 2.2243 1.187 15.381 0 0.0006 1
H3103E02-3 3.5722 2.5521 1.0201 10.473 0 0.0005 1
H3125D11-3 3.9078 2.8979 1.0099 10.23 0 0.0002 0 Tbc1d10
H3026E09-3 3.4348 2.4288 1.006 10.139 0 0.0002 0 Ttc19
H3148D07-3 3.6601 2.6733 0.9868 9.7 0 0 0 BC035044
H3091B05-3 3.2602 2.313 0.9472 8.855 0.0002 0.0017 1
H3018A01-3 4.3795 3.4399 0.9396 8.701 0 0 0
H3135B07-3 4.0332 3.0938 0.9394 8.697 0 0 0 2810001 A02Rik
H3060D08-3 3.3039 2.3749 0.929 8.491 0.0001 0.0014 1
H3138E02-3 2.5749 4.04889 -1.47399 29.784 0 0 0 Col4a2
H3113E11-3 3 1783 4.5148 -1 3365 21.702 0 0 0 Lamcl
H3137G02-3 2.3859 3.6258 -1.2399 17.374 0 0 0 Lcn7
H3103H10-3 2.4969 3.56629 -1.06939 11.732 0 0.0001 0
H3125A07-3 2.6247 3.679 -1.0543 11.331 0 0 0 Serpinhl
H3058E10-3 2.9767 3.9599 -0.9832 9.62 0 0.0003 0
H3153B03-3 2.5042 3.4306 -0.9264 8.441 0 0 0
H3153H07-3 2.6645 3.5742 -0.9097 8.122 0 0 0 LOC233332
H3146C02-3 2.5943 3.4988 -0.9045 8.026 0 0 0 Pdgfa
H3004A01 -3 3.1886 4.0925 -0.9039 8.014 0 0.0002 0
Figure 6.16: IM T-11 vs. ICM 105hpc. Top ten up regulated genes in red and 
down regulated genes in green below scatter plot.
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L o g - i n t e n s i t y
Featureid Mean(IMT_11) Mean(DICM._136hpc) Log Ratio FoldChng P FDR Noisy Symbol
H3148D07-3 36601 2.6898 0.9703 9.338 0 0.0002 0 BC035044
H3135B07-3 4.0332 3.14761 0.88559 7.684 0 0.0005 0 2810001A02Rik
H3107G09-3 3.4113 2.5583 0.853 7.128 0.0005 0.0099 1
H3103E02-3 3.5722 2.7315 0.8407 6.929 0.0001 0.006 1
H3136B08-3 4.2003 3.3713 0.829 6.745 0 0.001 0 Npm1
H3010D11-3 3.492 2.69221 0.79979 6.306 0 0.0012 0 D19Wsu162e
H3119A01-3 3.7328 2.9692 0,7636 5.802 0 0.003 0
H3134B09-3 3.6857 2.923 0.7627 5.79 0.0001 0.0045 0 1300006C19Rik
H3018A01 -3 4.3795 3.6214 0.7581 5.729 0 0.0002 0
H3086F03-3 3.215 2.518 0.697 4.977 0.0005 0.01 1
H3138E02-3 2.5749 4.0937 -1.5188 33.021 0 0.0002 0 Col4a2
H3113E11-3 3.1783 4.36439 -1.18609 15.349 0 0.0001 0 Lamcl
H3049A12-3 2.7341 3.72129 -0.98719 9.709 0 0.0005 0 Pramel7
H3123H09-3 2.6128 3.5851 -0.9723 9.382 0 0.004 1
H3024A05-3 3.3002 4.2596 -0.9594 9.107 0 0.0003 0
H3034H10-3 2 2 9 8 5 3.23129 -0.93279 8.566 0 0.0008 0 Tm4sf3
H3103E08-3 2.3882 3.3134 -0.9252 8.417 0 0.0012 0 Dppal
H3123G09-3 2.8086 3.72119 -0.91259 8.176 0 0.0028 0 H19
H3035D04-3 2.914 3.82069 -0.90669 8.066 0 0.0004 0 Gm2a
H3104D07-3 3.2747 4.16889 -0.89419 7.837 0.0001 0.0047 1 Fabp3
Figure 6.17: IM T-11 vs. Delayed ICM 136hpc. Top ten up regulated genes in
red and down regulated genes in green below scatter plot.
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Featureid Mean(IMT_11) Mean(DICM180hpc) LogRatio FoldChng P FDR Noisy Symbol
H3148D07-3 3.6601 2.59601 1.06409 11.59 0 0.0001 0 BC035044
H3051D10-3 3.4279 2.4197 1.0082 10.19 0.001 0.0058 1
H3018A01-3 4.3795 3.3834 0.9961 9.91 0 0.0001 0
H3135B07-3 4.0332 3.11201 0.92119 8.34 0 0.0001 0 2810001 A02Rik
H3048E11-3 3.2952 2.39171 0.90349 8.007 0 0.0003 0
H3021C01-3 4.6413 3.7465 0.8948 7.848 0 0.0002 0 Prkch
H3136B08-3 4 2003 3.3115 0.8888 7.741 0 0.0002 0 Npm1
H3023D06-3 4.2699 3.42411 0.84579 7.011 0 0.0002 0 Pgk1
H3125D09-3 3.2383 2.4055 0.8328 6.804 0 0.0001 0 St13
H3028A04-3 4.7448 3.92881 0.81599 6.546 0 0.0002 0 Ppia
H3138E02-3 2.5749 3.83789 -1.26299 18.322 0 0.0002 0 Col4a2
H3113E11-3 3.1783 4.2774 -1.0991 12.563 0 0.0001 0 Lamcl
H3153C07-3 2.8466 3.8045 -0.9579 9.076 0 0.0003 0 Lrpapl
H3125A07-3 2.6247 3.5641 -0.9394 8.697 0 0.0002 0 Serpinhl
H3147B02-3 2.5727 3.47479 -0.90209 7.981 0 0.0001 0 Rab11fip5
H3129B08-3 2.9778 3.8666 -0.8888 7.741 0 0.0005 0 H19
H3103H10-3 2.4969 3.36569 -0.86879 7.392 0 0.0007 0
H3097A02-3 3.3725 4.2297 -0.8572 7.197 0 0.0002 0 Lap3
H3153C04-3 2.5819 3.4371 -0.8552 7.164 0 0.0002 0 Ddt
H3153A11-3 2.9373 3.7863 -0.849 7.063 0 0.0001 0
Figure 6.18: IM T-11 vs. delayed ICM  180hpc.Top ten up regulated genes in red
and down regulated genes in green below scatter plot.
-0.3.
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L o g -  i  n t e n s  i  t.y
Feature id Mean(IMT_11) Mean(EmbEctDy5.5) LogRatio FoldChng P FDR Noisy Symbol
H3123E05-3 3.2512 1.7792 1.472 29.648 0 0.0053 1
H3069C12-3 2.4399 1.771 0.6689 4.665 0 0.0053 0
H3065D08-3 3.1796 2.56 0.6196 4.164 0 0.0053 0 More
H3036F04-3 3.3284 2.75151 0.57689 3.774 0 0.0088 0 Zfp42
H3057B02-3 4.2304 3.6641 0.5663 3.683 0 0.0053 0 Hnrpa3
H3005G04-3 3.3427 2.80031 0.54239 3.486 0 0.0082 0
H3018A01-3 4.3795 3.8427 0.5368 3.441 0 0.0053 0
H3096F04-3 4.4128 3.88611 0.52669 3.362 0 0.0094 0 573046!
H3053A05-3 2.5349 2.0128 0.5221 3.327 0 0.0095 0 1700041
H3050A07-3 3.201 2.6811 0.5199 3.31 0 0.0073 0 Nanog
H3138H06-3 4.174 3.6551 0.5189 3.302 0 0.0088 0
H3123H09-3 2.6128 3.7629 -1.1501 14.128 0 0.0073 1
H3123G09-3 2.8086 3.84049 -1.03189 10.761 0 0.006 0 H19
H3123G10-3 2.7042 3.54599 -0.84179 6.946 0 0.0053 0 Mgatl
H3032D12-3 2.4926 3.32839 -0.83579 6.851 0 0.009 0 Sf3a3
H3129B08-3 2.9778 3.789 -0.8112 6.474 0 0.0088 0 H19
H3036D02-3 2.538 3.2998 -0.7618 5.778 0 0.0053 0 Eomes
H3029A04-3 2.572 3.31849 -0.74649 5.578 0 0.0053 0
H3144B06-3 3.0389 3.7637 -0.7248 5.306 0 0.009 0 H19
H3122E06-3 2.7269 3.406 -0.6791 4.776 0 0.0077 0
H3127H02-3 3.3814 4.03709 -0.65569 4.525 0 0.0067 0 Wbp5
Figure 6.19: IM T-11 vs. epiblast day 5.5. Top ten up regulated genes in red and
down regulated genes in green below scatter plot.
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1.4542 1.797 62.661 0 O.UUU/'
2.2091 1.2188 16.55 0.0002 0.0039
2.1378 1.1224 13.255 0 0.0021
2.49651 1.07569 11.903 0 0.0015
2.2779 0.9996 9.99 0.0001 0.0024
1.8811 0.9985 9.965 0 0.0013
2.4439 0.9674 9.276 0.0002 0.0041
2.3272 0.9654 9.234 0.0001 0.0028
2.41661 0.92609 8.435 0 0.0005
2.22671 0.91569 8.235 0.0002 0.0033
2.417 0.9114 8.154 0 0.0006
3.7172 -1.2246 16.772 0 0.0008
3.3487 -1.0507 11.238 0 0.0008
3.7945 -1.0148 10.346 0 0.0014
3.4038 -0.9903 9.779 0 0.0009
3.64279 -0.83939 6.908 0 0.0005
3.3246 -0.8277 6.725 0 0.0018
3.40379 -0.82189 6.635 0 0.0008
3.3891 -0.8171 6.562 0 0.0009
3.474 -0.8131 6.502 0 0.0005
3.5108 -0.7941 6.224 0 0.0013
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Figure 6.20: IM T-11 vs. embryonic ectoderm day6.5.Top ten up regulated 
genes in red and down regulated genes in green below scatter plot.
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Hierarchical clustering produced the dendrograms in Figure 6.21 using the average 
distance method described in the NIA Array Analysis package. This also shows that 
IM T-11 ES cells are, of all the tissues tested, most similar to Day 5.5 embryonic 
ectoderm. The dendrogram in Figure 6.21 (a) shows both that the technical repeats 
cluster together and the tissues cluster together. Figure 6.21 (b) shows a clearer picture 
of how the tissues are related to each other and confirms that IMT-11 is most similar to 
Day5.5 epiblast. Furthermore the data clusters into two major groups: firstly 
preimplantation which consists of all the ICM samples and secondly the epiblast and 
ectoderm samples.
Hierarchical clustering was repeated using Cluster 3.0 (de Hoon et al., 2004; Eisen et 
al., 1998) and the Spearman rank correlation as the similarity metric, the data was 
loaded into Java TreeView (Saldanha, 2004) First only the significantly changed genes 
(from the NIA annotation) for the whole experiment were loaded (Figure 6.22). As for 
the NIA analysis, the tissues group together and in most cases the technical repeats 
group together. Furthermore, the same pattern (that IM T-11 most resembles day 5.5 
epiblast) is seen. Second, when the whole gene set was examined this gave the same 
result. Furthermore, where more than one probe for a particular gene has been printed 
on the array, they have clustered together Figure 6.23). This clustering method uses 
non-parametric methods and, in combination with the NIA analysis, suggests the data is 
robust.
Principal component analysis (PCA) was also used to associate genes with tissues and 
to produce gene expression patterns (Figure 6.24) and again show tissue repeats 
clustering together. When the biplots are examined with the 3D viewer it is also clear 
that the ES line IM T-11 is most similar to Day5.5 epiblast. This could not only be
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compared to the pattern produced by Cluster 3.0 but could be used for comparison to 
published data.
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Figure 6.21 Dendrogram of hierarchical clustering of ES cell line IMT-11 and 
pluripotent embryonic tissues. The top dendrogram (a) shows the clustering o f the 
repeated samples and (b) o f the tissues.
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Figure 6.22 : View of Java TreeView for regulated genes. In (b) red indicates high expression, green low.
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Figure 6.23: Image of Java TreeView analysis for all genes. In (b) red indicates high expression, green low.
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Figure 6.24: PCA of data, (a) biplot showing the relationship between the tissues 
and genes. This can be visualised in three dimensions within the NIA tool, (b) The 
PCA assigns each gene to a cluster according to a negative or positive direction 
correlation with the 5 principal components.
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Figure 6.25: Expression pattern for the gene nanog (a) from NIA Array 
analysis and pattern matching and (b) from Cluster 3.0 and Java TreeView. In (b) 
red indicates high expression, green low.
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Figure 6.26: Expression pattern  for Zfp42. (a) from NIA Array analysis pattern 
matching and (b) from C luster 3.0 and Java TreeView. In (b) red indicates high 
expression, green low.
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The patterns for nanog (Figure 6.25) and for Zfp42 (Figure 6.26) are as published for 
the embryo tissues (Chambers et al., 2003; Pelton et al., 2002). This demonstrates both 
that the expression profiles produced by these studies reflect well the profiles produced 
by other means (in this case in situ hybridisation). It also suggests that the study of the 
expression of single genes can be misleading.
6.4. Conclusions
The first experiment described in this chapter where the ES cell line IMT-ll was 
directly compared with various dissected embryo tissues was a preliminary experiment 
which performed two principal functions. As this was an experiment carried out at the 
early stages of the investigations it allowed practice with the dissection of the early 
embryonic material and showed that such material could be routinely amplified and 
used in array experiments. The array experiment showed that the target hybridised to the 
probes on the slides. Although the number of spots detected on these slides was not high 
due to printing problems, they did show that the ES cells did hybridise with the probes 
at a rate similar to the different developmental stages.
Notwithstanding the poor hybridisation on these slides, it was clear that a common 
reference design where the reference sample would not be part of the final analysis 
would use fewer array slides and simplify the analysis in this study. Therefore a 
common reference sample was assembled from amplified RNA from the tissues used to 
make the libraries represented in the NIA 15kprobe set. This also produced data about 
the potential usefulness of amplified RNA from ES cells as a universal reference 
sample. This showed that the number of probe spots hybridised at an intensity more 
than two standard deviations above the mean background intensity is high, greater than
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87%, and very similar for ES cells and the common reference pool. This suggests that 
amplified RNA from ES cells would probably make a good universal reference sample 
at least for the NIA 15K gene set.
Image analysis of large numbers of array slides is very time consuming and potentially 
a source of variation. Batch processing allows each slide in a set from the same print run 
to be analysed using the same conditions and minimising operator intervention. This 
should both reduce operator variation and the amount of time required to analyse the 
slide images. The image analysis program ImaGene™ was used in most of the early 
experiments but this institute does not have the module which allows for batch 
processing thus the grid must be applied for each slide. While this produces very good 
results due to the flexibility of the placement and spot finding procedure, only four 
slides can be analysed in a day and the slides should only be analysed by one person. 
Spot, which can analyse a batch of slides so the grid is only set for one slide, is slightly 
less flexible in the placement of the grids so some spots will be lost and cannot be 
retrieved by manual adjustment. As the two programs use different methods of 
addressing and spot finding the results obtained are slightly different. As Spot uses all 
the information in a spot and does not discard the highest and lowest pixel values as is 
done by ImaGene™  it is more sensitive at lower spot intensities. Furthermore, the 
background variance is lower due to the method of background measurement and is 
more stable in Spot. Thus the results from Spot may reflect better the actual gene 
expression ratios; particularly for low expression levels.
The measurement of background has implications for the normalisation of the data. 
Limma with its wide range of normalisation options and visualisation methods was 
ideal for looking at the interaction between the image analysis methods and the
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normalisation procedure. It was clear from the density distribution that the Spot 
analysed slides needed less adjustment than those analysed using ImaGene™ i.e. the 
data produced had less noise. Furthermore, background subtraction with ImaGene™ 
analysed data introduced noise, a phenomena noted by other workers (personal 
communication, Ben Routley).
The normalised data was extracted from limma and put into the NIA array analysis tool 
(http://stemcell.biosi.cf.ac.uk/ ) for ANOVA (analysis of variance), PCA (principal 
component analysis) and clustering. The use of Cluster 3.0 (de Hoon et al., 2004; Eisen 
et al., 1998) Java TreeView (Saldanha, 2004) allowed the clustering result to be 
confirmed using the non-parametric Spearman Rank correlation as the similarity 
measurement. The clustering pattern of the technical and biological repeats suggested 
high quality data as did the clustering of tissues. The number of regulated genes 
between each tissue pair was used as a measure of similarity and showed that the ES 
cell line IMT-11 was most similar to the epiblast on day5.5 of gestation despite the 
expression of individual genes suggesting ES cells are homologous to the ICM of the 
early blastocyst stage.
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7. Discussion
The aim of this project was to develop techniques which would allow transcriptome 
phenotyping of the pluripotent compartment of the mouse embryo and embryonic stem 
cells. This would also enable gene expression comparisons to be carried out at a global 
level and has involved development of techniques for labelling of the target, 
amplification of RNA and handling of the data generated.
7.1 Labelling of Target
The development of labelling techniques was carried out using cytoplasmic RNA. Not 
only is this easily obtained in large quantities but amplified RNA takes several days to 
generate and is therefore a valuable resource. Nevertheless, the methods of labelling 
amplified RNA would be expected to be similar to those for cytoplasmic RNA.
Direct labelling of the mRNA was worth exploring as it is less likely to suffer from 
sequence specific dye biases or 3' biases which are inherent in methods which use 
enzymes. This method produced excellent array data (not presented in this thesis). The 
instability, however, of the reagents reduced reliability and increased cost.
It is generally recommended that at least lOpmols of dye labelled target is applied to 
each array slide. The direct integration of labelled nucleotides (Cy-dUTP) into cDNA 
by means of reverse transcription, which was already in use in this institute required 
lOpg of total RNA to produce barely enough Cy5™ labelled cDNA for a single 
microarray slide. This is irrelevant where the amount of RNA is not limiting but the 
amount of RNA available from the early embryo tissue samples was inevitably small. 
Furthermore, the unequal incorporation in the two dyes is also a potential problem. If
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the dyes are not adequately balanced, the normalisation process can be detrimentally 
affected.
Integration of aminoallyl dUTP into the cDNA followed by conjugation of the dyes 
appeared to have a number of advantages over the direct incorporation of dye modified 
nucleotides. Firstly, the aminoallyl modified nucleotides are much less bulky than the 
dye modified molecules and thus are more efficiently incorporated into the cDNA. 
Secondly, the monoreactive dyes, Cy3™ and Cy5™, bind with similar avidity to the 
modified cDNA. Thirdly the dyes bound via a linker cause less interference with 
hybridisation.
The use of the reverse transcription reaction is a basic tool in this laboratory and it 
might seem that with optimised levels of reagents, in particular the relative level of 
aminoallyl dUTP to unmodified dUTP, there would be little benefit in using a 
commercial kit. However, the results obtained without a kit were highly variable. The 
relative levels of modified to unmodified dUTP can be expected to affect both the yield 
of cDNA and the level of incorporation. Much of the variation in yield can be attributed 
to the purification steps between reverse transcription and dye coupling and in the final 
removal of unbound free dye from the finished probe. With a kit, both yield of cDNA 
and the amount of dye incorporated are still variable but on the whole are more reliable 
than the in-house methods.
Destruction of the RNA template can be achieved by either the enzyme RNase H or 
sodium hydroxide. The kits which were being trialled, the Atlas™ Glass Fluorescent 
Labelling kit and the Atlas™ PowerScript™ Fluorescent Labelling kit (BD 
Biosciences) both used RNase H to destroy the template. As RNase H only destroys the 
RNA which is hybridised to DNA, spectrophotometric analysis could not be used to
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assess the amount of cDNA synthesised against the background of cellular total RNA. 
Furthermore, inefficient removal of the RNA template could potentially lead to a drop 
in hybridisation of the probe due to these RNA fragments hybridising back to the 
labelled cDNA. Therefore RNase H and NaOH degradation of the RNA was tested. 
Degradation with NaOH allowed the amount of cDNA and the frequency of 
incorporation (FOI) of the labelled nucleotides to be estimated. This is important 
because cDNA with too high an FOI is inhibited from hybridisation. Further analysis of 
microarrays demonstrated that neither the number of spots detected nor the total 
intensity was affected by the method of RNA degradation when the same amount of dye 
labelled probe (15pmol) is hybridised with the probes on the slide. Thus the evidence is 
that the RNase H removes the template as efficiently as NaOH however to give a clearer 
picture of probe quality before use, the degradation of the template was in subsequent 
experiments carried out with NaOH.
The amount of cDNA synthesised in the reverse transcription reaction is affected by the 
molecule being incorporated. Aminoallyl dUTP does not inhibit the synthesis of cDNA 
to the same extent as Cy3™ or Cy5™ dUTP. Thus amount of cDNA synthesised per 
lOpg of RNA is higher for aminoallyl incorporation than for Cy™ conjugated dyes as is 
the amount of dye incorporated into target. Although Cy3™ dUTP incorporates into 
cDNA at a similar FOI as aminoallyl dUTP Cy5™ only incorporates about half as 
much. Overall 5pg of total RNA will provide enough labelled target for 1 array slide 
when incorporating Cy3™ dUTP or only half the required amount when incorporating 
Cy5™ dUTP. When using the incorporation of aminoallyl dUTP 5pg of total RNA 
provides enough labelled target for 2 and often 3 array slides irrespective of which Cy™ 
dye is being used. Interestingly, although both probes appeared to be equally labelled, 
the slope of the correlation line between Cy3™ and Cy5™ probes (Section 3. 3. 3c,
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Figure 3.7 and Table 3.22) shows a difference in hybridisation between the two dyes, 
namely Cy5™ labelled target appears to hybridise with a higher affinity than Cy3™.
Overall, the labelling by the indirect method of incorporating aminoallyl dUTP into 
cDNA by reverse transcription followed by conjugation of monoreactive Cy™ dye has 
proved to be the best in terms of yield of labelled target. There was no detectable 
difference in the performance of the CyScribe™ Post-Labelling Kit (Amersham 
Pharmacia Biotech) and the Atlas™ PowerScript™ Labelling Kit (BD Biosciences) 
with the modification of NaOH degradation. The procedure with the later is slightly 
shorter so this was used in all subsequent experiments. The method was further 
modified by adding PelletPaintNF™ (Novagen, Merk Biosciences) (Section 3. 4) to the 
ethanol precipitation of the aminoallyl modified cDNA. This reduces losses of the 
aminoallyl cDNA by improving visibility of the pellet and making a more compact 
pellet which is less easily dislodged.
As a result of these tests it was decided to use the Atlas™ PowerScript™ Labelling kit 
(BD Biosciences) modified by degrading the RNA template with NaOH and the 
addition of PelletPaintNF™ (Novagen, Merk Biosciences) to promote pellet recovery 
during ethanol precipitation
7.1.2 Amplification
The primary aim of this thesis was to apply global transcriptome analysis to investigate 
the homology of ES cells to the pluripotent compartment of the embryo. Paucity of 
experimental material has restricted these studies in the past. (Tanaka and Ko, 2004) 
used 2510 morulae and 1149 blastocysts (+ other stages) from superovulated females to 
carry out a microarray experiment. The work of (Hamatani et al., 2006) involved the
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collection of pools of 500 embryos for each sample to generate the gene expression 
profile from superovulated embryos. Although it is generally adequate to produce early 
pre-implantation stages by superovulation, superovulated mothers rarely yield 
satisfactory embryos at later pre-implantation stages such as morula and blastocysts. 
Furthermore, not only would post-implantation development not be expected to be 
satisfactory after superovulation, but also the amount of “hands on” manipulation of 
each post-implantation embryo to isolate the embryonic ectoderm would hamper such 
studies. Thus development of an amplification method for the RNA was central to this 
study.
In the same way as the labelling procedure the enzymatic reactions carried out are 
routine (reverse transcription, double stranding and in vitro transcription) but are being 
carried out at the limits of their sensitivity. This not only means the optimisation of each 
reaction step is critical, but also the cleaning and buffer exchange steps are critical to 
ensure no carryover of components from one reaction to the next or loss of scant 
sample.
Although each reaction appeared to function and even some amplified RNA was made, 
the whole procedure did not lead to amplification. To achieve adequate amplification in 
a reproducible manner required the RiboAmp™ kit (Arcturus).
Labelled amplified RNA has the advantage of producing much brighter arrays than 
labelled total or cytoplasmic RNA. This is because the 3-5pg of amplified RNA being 
put into the labelling reaction is the equivalent of 3pg of highly purified mRNA. The 
disadvantage of amplified RNA is that it is 3 ' biased due to the lack of processivity of 
reverse transcriptase. Although this would have an impact on oligonucleotide arrays it 
has little impact on the cDNA arrays being used in this study because the probes are, in
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the majority of cases derived from the 3' end of the gene. The disadvantage of cDNA 
arrays is that they do not give absolute transcript levels, but only relative. Furthermore, 
the NIA 15k gene set has a great many unidentified genes in it and the annotation is 
poor.
7.1.2 Image Analysis
Printed microarray slides are rarely perfect. Bent or worn pins introduce distortions in 
the grids of spots. More problematical is variation between slides.
In this study two different image analysis programs were used; namely ImaGene™ and 
Spot. ImaGene ™ is more labour intensive in that the grid is placed for each slide 
image. However, this hand placed grid can be distorted and the metagrids moved to 
allow for variation from a true square grid. As this institution does not have the batch 
processor for this program, between slides variation is not a problem. On the other hand, 
with Spot, after initial calibration for a batch of slides, variation is handled by the 
program limited by preset parameters.
Segmentation into foreground and background with ImaGene™ is carried out by 
histograms which unlike fixed circle or adaptive circle segmentation does not depend on 
a precise location for the spot if it is within the mask area, nor is a perfectly circular spot 
required. Pixels are allocated to foreground or background on the basis of their 
intensity. If a spot is too far from its expected location, it can be adjusted manually. 
Spot, an adaptive shape segmentation method, also does not require perfectly circular 
spots or very precise information about the location of the spots as there are multiple 
seed points for the growth of the features. However, if the spot is too far from its
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expected location, it can be missed. As it is not possible to adjust this manually, the data 
is lost (Figure 6.6 bottom left picture of segmented metagrid).
Another variable in image analysis is background acquisition. ImaGene™ with its 
histogram method uses the low intensity pixels between two low percentiles as 
background. This has the effect of filtering out high pixels due to dust, scratches or 
neighbouring spots resulting in lower backgrounds a than for fixed or adaptive circle 
segmentation. Spot on the other hand takes seed points round the intersection point o f 
the valleys between spots and calculates a background based on a mask more than twice 
the size of the spot distance. This has the effect of “peeling o ff’ the spots leaving the 
background behind. The background measurement is taken from directly under the spot. 
This method has the effect of returning a lower background than fixed or adaptive circle 
methods and to a lesser extent also to histogram methods. However, it also has the 
effect of smoothing out the background and assumes that spatial changes in background 
are gradual. This is often not the case, background can change more abruptly. Thus 
ImaGene™ probably more closely reflects the reality on the slide. However, the aim is 
to reduce noise introduced by the background measurement so the Spot method and 
morph reduces the dependence of variability on intensity.
In addition to the background measurements for ImaGene™ and Spot, blank spots 
printed only with buffer are available for background subtraction. These are distributed 
across the whole slide to avoid spatial errors and can be used in a global manner or by 
metagrid. At present we have no algorithms available and can only use these with 
spreadsheet programs such as Excel.
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7.1.3 Background Subtraction and Normalisation
The purpose of normalisation is to account for loading differences thus allowing 
comparison between slides, and to remove systematic biases inherent in the experiments 
which permit the extraction of data from microarrays. The most common forms of bias 
are dye bias and spatial bias. In these experiments, since a common reference design 
using a reference sample is used, sequence specific dye bias is not a problem. However, 
the dye balance between the two channels, which is not only related to differences in the 
efficiency of incorporation of the two labels but also differences in excitation and 
detection and loading, must be corrected. Most microarrays require some form of spatial 
normalisation as they often have darker areas especially round the edges. In this study, 
we used print-tip loess as our method of normalisation. Loess normalisation estimates 
the dependence of the log ratio M on the log intensity A. Applied globally, it does not 
correct for spatial variation and a separate algorithm would have to be applied. It is only 
appropriate where the bulk of the genes are not differentially regulated. Most spatial 
variation is associated with individual print tips due to for example wear or a bent pin, 
or edge effects due to drying of the hybridisation mix at the edge of the coverslips. 
When applied to each print-tip group individually, loess also performs as a spatial 
normalisation method; providing the print tip groups are not too large and there is not 
excessive variation across the metagrid area due to other spatial factors i.e. the metagrid 
must not act as an individual array. If the print tip groups are too small, then there will 
not be enough spots to carry out a reliable regression. Although other algorithms are 
available for spatial normalisation, as the number of separate manipulations to the data 
increase, the noise in the data increases. Thus print-tip loess carries out the jobs both of 
global normalisation; balancing the channels and smoothing the regression line, and of 
spatial normalisation.
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Background subtraction is a more contentious issue. It is generally believed that spot 
intensity consists of signal due to hybridisation of labelled target to the probe, plus other 
fluorescent contamination from slide coatings, scanner filters etc, and furthermore is 
assumed to be additive. This contamination is represented by background. The 
measurement o f background has its own noise associated with it, and since this can be 
high, subtraction can lead to zero and negative red or green intensity values and thus 
loss of data. This is strongly affected by the method of background measurement. 
Moreover additional noise is being added to the data which impacts on detection of 
differential gene expression particularly at lower intensities. Although it has been 
argued that background removal should be omitted from the analysis because Spot 
provides the morph measurement of background it was subtracted in these analyses. For 
ImaGene™ analysis, the limma function normexp was used as the background removal 
algorithm which gives a similar result to the subtraction of morph in Spot.
7.2 Embryonic Stem Cells
The only other study to compare the global transcriptome of ES cells and embryos was 
the study by Sharov et al (2003). This study compared the expression profile of ES 
cells, lineage restricted stem cells, whole embryos and newborn tissues. They showed 
that ES cells are closest in expression profile to the day 6.5 embryo rather than the day 
4.5 blastocyst and EG cells are more similar to post-gastrulation day 8.5 embryos. 
Embryos on day 5.5 of gestation were not included in this study. Other studies have 
looked only at comparisons of different categories of stem cells in attempts to identify 
“sternness” genes and genes associated with the pluripotent state (Ivanova et a l, 2002; 
Kelly, 1977; Ramalho-Santos et al., 2002; Sene et a l,  2007; Tanaka et a l, 2002) or pre­
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implantation development and processes such as the activation of the zygotic genome 
(Tanaka et al., 2000; Wang et al., 2004; Zeng and Schultz, 2005) blastulation, (Tanaka 
and Ko, 2004) two-cell block (Jeong et al., 2006) and activation of the diapause embryo 
(Hamatani et al., 2004b) or have compared tissues from the same developmental stage 
(Frankenberg et al., 2007). The study described here differs from the Sharov et al 
(2003) in many significant ways. First the Sharov et al (2003) study did not use 
microarray as its experimental platform but used the frequency of ESTs in many 
different libraries to describe their samples. This had the advantage of using the large 
number of clones in libraries already identified. This work led to the production of the 
NIA cDNA gene set used in our study. This study had the advantage of breadth and 
showed that many of the genes identified in microarray studies as unique to ES cells in 
other studies were in fact expressed in a differentiated tissue.
A feature of many array studies is the lack of repeatability between different research 
groups. This has been particularly noted in studies of stem cells. Although in many 
cases this variability can be at least partly assigned to different array platforms some can 
be put down to heterogeneity of cells in culture. This may be a particular problem in ES 
cells as they show heterogeneity which cannot simply be ascribed to the cell cycle. The 
gene nanog is an example of an ES marker which appears to be expressed at different 
levels in the population of cells growing in a dish (Singh et a l , 2007). This may 
partially account for the differences between the studies of Ivanova et al (2002) and 
Ramalho-Santos et al (2002) (Fortunel et al., 2003) both of which used the Affimetrix 
gene chip platform.
Examination of the under-expressed gene list from the ES cells against Day5.5 epiblast 
reveals a number of genes normally associated with the extra-embryonic portion of the
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embryo namely eotnes and H I9. This would suggest contamination of the epiblast 
samples with extra-embryonic ectoderm which might be expected since the embryos are 
both very small and the egg cylinder only partially segmented. Eomes is expressed in 
the polar trophectoderm and giant cells of the embryo on day 5.0 of gestation but this 
extends into the primitive streak by day 5.75 of gestation (Russ et al., 2000). Thus 
eomes expression may not indicate contamination rather a spread in developmental 
stages. On the other hand H19 is expressed in the extra-embryonic ectoderm and 
ectoplacental cone on day 5.4 of gestation and is not expressed in the embryonic portion 
on day 6.5 of gestation (Poirier et al., 1991) and most probably indicates contamination. 
This is confirmed on examination of the over-expressed gene list for day 5.5 epiblast 
against the ectoderm on day 6.5 (data not shown) where although eomes is not detected 
as differentially expressed, H19 and Pletl (H3011D11) which is expressed in the distal 
extra-embryonic ectoderm (Frankenberg et al., 2007) are. Handl appears to be more 
proximally expressed in the extra-embryonic ectoderm on day5.5 of gestation (Auman 
et al., 2002) and is not listed in the under-expressed gene list for ES cells against day 
5.5epiblast although it is found in the list of over-expressed genes day 5.5 against day 
6.5. However the expression data published for Handl is not clear and Handl may be 
expressed at low levels in ES cells assayed by PCR (Takada et al., 2005).
The vast majority of ES lines have been isolated from the ICM of blastocyst stage 
embryos. They have also been isolated from morulae (Eistetter, 1989) and from early 
post-implantation, egg cylinder stages on day 5.5 pc (Wells et a l , 1991). However their 
homology to these in vivo stages is not clear. Although ES cell lines have been derived 
from up to day 5.5. of development, the expression of the known pluripotency markers 
reflects that of the earlier ICM (Section 1.1.7, Figure 1.1). Furthermore, their ability to 
contribute to chimaeras reflects this earlier homology. EC cells, which may be an ES
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homologue, were compared to the ICM in an earlier proteomics study (Lovell-Badge 
and Evans, 1980). In this study 600 polypeptide spots could be compared with 
confidence. On the basis of the 32 spots which varied over the time course of the EC 
cells differentiating in vitro, the ICM from early blastocysts (shortly after blastulation) 
most resembled EC cells 6-12h after initiation of differentiation by embryoid body 
formation. At this time the embryoid bodies would be expected to be differentiating a 
layer of endoderm as would the ICMs and these common spots were postulated to be 
associated with this process. An advantage of this approach is the role of post- 
translational modification can be examined. However, although the technology has 
improved since this study it is still difficult to identify the proteins.
In this study global gene expression was analysed by transcriptome analysis for ES cells 
and the pluripotent component of the embryo between the blastocyst stage on day 3.5 
and the embryonic ectoderm stage before gastrulation on day 6.5. Using the 15kNIA 
gene set allowed the expression profile of approximately 12,000 unique genes, for many 
of which the identity is known. A clear answer was obtained that the ES cell samples 
most resemble the day 5.5 epiblast samples, the two tissues only differing by 97 spots 
out of 15,248.
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Lof-lntmlty
Tissue Log-mean SD
ICM_88hpc 3.4777 0.0584
ICM_105hpc 2.959 0.0477
DICM_136hpc 3.0967 0.0477
DICM 180hpc 3.12 0.0522
EmEct_Dy6.5 2.7576 0.0522
EmbEctDy5.5 2.6811 0.0477
IM T J l 3.201 0.0477
(b)
Tissue Log-mean SD
ICM_88hpc 3.03 0.0716
ICM_105hpc 2.8958 0.0584
DICM_136hpc 3.2388 0.0584
DICM180hpc 2.9835 0.064
EmEct_Dy6.5 2.417 0.064
EmbEctDy5.5 2.7514 0.0584
IM T J l 3.3283 0.0584
Figure 7.1: Expression profile for (a) nanog and (b) Zfp42. Generated by the NIA 
array analysis tool. These graphs do not imply a time course.
Prominent in the list o f over-expressed genes are Zfp42 and nanog. The expression level 
of Nanog and Zfp42 in the ES cells is significantly different from those of the day 5.5 
epiblast. Nanog expression in the ES cells is most similar to the ICM of delayed 
blastocysts isolated at 180h.p.c. and Zfp42 to the ICM of delayed embryos 136h.p.c. For 
homology to Day 5.5 of development, expression of these two genes would be expected 
to be lower in ES cells. This is unlikely to be an artefact of the microarray methodology 
as the expression profiles for Zfp42 reflect the published expression profile (Pelton et 
al., 2002). The expression profile for Nanog suggests slightly earlier down-regulation
L O f-ln t.ro  I t ,
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than the published literature but this may be due to differences in embryo staging. Thus 
the known pluripotency genes may not be useful for characterisation of homology. 
Conversly, the level of Gsk-3p is present in the list of down-regulated genes perhaps 
reflecting the activity of the canonical Wnt pathway. The expression of higher levels of 
the pluripotency associated genes in ES cells may reflect a metastable state adopted by 
pluripotent cells in culture under the serendipitous influence of the Gpl30-STAT3 
pathway which does not appear to act to maintain pluripotency in the embryo.
Over this period of development the embryo is initiating a wave of morphological 
change which leads to formation of the pro-amniotic cavity and rearrangement of the 
structure of the epiblast to form the ectoderm. It has been shown that a distinct cell type, 
EPL cells can be derived from ES cells by means of culture medium conditioned by the 
human hepatocarcinoma cell line HepG2 (Lake et a l,  2000). These cells have an 
expression profile of pluripotency markers like day 5.5 embryonic ectoderm (Pelton et 
al., 2002). These cells are distinguished by being more like human ES cells in 
morphology; flatter, epithelial colonies rather than the heaped colonies of mouse ES. 
These cells also do not integrate into the blastocyst to form chimaeras. However, this 
state can be reversed. By modifying the growth conditions, notably by the addition of 
Lif, they can revert to an ES phenotype and regain their ability to contribute to 
chimaeras. It has also been demonstrated that under the influence of these culture 
conditions, the day 5.5 embryonic ectoderm can be maintained and furthermore these 
can be induced to give ES cell like lines which survive for up to five weeks (Rathjen et 
a l,  2003).
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Recently, two groups have isolated stable cell lines, post-ES cells, from day 5.5 epiblast 
which had initiated pro-amniotic cavity formation (Brons et al., 2007; Tesar et al., 
2007). These cells like EPL cells and human ES cells express Fgf5 and Oct3/4 but not 
Rex 1. They also share with murine EPL and human ES an epithelial morphology and 
the inability to contribute to chimaeras (obviously this later property has not been tested 
in humans). These cells were derived using the same culture conditions as for human ES 
cells. This suggests that post ES cells, EPL cells and human ES cells, which grow in the 
absence of Lif, may reflect the in vivo epiblast. ES cells, being for the most part 
homologous to Day5.5 epiblast under the influence of Lif, the pluripotency markers of 
an earlier stage are enhanced.
It may be possible to test this by attempting to grow post-ES cells in the presence of Lif 
and observing if they can like the EPL cells described by Lake et al (Lake et al., 2000) 
revert and form ES like lines which can contribute to chimaeras. The expression of 
individual pluripotency markers reflects the adaptation of these cells to culture and in 
particular the use of the gpl30, Jak/STAT pathway which in vivo does not appear to 
have a role in the maintenance of the pluripotent state.
In combination with the ability to grow ES cells in the reversible EPL state it appears 
that ES cells in culture most resemble the embryonic epiblast on day 5.5 at the early 
pro-amniotic cavity stage. At this stage the pro-amniotic cavity is confined to the 
embryonic region of the early egg cylinder and has not extended into the extra- 
embryonic ectoderm and is equivalent to between day 5.25 and 5. 5 as assessed by 
Pelton et al. The embryos used by Tesar et al (personal communication) to derive post- 
ES cells were also at this stage. Unfortunately, the paper by Wells et al (Wells et al., 
1991) was not precise in staging the embryos used
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7.3 Future Work
As well as suggesting further work this data set contains a great deal of unanalysed 
information. Experiments to confirm gene expression profiles by other methods such as 
PCR are a priority although the errors from careful microarray studies such as those 
reported here are in many cases no larger than those from quantitative PCR. Further to 
the homology of ES cells to other pluripotent cell types, profiles of EC cells both of 
germ cell origin and ectoderm origin should be examined as should EG cells and 
primordial germ cells. Hopefully in the future it will be possible to profile EPL cells and 
post-ES cells
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Embryonic
developmental
Stage
Time of 
isolation in 
days post 
coitum to 
nearest half 
day
Time of 
isolation in 
hours post 
coitum
Morphological Markers Use
Oocytes 0.5 6-8 1-cell, zona pellucida, 1st polar body 
only.
Reference pool
Fertilised eggs 
1-cell 0 © 0.5 8-10 1-cell, zona pellucida, 1st and 2nd polar body. Reference pool
2 cell
© m 1.5 32-35 2-cell, zona pellucida, 1st and 2nd polar body. Reference pool
3-4 cell
©
2.0 45-46 4-cells, zona pellucida, 1st and 2nd 
polar body. 1st polar body may have 
degenerated
Reference pool
4-8 cell
50
2.5 55-58 Anywhere between 5 and 8 cells. 
Later embryos with may have started 
compaction. 1st polar body may have 
degenerated
Reference pool
Morula, 8-16 
cell
k
3 67-68 Compacted morula, between 8 and 16 
cells, exact number unknown due to 
compaction, zona pellucida
Reference pool
early blastocysts 0 3.5 80-84 Zona pellucida, blastocoel cavity half to fully expanded. Intact embryos in reference pool. Isolated ICM in samples.
0©■
Late blastocysts
0
4.5 103-107 Hatched (no zona pellucida) often 
collapsed and with maternal cells 
adhering to distal mural 
trophectoderm.
Isolated ICM in 
samples.
Early post- 
imlantation
(t)
5.5 132-135 Early post-implantation. Reichert’s 
membrane with maternal cells. Early 
segmentation of egg cylinder. Early 
proamniotic cavity not extending into 
extra-embryonic ectoderm.
Isolated epiblast 
in samples
274
Egg Cylinder §I 6.5 150-154 Segmented egg cylinder. Reichert's membrane with maternal cells. Pro- amniotic cavity. Ectoderm pseudo stratified epithelium. Isolated embryonic ectoderm in samples.
Appendix 1: Stages of embryonic development. The drawings were ta 
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Appendix 2. Formulae used in Analysis of Labelled Target
Beer’s Law A(x) = ecm '1m o rl)*pathlength(cm)*concentrationC(mol/L), 
where A is the absorbance at a wavelength x(nm), e is the extinction coefficient for the 
substance being analysed (1cm'1 mol'1).
The pathlength in a standard cuvette is 1cm C(mol/L) = A/e mol of dye incorporated = 
A/e*vol(L)
pmol of dye incorporated = A/e*vol(|il)*10'6
for Cy3™, £=150,000 and absorbance maximum is 550nm
pmol of dye incorporated = A(550/O.15*vol(fil)
and for Cy5™, £= 250,000 and absorbance maximum is 650nm
pmol of dye incorporated = A(65o/0.25*vol(|xl)
The average molecular weight of a deoxynucleotide is 324.5 and assumes average 
cDNA is 1 kb
£=8919 for single stranded DNA at the absorbance maximum of 260nm 
concentration of single stranded DNA = A26o*324000/8919g/l
= A 26o*37pg/m l 
Frequency of incorporation per 1000 nucleotides (FOI)
For Cy3 FOI= ng. Cy3™/ng cD N A = A 55o/e55o*324)/A26o*37
= A 55o/ A 26o* 5 8 .  5 
For C y 5 ™  FOI= ( A 65 o /e 6 5 o * 3 2 4 )/A 26o * 3 7  
= A 65o/ A 26o* 3 5 .
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Appendix 3: Commands for Analysis in Limma
This is a protocol for the analysis of files into Limma and uses the files from the DNase 
experiment described in Chapter 5. The typed commands are in red. The base package R 
and limma were downloaded from the web.
> library(limma)
> limmaUsersGuideO
[1] "C:/PROGRA~l/R/rw2011 /library/limma/doc/usersguide.pdf"
Go to file pulldown menu and select Change Directory. Go to where your files for 
limma analysis are stored.
> spottypes <- readSpotTypes()
> objects()
[1] "spottypes" "targets"
> show(spottypes)
SpotType Gene ID Color
1 gene * black
2 landmark Landmark green
3 scorecard Scorecard* red
4 Rich Rich* blue
5 BLANK BLANK yellow
6 empty empty purple
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7 null orange
> targets<-readTargets()
> show (targets)
SlideNumber FileNameCy3
1 1 1 Cyanine3_052405_l 119_Exp4al5pmol65pmt.txt
2 12 Cyanine3_052405_ 1139_Exp4a 15pmol65pmt.txt
3 13 Cyanine3_060305_ 1113_Exp4a 15pmol65pmt.txt
4 14 Cyanine3_060305_l 137_Exp4al5pmol65pmt.txt
FileNameCy5 Cy3 Cy5
1 Cyanine5_052405_l 119__Exp4al5pmol65pmt.txt Dnase control
2 Cyanine5_052405_ 1139_Exp4a 15pmol65pmt.txt Dnase control
3 Cyanine5_060305_ 1113_Exp4a 15pmol65pmt.txt control Dnase
4 Cyanine5_060305_ 1137__Exp4a 15pmol65pmt.txt control Dnase
> files <- targets[,c("FileNam eCy3","FileNam eCy5")]
> RG <- read.m aim ages(files, source="im agene")
Read header information
Read Cyanine3_052405_l 119_Exp4al5pmol65pmt.txt 
Read Cyanine5_052405_l 119_Exp4al5pmol65pmt.txt 
Read Cyanine3_052405_l 139_Exp4al5pmol65pmt.txt 
Read Cyanine5_052405_l 139_Exp4al5pmol65pmt.txt 
Read Cyanine3_060305_l 113_Exp4al5pmol65pmt.txt 
Read Cyanine5_060305_l 113_Exp4al5pmol65pmt.txt 
Read Cyanine3_060305_l 137_Exp4al5pmol65pmt.txt 
Read Cyanine5_060305_l 137_Exp4al5pmol65pmt.txt
> RG$genes$Status <- controlStatus(spottypes, RG)
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Matching patterns for: Gene ID 
Found 16128 gene 
Found 48 landmark 
Found 230 scorecard 
Found 48 Rich 
Found 10 BLANK 
Found 65 empty 
Found 480 null
Setting attributes: values Color
An imageplot of the background intensities allows one to visualise any defects in the 
slide.
> imageplot(log2(RG$Rb[,l]), RG$printer, low="white", high=’Ted")
> imageplot(log2(RG$Gb[,l]), RG$printer, low="white", high="green")
The MA plot of each slide is also useful particularly for visualising intensity bias on the 
array.
> plotM A(RG,array=l)
The scale on the x and y can be set using: 
>plotMA(RG,array=l,xlim=c(4,16),ylim=c(-3,3))
otherwise limma will set to fit data. Lines showing the unregulated M=0 and 2-fold 
regulated cut off can be added by:
> abline(0,0,col="blue")
> abline(-l,0,col="red")
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> abline( 1,0,col="red")
A plot of printtiploess loess shows the loess curves for each print tip
> plotPrintTipLoess(RG,array=1)
Background correction and Normalisation
A)Normalise within arrays
1 No background correction, print tip loess normalisation
> RGb1 <-backgroundCorrect(RG,method="none")
> Norm1<-normalizeWithinArrays(RGb1)
> plotMA(Norm1 ,array=1)
2 Background correction with “normexp” function, print tip loess normalisation
> RGb2<-backgroundCorrect(RG,method="normexp",offset=50)
> Norm2<-normalizeWithinArrays(RGb2)
> plotMA(Norm2,array=1)
3 Background correction with “normexp” function, robust spline normalisation
> RGb2<-backgroundCorrect(RG,method="normexp",offset=50)
> Norm3<-normalizeWithinArrays(RGb2,method="robustspline")
> plotMA(Norm3,array=1)
B) Normalise between arrays
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Boxplot and Density plot to display arrays using Norm2
> boxplot(Norm2$M~col(Norm2$M)) or
> boxplot(Norm2$M~col(Norm2$M),ylim=c(-4,3))
> plotDensities(Norm2)
1 Scale
> Norm4 <- normalizeBetweenArrays(Norm2)
> boxplot(Norm4$M~col(Norm4$M))
> plotDensities(Norm4)
2 Aquantile
> Norm5Aq <- normalizeBetweenArrays(Norm2, method="Aquantile")
> plotDensities(Norm5Aq)
> boxplot(Norm5Aq$M~col(Norm5Aq$M))
3 Quantile
> Norm6q <- normalizeBetweenArrays(Norm2, method="quantileM)
> plotDensities(Norm6q)
>boxplot(Norm6q$M~col(Norm6q$M))
Make the linear model
>design <- modelMatrix(targets,ref="control") 
show the design
> design
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For the experiment described in Chapter 5, this should be 
Dnase 
1 -1 
2 -1
3 1
4 1
The linear model is fitted to the data and the statistics calculated.
> fit <- lmFit(Norm5Aq, design)
>fit <- eBayes(fit)
The output is read out with the decimal places set to three. The number= argument can be 
omitted if the top ten is required as 10 is the default.
>options(digits=3)
>topTable(fit, number=10, adjust="fdrH)
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Appendix 4 Analysis of array data using NIA tool
The scanned images were stored as pairs of 16 bit tiff files. These were analysed using 
the program “Spot” from CSIRO following the instructions provided 
(http://www.cmis.csiro.au/iap/Spot/spotmanual.htm). The program was implemented on 
a LINUX machine with 4G RAM and run under R. Image files were analysed in batches 
corresponding to their scanning batch.
The data output as “.spot” files were imported into Limma and normalised within arrays 
by “Print tip group loess” and between arrays by “scale”.
Data were exported as M and A values. M is defined as log2(R/G) and A as 0.5(log2(R) 
+ log2(G)) where R is Cy5™ and G is Cy3™.
M=log2R-log2G
A=0.5(log2R+log2G)
log2G=log2R-M
log2G=2A-log2R
21og2G=2A-M
log2G=A-M/2
log2R=M+log2G
log2R=2A-log2G
21og2R=2A+M
log2R=A+M/2
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These values were then assembled into a tab delimited text file for entry into NIA 
anova. (http://lgsun.grc.nia.nih.g0 v/ANOVA/help.html#format The first row consists o f 
column headers. The first column has gene IDs which can he numerical or textual.))
For input into Cluster the ratio was calculated for each spot as 2A( log2(G) - log2(R)) in a 
tab delimited file.
Annotation was taken from the file NIA-15k-GeneID.tsv
The following pages show the settings used for the NIA anova analysis
NIA Array Analysis
& 0  http://stemcell.biosi.cf.ac.uk/
Getting Started Latest Headlines
Developed at the National Institute 
"  •  on A g ing (NIA/NIH), Laboratory o f  
—  Genetics. Baltimore MD
Public Data Sets I H open
Description of NIA Array Analysis tool
• General description
AjvfOVA
Principal Component'Analysis (PCA/SVD/biplot)
Download the latest 
Do your own data analysis
User login: 
Password:
|martin
Login |
You can log in as ''guest” or
Sign in to get a passw-ord (no restriction)
False discovery rate (FDR)
ANOVA with error variance correction 
3D PCA/SVD-biplot 
PC A import for experiment comparison 
Pattern matching 
Optional permutation test 
Server-based softw are
Related links
NLA Mouse Gene Index 
NLA 44K mouse array
SAM (significance analysis of microarravs)
T1GR array analysis software 
Microarray Data Analysis resources
Reference:
Sharov. A .A .. Dudckula. D.B.. Ko. M.S.H. 2005. A web-based 
tool for principal component and significance analysis of microarray 
data. Bioinformatics (submitted)
Report problems to Alexei Sharov (sharoval@ m ailjiih .vov) 
D o n e
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NIA Array Analysis Tool
HELP: General description of NIA Array Analysis Tool
Array join Tool (Windows) for building the input file from multiple scanner files (DOWNLOAD)
Upload Data FBe: | Browse... 1 Upload j see file format [~ Normalize T  SpUfcUQDMliZC
upload as: j Data name (use 1-word; if blank, * filename)
| None Log-transformation in input file | Computer guess 3  I Lower cutoff value
Select data file lo r analysis 
12802new Analysis j 
annotationforanova
View data | Delete file j
Bayesian 
50 3
0.0S zl 
10 3  
0.01 3
100 3
2-color arrays j J  
(-9999 
|-9999
| don't analyze reference j J  
[control
Descriptioo: |2B02new 
Array annotation view array I Add array 1
Threshold z-value to remove outliers 
Eiror model
Size of sliding window for averaging error variances
Proportion of highest variance values to be removed before variance averaging
Desirable degrees of freedom for Bayesian error model
FDR false discovery rate threshold
Number of permutations
Number of colors in the array
Minimum log-in tensity cutoff (-9999 = orate)
Maximum log-intensity cutoff (-9999 = none)
Include reference into ANOVA analysis 
Reference name 
N o cross-channel correction
Table of tfesues/experfcnents (see help) Show design 1 N data columns=|76
No. of re­
plications Name of tissue/experiment
1 4 ICM_8&hpc
2 6 ICM_10Shpc
3 6 DICM_136hpc
4 S D!CM180hpc
5 s EmEct_Dy6.5
6 6 EmbEctDyS.S
7 6 IM T.ll
8
Q
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O O O
Getting Started
ANOVA results
Us (0  http://stemcell.blosl.cf.ac.uk/cgi-bin/anova.cgi 
Latest Headlines
Search [ Term:
Results Results of ANOVA
Download 1 Input file 
Download | Means (significant genes only) 
Download | T1GR-MEV file (Stanford format)
In: JAM zJ
Co | Cluster tissues I-  Find specific genes 
| Significantly specific 
Minimum fold change: [1 3
| Plot the error function
Plot the dendrogram for replications
I Make correlation matrix
Principal Component Analysis (PCA)
F  Center valuesCovariance Matrix type for PCA 
4 Select the number of principal components
2 jd Fold-change threshold for clusters
0.7 Correlation threshold for clusters
9992 significant genes Genes to analyze
20% genes Gene number to display
PCA by | Probe ID 
Submit | Start PCA
zJ
Compare | IMT_11 3  with | EmbEctDy5.S 3
| Log-ratio 3  IWotf | Over-expressed genes | Under-expressed genes 
Use | FDR 3  Use 10.01 3  and fold-change threshold [1 3
Type (or paste) a probe. OR a column of probes. OR a column of gene symbols (if present in the annotation file). 
OR a table with 2 columns: tissue_name and expression (separated by tabs or "=")
If multiple probes, then the pattern is averaged. Only exact matches are found.
If a gene has multiple gene symbols, only the first one is considered.
| Probe ID
r  Plot genes listed above only
Annotation field
